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Abstract 
 
NMR spectroscopy of proteins with paramagnetic metal ions, first performed with 
metalloproteins, is a unique technique to obtain long-range distance information for 
three-dimensional structure determinations. This thesis focuses on developing 
applications of paramagnetic NMR spectroscopy, particularly pseudocontact shifts, in 
drug discovery. The two-component dengue virus NS2B-NS3 protease (NS2B-
NS3pro) from serotype 2 is a well-established drug target, but drug development has 
been hampered for many years by lack of structural information. In earlier work, 
pseudocontact shifts (PCSs) induced by lanthanide binding tags at multiple sites had 
successfully been used to determine the closed conformation of NS2B in the presence 
of a small inhibitor molecule. Subsequently, PCSs were used to prove that an 
unlinked construct of NS2B-NS3pro exists predominately in the closed conformation 
in solution, showing that the open conformation observed previously is an artefact 
generated by a covalent link between NS2B and NS3 (Paper 1). Next, PCSs generated 
for NS2B, NS3pro and bovine pancreatic trypsin inhibitor (BPTI) were used to show 
that the C-terminal segment of NS2B remains in the closed conformation in the 
presence of BPTI, correcting a crystallographic artefact (Paper 2). The work described 
in Papers 1 and 2 confirmed that the closed conformation of dengue virus NS2B-
NS3pro is the best model for structure-guided drug design. As the sensitivity of NMR 
spectra of dynamic proteins, such as the dengue virus protease, is compromised by 
excessive line broadening, alternative NMR tags were sought. O-tert-butyltyrosine 
incorporated in proteins proved to be an outstanding NMR probe for conformational 
studies of high-molecular-weight systems and measurement of submicromolar ligand 
binding affinities in one-dimensional 1H-NMR spectra without any isotope labelling 
(Paper 3). A tert-butyl probe was also introduced into a tightly binding lead 
compound against the dengue virus protease. Measurement of ligand PCSs from 
intense intramolecular NOESY cross-peaks with the tert-butyl group allowed 
positioning of the ligand on the protein with respect to the paramagnetic centre, while 
strong intermolecular NOEs validated the structural model of the complex established 
with the use of PCSs (Paper 4). In summary, the paramagnetic NMR approach, 
demonstrated on the dengue virus NS2B-NS3 protease, presents a broadly applicable 
and elegant way for structure-guided drug design at atomic resolution.  
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Introduction 
 
1.1 Biological NMR spectroscopy  
 
Nuclear magnetic resonance (NMR) spectroscopy can determine three-dimensional 
(3D) structures of biological macromolecules in solution at atomic resolution and thus 
presents a structure determination method complementary to crystallography 
(Wüthrich 1990). Nowadays, high-resolution 3D structures of macromolecular 
systems are most often obtained by X-ray diffraction or cryo-electron microscopy 
(EM), whereas NMR spectroscopists tend to focus more on systems, which are not 
amenable to atomic-resolution studies by other methods or subject to artefacts (Sekhar 
and Kay 2013). 
 
Single-crystal structures present frozen snapshots of protein states that sometimes do 
not reflect all physiologically relevant conformations. In addition, dense packing in a 
crystal lattice can produce crystallization artefacts (Carugo and Argos 2008; Chen et 
al. 2014). In contrast, the NMR method is uniquely suited for studies of protein 
dynamics (Skora et al. 2013; Saio et al. 2015), low-affinity interactions (Okude et al. 
2015), denaturation by heat or pressure (Rochdi et al. 2000; Nucci et al. 2014; Maeno 
et al. 2015) , pH effects (Zong et al. 2004), effects from paramagnetic centres in 
metalloproteins (Ubbink et al. 2002; Bertini et al. 2005; Carruthers et al. 2014) and 
other properties that are best studied under near-physiological conditions.  
 
In particular, NMR spectroscopy is widely used in drug discovery approaches 
(Diercks et al. 2001; Pellecchia et al. 2002), e.g. to screen compound libraries against 
protein targets (Kim and Wyss 2015; Pfaff et al. 2015). Even in the case of weak 
binding, chemical shift changes of either the protein targets or inhibitors can provide 
evidence for interactions (Viegas et al. 2011). In this thesis, Paper 3 describes 
examples, where the chemical shift change of a single intense NMR resonance in a 
protein serves as evidence of ligand binding either in slow exchange or in the fast 
exchange regime, establishing a rapid method to detect ligand binding in proteins in 
presence or absence of a metal ion and facilitating binding affinity measurements for 
large molecular targets (>30 kDa) (Chen et al. 2015). Conventionally, analysis of 
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ligand binding modes relies on analysis of the chemical shift perturbations (Shuker et 
al. 1996; Medek et al. 2000; Meyer and Peters 2003; Aguirre et al. 2014) and nuclear 
Overhauser effects (NOEs) (Breeze 2000; Eichmüller et al. 2001) observed in protein 
NMR spectra to yield detailed information about the binding sites. However, these 
methods rely on a large number of sequence-specific resonance assignments for the 
target proteins. Furthermore, line broadening effect and signal overlapping often make 
the analysis of intermolecular NOESY cross-peaks and chemical shift perturbations 
difficult on 2D spectra. A convenient way of detecting intermolecular NOEs and 
achieving site-specific resonance assignments in a dynamic protein target is described 
in Paper 4, which does not depend on a large number of resonance assignments.  
 
High molecular weights present a barrier for studies by NMR spectroscopy (Wagner 
1993; Riek et al. 2002). This problem has been reduced significantly by the 
development of high-field magnets (Markiewicz et al. 1996; Lin et al. 2000; 
Markiewicz et al. 2006), rapid data collection and processing methods for 
multidimensional NMR experiments, including automated projection spectroscopy 
(Hiller et al. 2005; Hiller and Wider 2011) and sparse sampling methods (Rovnyak et 
al. 2004; Hyberts et al. 2012; Mobli and Hoch 2014), dynamic nuclear polarisation 
(DNP) enhancement (Ardenkjær-Larsen et al. 2003; Maly et al. 2008; Idehara et al. 
2015), magic angle spinning (MAS) (Medek et al. 1995; Griffin 1998; Comellas and 
Rienstra 2013) and stable isotope labelling (Yamazaki et al. 1998; Ozawa et al. 2004; 
Kainosho et al. 2006; Tugarinov et al. 2006; Ruschak and Kay 2012). Pushing the 
molecular weight limits has always been a motivating goal for NMR spectroscopists. 
For example, it has been shown that selectively protonated methyl groups in 
perdeuterated proteins combined with methyl-TROSY allow studies of supra-
molecular systems up to 1 MDa (Sprangers and Kay 2007; Kay 2011). Paper 3 
presents a highly sensitive NMR probe that is based on an unnatural amino acid and 
can be detected in high molecular weight systems (>300 kDa) without any isotope 
labelling (Chen et al. 2015).  
 
Over more than 20 years and importantly for this thesis, NMR studies on 
metalloproteins containing paramagnetic metal ions have stimulated the development 
of paramagnetic NMR spectroscopy (Bertini et al. 1993; Banci et al. 1994; Banci et al. 
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1996; Banci et al. 1997). Specific applications and software have been developed to 
make best use of the structural information provided by paramagnetic centres.  
 
1.2 Paramagnetic NMR spectroscopy 
 
1.2.1 Paramagnetic effects 
 
The magnetic moment of unpaired electrons is almost three orders of magnitude 
larger than that of protons. In a static magnetic field, magnetic dipolar fields 
generated by unpaired electrons are modulated by molecular re-orientation and thus 
perturb nuclear spins. Paramagnetic NMR spectroscopy takes advantage of the 
paramagnetism originating from unpaired electrons to study molecular structures and 
dynamics with respect to the paramagnetic centres.  
 
Paramagnetism causes pronounced long-range paramagnetic effects, which are 
manifested in NMR spectra as changes in chemical shifts, line widths and coupling 
constants. Pseudocontact shifts (PCS), paramagnetic relaxation enhancements (PRE), 
cross-correlation between Curie spin and 1H-15N dipole-dipole relaxation (CCR) and 
residual dipolar couplings (RDC) are four paramagnetic effects studied widely (Figure 
1). These paramagnetic effects can be described by equations 1-7:  
i) PCS (Bertini et al. 2002): 
                    (1) 
ii) PRE (Vega and Fiat 1976): 
                                                  (2) 
                                (3) 
iii) CCR (Ghose and Prestegard 1997): 
                                (4) 
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                        (5) 
iv) RDC (Tolman et al. 1995; Barbieri et al. 2002): 
                  (6) 
                                  (7) 
 
where Δχax and Δχrh are the axial and rhombic components of the anisotropic 
component of the magnetic susceptibility (χ) tensor; r, θ and φ are the polar 
coordinates of the nuclear spin with respect to the metal centre; τr is the rotational 
correlation time; ωH is the proton Larmor frequency; µ0 is the vacuum permeability; Β0 
is the magnetic field; γΗ and γN are the proton and nitrogen magnetogyric ratios; gJ is 
the g-factor; µΒ is the Bohr magneton; J is the total spin moment; kB is the Boltzmann 
constant; T is the temperature; ћ is Planck’s constant divided by 2π; Θ and Φ are the 
polar angles of an internuclear vector with respect to the principal axes of the χ 
tensor; S is the order parameter of the molecular alignment (for backbone amide 
protons, S2 is often set to 0.9 (Pintacuda et al. 2004)); rNH is the distance between N 




Figure 1. Geometric information contained in the four paramagnetic effects. (a) 1HN 
pseudocontact shift (PCS), (b) paramagnetic relaxation enhancement (PRE), (c) cross-
correlation between Curie and 1H-15N dipole-dipole relaxation (CCR), (d) residual 
dipolar coupling (RDC) between a 1H and a 15N spin. Reproduced from Pintacuda et 
al. (2004).  
As the chemical shifts of a protein are sensitive to the presence of a bound metal ion 
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regardless of whether it is diamagnetic or paramagnetic, paramagnetic effects are 
necessarily measured as differences in NMR spectra recorded for the target molecule 
in its paramagnetic and diamagnetic states (Otting 2010). 
 
1.2.2 Unique advantages of PCSs 
 
The great attraction of paramagnetic effects lies in their capability of providing long-
range structural restraints. Unlike PRE, CCR and RDC (which increase with field 
strength), the PCS effect is field independent, if measured in ppm (Bertini et al. 2002; 
Otting 2008). In contrast to RDCs, PCSs provide information about the distances r of 
nuclear spins from the metal centres (Otting 2008). The r-6 distance dependence of 
PREs is much stronger than the r-3 distance dependence of PCSs (Equations 1 and 2). 
Therefore, PREs decay much more rapidly than PCSs with increasing distance of 
nuclear spins from the metal centre. Even though nuclear spins near the paramagnetic 
centre are easily broadened beyond detection, nuclear spins that are sufficiently far 
from the metal centre can deliver easily measurable PCSs with little PREs. PCSs are 
only little sensitive to small translational movements of the metal ions or small-
amplitude motions of the nuclear spins, due to the relatively long distance from the 
metal centre. In addition, PCSs can be measured and analysed even for low-affinity 
protein-ligand complexes, even if they are averaged due to incomplete complex 
formation (Crowley and Ubbink 2003; John et al. 2006). Finally, PCSs can be 
measured for nuclear spins over 40 Å away from the paramagnetic metal centre 
(Biekofsky et al. 1999; Allegrozzi et al. 2000). All these properties make PCSs a 
unique and powerful tool. 
 
The measurement of PCSs is simple, as they are measured as the chemical shift 
differences between paramagnetic and diamagnetic states. Following superimposition 
of the 2D NMR spectra of diamagnetic and paramagnetic samples, the diamagnetic 
peak and its corresponding shifted paramagnetic cross-peaks, originating from the 
same nuclear spin, can be connected by mostly straight lines. Most accurate results 
are obtained for nuclear spins with little chemical shift anisotropy (CSA), as the weak 
molecular alignment in the magnetic field arising from non-vanishing Δχ tensors 
combined with CSA can contribute small chemical shift changes in the paramagnetic 
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sample that do not stem from PCSs (John et al. 2005).   
 
Experimental PCSs present extraordinarily powerful restraints for 3D structure 
determination. The power of PCSs lies in the Δχ tensors fitted from the limited 
number of observed PCSs. Δχ tensors can be characterized by 8 parameters, which 
include 3 parameters describing the position of the metal ion (x, y and z coordinates), 
3 parameters describing the orientation of the Δχ tensors with respect to the molecular 
coordinates (Euler angles α, β and γ) and 2 parameters for the axial and rhombic 
components of the anisotropy tensor (Δχax and Δχrh). PCS isosurfaces, which depict 
the coordinates for which Equation 1 predicts the same PCS values, can be plotted 
onto the 3D structure of a target protein to give an alternative representation of a Δχ 
tensor and its orientation with respect to the protein (Figure 2). The Δχ tensor and its 
associated PCS isosurfaces correspond to a coordinate system, which is tied to the 
protein molecule and its metal ion centre (Otting 2010). Theoretically, measurement 
of eight PCSs is sufficient to fit the Δχ-tensor parameters. Once a Δχ tensor has been 
obtained, its coordinate frame can be used to interpret other PCSs, which were not 
included in the fit, for example to guide the structure modelling using other nuclear 
spins for which PCSs are available. Paper 2 in this thesis presents an example of this 
methodology. Notably, any small structural variation of the protein or mobility of the 
metal ion can lead to discrepancies between the experimental PCSs and the predicted 
PCSs, which needs to be taken into account in the analysis. 
 
Figure 2. Isosurfaces depicting the PCSs induced by Dy3+ are plotted on a ribbon 
representation of a crystal structure. Blue and red surfaces identify the spatial 
locations of positive and negative PCSs of ±3, ±1.5 and ±0.5 ppm, respectively. The 
PCS isosurfaces constitute a representation of the Δχ tensors. Reproduced from Otting 
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Lanthanides comprise fifteen metallic chemical elements, all of which form trivalent 
cations (Ln3+) and have unpaired electrons in f-orbitals (except lanthanum and 
lutetium). In the past, lanthanide ions have been used to introduce anisotropic 
magnetic susceptibilities in diamagnetic molecules partly because many of them 
exhibit very large PCS effects. The particular magnetic properties of Ln3+ ions make 
them powerful tools to induce paramagnetic effects in NMR spectra.  
 
Figure 3. Paramagnetic properties of paramagnetic and non-radioactive lanthanide 
ions. Representative PCS isosurfaces are plotted at ±5 ppm (positive PCS in red and 
negative PCS in blue), using tensors reported by Bertini et al. (2001). The radii of the 
yellow spheres indicate the distances from the metal ion at which 1H NMR signals of 
macromolecules with a rotational correlation time of 15 ns broaden by 80 Hz due to 
PRE at a magnetic field strength of 18.8 T. Typical electronic relaxation times 
representative for the same field strength are indicated underneath. Reproduced from 
Pintacuda et al. (2007).             
 
The magnetic properties of lanthanide ions are well understood. Different lanthanide 
ions display very different magnitudes of the χ tensor and its anisotropy (Figure 3) 
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(Bleaney 1972; Bertini et al. 2001). Based on the magnitude of Δχ tensors, Dy3+, Tb3+ 
and Tm3+ can be classed, somewhat arbitrarily, as highly paramagnetic, Er3+ and Yb3+ 
as moderately paramagnetic, and Eu3+, Ce3+ and Sm3+ as little paramagnetic (Otting 
2008). The magnitudes of the Δχ tensors of Dy3+ and Tb3+ are similar, but Dy3+ tends 
to cause more severe PRE effects than Tb3+. Usually, the signs of the Δχ tensors for 
Tb3+ and Tm3+ are opposite. Therefore, Tb3+ is often used in combination with Tm3+ 
(de la Cruz et al. 2011; Graham et al. 2011). As a diamagnetic reference, other 
trivalent diamagnetic metal ions, such as Sc3+, La3+, Y3+ and Lu3+, can be used. Due to 
the similar ionic radius of Y3+ compared with Tb3+ and Tm3+, Tb3+-Y3+-Tm3+ is the 
diamagnetic and paramagnetic ion combination used most frequently in the 
paramagnetic studies of this thesis to generate PCSs.                      
 
1.2.4 Introduction of lanthanides onto proteins 
 
Lanthanides are not readily available biologically and have not yet been found to 
occur naturally in, e.g., proteins. “Natural” lanthanide binding sites sometimes can be 
generated by the displacement of different metal ions (for example Ca2+ or Fe3+) from 
the metal binding site of a metalloprotein (Figure 4C). In this case, the binding of a 
lanthanide ion can be achieved simply by titrating the corresponding lanthanide 
chloride or lanthanide sulfate into a solution of the metal-free target protein.  
 
A famous example of metal replacement for paramagnetic NMR studies is the Ca3Ln 
complex of vertebrate calmodulin (CaM), where the mutation N60D at site II of the 
four natural calcium-binding sites achieves selective and site-specific lanthanide 
binding even in the presence of excess calcium (Bertini et al. 2003). The introduction 
of paramagnetic lanthanides stimulated extensive paramagnetic NMR studies on the 
Ca3Ln-CaM complex and various complexes with different peptides (Bertini et al. 
2003; Bertini et al. 2004; Bertini et al. 2007; Russo et al. 2013). However, in general 
the lanthanide ions have to compete with the naturally occurring metal, which often 
results in low specificity of lanthanide labelling. In addition, not all proteins have 
natural binding sites that can accommodate lanthanide ions. Therefore, different 
methods for lanthanide tag attachments to proteins were developed (Figure 4) (Liu et 
al. 2014). 
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Figure 4. Approaches for introducing lanthanide ions on target proteins. (A) 
Synthetic tags can be linked to a cysteine residue or an unnatural amino acid. (B) A 
lanthanide binding peptide can be engineered genetically into a protein. (C) The metal 
ion of a metalloprotein can be replaced by a lanthanoid. Reproduced from Liu et al. 
(2014).  
 
1.2.4.1 Lanthanide binding peptides 
 
Early on, an “EF-hand” motif derived from calcium binding proteins consisting of 12 
amino acid residues fused to the N-terminus of a membrane protein was shown to 
enable specific lanthanide binding (Figure 4B) (Ma and Opella 2000). Later, 
lanthanide binding peptides (LBPs), which are short peptides modified to improve the 
affinity for lanthanide ions (Franz et al. 2003; Nitz et al. 2003; Nitz et al. 2004), were 
appended to the N-terminus of ubiquitin to obtain better alignment tensors for RDC 
studies (Wöhnert et al. 2003). Obviously, fusion of LBPs at the N- or C-terminus 
limits the number of possible attachment sites to two.  
 
It is important to note that movement of the metal ion with respect to the protein will 
lead to an averaged tensor. Therefore, tag mobility is problematic, especially when 
PCSs as well as PREs are interpreted (Ma and Opella 2000; Wöhnert et al. 2003). An 
improved LBP was later anchored to the target protein via a disulfide bridge and an 
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N-terminal fusion; it was shown that this two-point anchoring yielded two- to three-
fold larger anisotropic paramagnetic effects due to better defined localisation of the 
LBPs and their bound metal ions (Saio et al. 2009; Saio et al. 2010). A double-armed 
LBP was also successfully engineered into the turn of two β strands to immobilize 
lanthanides (Barthelmes et al. 2010; Kobashigawa et al. 2012). However, LBPs 
typically contain between 12 and 20 amino acid residues. Insertion of LBPs can thus 
easily perturb the protein structure in their vicinity.  
 
1.2.4.2 Chemical lanthanide tags 
 
A more general approach for the introduction of lanthanide ions involves chemically 
synthesised metal chelators. Key aims in lanthanide tag design are to improve the 
affinity of lanthanide ions and also reduce tag mobility. The more rigid the metal ion, 
the larger anisotropic paramagnetic effects can be induced in the protein. The crystal 
structures of the protein targets, which are frequently known prior to NMR study, 
make it possible to select and engineer specific sites for chemical lanthanide tags, 
which can be ligated to a single cysteine residue or unnatural amino acid. 
 
EDTA, DTPA, TAHA and DOTA have been shown to produce suitable Ln3+ 
chelating ligands (Cotton 2013). A number of synthetic lanthanide tags have been 
developed to enable site-specific introduction of lanthanide ions (Figure 5) (Su and 
Otting 2010; Liu et al. 2014). Similar to lanthanide binding peptides, chemical 
lanthanide tags can be introduced via single and double-arm tethers. In the case of 
synthetic lanthanide tags, however, single-arm attachment can be more attractive by 
offering more options for attachment and the possibility to use an unnatural amino 
acid for attachment to avoid mutations of naturally occurring cysteines. Lanthanide 
tags attached via a single tether produce effective Δχ tensors, which can describe 
PCSs and RDCs of protein nuclear spins in the presence of considerable tag mobility 
(Shishmarev and Otting 2013). In the case of the C1 tag (10; Figure 5), three chiral 
amide pendants are sufficient to provide an 8-coordinate lanthanide binding site and 
maintain a single enantiomeric species to produce a single set of peaks in the NMR 
spectrum of the protein (Graham et al. 2011). The C1 tag and its opposite enantiomer, 
named C2 tag, have successfully been used in different protein conformation studies 
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(de la Cruz et al. 2011; Yagi et al. 2013; Chen et al. 2014; de la Cruz et al. 2014). Due 
to the sizeable PCSs induced by the C2 tag (de la Cruz et al. 2011), it was the tag of 
choice for the dengue virus protease studies in this thesis.  
 
Figure 5. Chemical structures of lanthanide tags. (1-3) EDTA-based probes: S-(2-
pyridylthio)-cysteaminyl-EDTA, EDTA-CA-MTS and ent-6; (4) TAHA based probe: 
Cys-Ph-TAHA; (5) DTPA-based probe: CLaNP1; (6-11) DOTA-based probes: 
CLaNP3, CLaNP7, DOTAM8, C1 and C4; (12) pyridine-core probe: 4VPyMTA. 
Reproduced from Liu et al. (2014).  
 
1.2.5 Assignment of paramagnetic NMR spectra 
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The measurement of PCSs requires the resonance assignment of the paramagnetic 
NMR spectra. In practice, assigning paramagnetic NMR spectra can be hard because 
NMR signals near the paramagnetic ion centre are significantly broadened or even 
missing due to dipole moment of the metal ion. Although it is not necessary to 
measure PCSs for every single nuclear spin in the system of interest, the accuracy of 
Δχ tensors determination increases greatly, if more than eight experimental PCSs are 
available. Therefore, it is essential to get as many initial experimental PCS data as 
possible. A robust Δχ-tensor fit should be insensitive with regard to the deletion or 
addition of some PCS data. 
 
Even though unambiguous PCS assignments could be obtained using conventional 3D 
NMR spectra (Russo et al. 2013), such experiments have limited sensitivity. An 
alternative and rapid assignment strategy is to use 15N-HSQC spectra to transfer the 
assignment of cross-peaks from the diamagnetic to the paramagnetic state of the target 
protein (Figure 6) (Pintacuda et al. 2004). This method requires no 13C labelling and 
no NMR data other than a limited number of assigned 15N-HSQC cross-peaks. 
Nuclear spins, which are close in space compared to their distances from the 
paramagnetic centre such as the amide protons and amide nitrogens of backbone NH 
groups, exhibit similar PCSs. 15N-HSQC cross-peaks are thus displaced by similar 
PCSs in both the 1H and 15N dimension, resulting in a diagonal shift from their 
diamagnetic position (Allegrozzi et al. 2000; Bertini et al. 2001). For resolved cross-
peaks, the pairs of diamagnetic and paramagnetic peaks can thus be identified 
unambiguously by simple superimposition of the 15N-HSQC spectra. For NH groups 
in the vicinity of the paramagnetic centre, PCSs can be large and the shifts may no 
longer align along a diagonal line (John et al. 2007). In this situation it is helpful to 
superimpose three 15N-HSQC spectra, recorded with two different paramagnetic ions 
and one diamagnetic ion. If the Δχ tensors of the two paramagnetic ions are 
proportional to each other, it will be possible to draw a parallel or near-parallel line 
through the three cross-peaks to correlate the paramagnetic and the diamagnetic peaks 
(Su et al. 2009b; Man et al. 2010). Combinations of paramagnetic lanthanide ions 
with opposite sign of Δχ tensor are favoured, since this will position the two 
paramagnetic peaks on either side of the diamagnetic peak. In connecting the three 
cross-peaks, one should also consider the relative magnitude of the Δχ tensors as an 
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aid in the assignment. For example, we frequently use tags loaded with Tb3+, Tm3+ 
and Y3+, where the Δχ tensors of Tb3+ tags tend to be larger and of opposite sign than 
the Δχ tensors of Tm3+ tags. 
 
Figure 6. PCSs measured for a protein labelled with 15N-Leu. The diamagnetic and 
paramagnetic spectra recorded with La3+ and Tb3+ were plotted in black and red, 
respectively. Reproduced from Pintacuda et al. (2007). 
 
1.3 E. coli cell-free protein synthesis and genetically encoded unnatural amino 
acids for NMR spectroscopy 
 
1.3.1 E. coli cell-free protein synthesis 
 
Protein synthesis can be achieved in three ways, including chemical synthesis, in vivo 
expression and cell-free protein synthesis. Cell-free protein synthesis systems can 
synthesize proteins with high speed (Pavlov and Ehrenberg 1996) and accuracy 
(Kurland 1982). In cell-free protein synthesis systems, protein is produced using 
crude lysate from cells to provide the translational machinery, accessory enzymes, 
tRNA, and cofactors in combination with added RNA template, amino acids and 
energy supply (Nirenberg and Matthaei 1961). 
 
Cell extracts used in cell-free synthesis systems can be derived both from prokaryotic 
(Escherichia coli) and eukaryotic (e.g. wheat germ, rabbit reticulocyte lysate, insect 
cells, HeLa cells, Xenopus eggs) origin. Since the mid-nineteenth century, cell-free 
systems have been developed extensively (Figure 7) to increase the protein yields by 
modification and improvement of the reaction conditions. Coupled 
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transcription/translation from DNA templates has been developed (DeVries and 
Zubay 1967; Kigawa and Yokoyama 1991) as well as dialysis methods (Spirin et al. 
1988; Kigawa and Yokoyama 1991; Davis et al. 1996; Kim and Choi 1996; Kigawa et 
al. 1999), alternative energy regenerating systems (Kim et al. 1996; Kigawa et al. 
1999) and optimized cell extract preparation protocols (Kigawa et al. 2004).  
 
 
Figure 7. Principal composition of cell-free translation systems. Reproduced from 
Kigawa et al. (1999).  
 
While different cell-free systems have specific advantages, the E. coli-based system is 
most commonly used because E. coli grow quickly, are well characterised, allow cost-
effective extract preparation, and generally produce high recombinant protein yields. 
Milligram quantities of proteins with stable isotope labelling and/or unnatural amino 
acids (UAAs) can be produced by E. coli based cell-free protein synthesis, which is 
sufficient for NMR studies. In particular, E. coli-based cell-free protein synthesis 
offers inexpensive access to selectively isotope labelled protein. Depending on the 
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requirements of NMR experiments, single or combinatorial isotope labelling can be 
obtained by replacing unlabelled amino acids in the amino acid mixture with isotope-
labelled ones (Kigawa et al. 1995; Ozawa et al. 2004; Etezady-Esfarjani et al. 2007; 
Apponyi et al. 2008). Isotope scrambling can be efficiently suppressed by inhibiting 
5’-phosphate (PLP) enzymes (Su et al. 2011). For example, in this thesis, partially 
deuterated NMR samples were easily made in an overnight cell-free expression, 
which highlights the time saving achievable by cell-free synthesis (Paper 4).  
 
1.3.2 Genetically encoded unnatural amino acids 
 
Genetic incorporation of UAAs into proteins also has become popular with the arrival 
of orthogonal aminoacyl-tRNA synthetase (aaRS)-amber suppressor tRNA 
(tRNACUA) pairs (Figure 8) (Furter 1998; Wang and Schultz 2001; Neumann et al. 
2008). The most extensively used UAA incorporation system is based on suppressor 
tRNA recognising the amber stop codon TAG in E. coli by an orthogonal 
tRNACUATyr/TyrRS pair derived from Methanocaldococcus jannaschii (Liu and 
Schultz 2010; Hoesl and Budisa 2012).  
 
In living cells, the incorporation of an UAA is usually achieved in response to a TAG 
stop codon in competition with termination of translation by the endogenous release 
factor 1 (RF1), which can result in low productivity of full-length protein particularly 
for multiple incorporations and for in-cell approches (Liu et al. 2007; Lin and Wang 
2008). Ueda and co-workers reported that, in a PURE cell-free system reconstituted 
from purified recombinant protein factors (IF1, IF2, IF3, EF-G, EF-Tu, EF-Ts, RF1, 
RF3, RRF, 20 aaRS, MTF and T7 RNA polymerase), omission of RF1 allowed 
efficient incorporation of a UAA (Shimizu et al. 2001). Complete removal of RF1 
from the S30 extract derived from E. coli cells successfully suppresses the production 
of truncated products; moreover, by adding purified orthogonal amber suppressor 
tRNA/aaRS pairs into the standard cell-free system, one UAA can be incorporated 
into multiple sites with high yields (Loscha et al. 2012).  
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Figure 8. Site-specific incorporation of an unnatural amino acid into proteins. 
Reproduced from Lin et al. (2008).  
 
In an alternative approach, many researchers attempted to create RF1-free E. coli 
strains to facilitate incorporation of UAAs. In the rEc.E13.ΔprfA strain, the TAG 
codons of seven essential genes were reassigned to allow their expression in the 
absence of RF1, while other house-hold proteins, requiring UAG stop signals, were 
synthesized with unnecessary read-through peptide tails terminated by in-frame UAA 
or UGA codons (Mukai et al. 2010). In the JX33 strain, RF2 was engineered to 
recognise the TAG stop codon, but this renews the competition of a release factor 
with suppressor tRNA (Johnson et al. 2011). Ultimately, the genomically recoded E. 
coli strain C321.ΔA was successfully constructed, in which all TAG stop codons were 
replaced and RF1 was deleted to abolish UAG-mediated translation termination 
(Lajoie et al. 2013). These RF1-depleted strains have successfully been used for the 
incorporation of UAAs, achieving enhanced suppression in response to UAG or 
UAGN codons both in vivo (Chatterjee et al. 2014; Schmidt et al. 2014; Lim et al. 
2015; Pirman et al. 2015; Wilkins et al. 2015) and in cell-free synthesis setups (Hong 
et al. 2014; Chemla et al. 2015; Li et al. 2015; Sullivan et al. 2015). For NMR 
applications, UAAs containing reactive groups (Loh et al. 2013; Abdelkader et al. 
2016) or acting as specific NMR probes, e.g. by introducing 19F (Jackson et al. 2007; 
Shi et al. 2011; Li et al. 2013; Yang et al. 2015), 13C/15N (Jones et al. 2010) or tert-
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butyl group labels (Chen et al. 2015) have successfully been incorporated into many 
proteins.  
 
The ongoing development of both cell-free protein synthesis and genetic 
incorporation of UAAs will further broaden their applications in NMR spectroscopy. 
In particular, the unnatural amino acid O-tert-butyl tyrosine, incorporated both by in 
vivo and in vitro techniques, proved to deliver a highly sensitive NMR probe for high-
molecular-weight systems and measurement of sub-micromolar binding affinities, 
which is described in Paper 3 (Chen et al. 2015).  
 
1.4 Software supporting the experimental approaches 
 
Computational methods play an important role in paramagnetic NMR studies, for 
example to help with the selection and design of tagging sites, as well as the analysis 
of experimental data.  
 
1.4.1 Mutation guided by PyMOL  
 
Point mutation or site-directed mutagenesis is widely used to support resonance 
assignments by NMR spectroscopy and to produce a single site for tagging with a 
lanthanide complex or for UAA incorporation. In order to increase the success rate of 
lanthanide tagging, it is of great importance to predict the outcome of a mutation 
based on the protein structure. For many protein targets, crystal structures, NMR 
structures or computational models are available. Crystal structures tend to be the best 
choice because they provide the most accurate atomic positions. 
 
PyMOL is a molecular visualization software, built on an open-source platform. The 
mutagenesis wizard function in PyMOL has been developed to display the effect of a 
mutation prior to experiment. By inspecting the rotamers of specific amino acid 
substitutions in PyMOL, one can gain an idea about possible van der Waals violations 
and the possible χ1 angles compatible with the site-directed mutagenesis or unnatural 
amino acid incorporation. 
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1.4.2 Δχ-tensors fitting and PCS prediction by Numbat 
 
For the situation where the 3D structure of the protein is known, several integrated 
software tools have been developed to determine the Δχ tensors from PCSs, including 
Fantasia (Banci et al. 1996), Fantasian (Banci et al. 1997), Platypus (Pintacuda et al. 
2004), Echidna (Schmitz et al. 2006), Xplor-NIH (Schwieters et al. 2003; Schwieters 
et al. 2006) with PARA restraint (Banci et al. 2004), GROMACS (Van Der Spoel et 
al. 2005) with an implementation of orientation restraints (Hess and Scheek 2003) and 
DYANA (Güntert et al. 1997) with PSEUDYANA module (Banci et al. 1998). All 
these programs are very powerful and capable of doing much more than fitting Δχ 
tensors to protein structures, making them relatively cumbersome to use. The program 
Numbat (New User-friendly Method Built for Automatic Δχ-Tensor determination) is 
designed for the determination of Δχ tensors and metal ion position in an easy and 
user-friendly way (Schmitz et al. 2008). 
 
The input files for Numbat are simply pdb files that comprise the atomic coordinates 
of the protein and text files (with the extension .npc) containing the PCS data. Two 
particularly helpful features of Numbat include PCS prediction and a combined fit 
using multiple PCS data sets obtained from different samples with different metal ions 
located at the same site. Fitting the metal position using PCS data sets from multiple 
different metals at the same tagging site improves the accuracy of the fitting. This 
approach helps to overcome limitations arising from small numbers of PCSs available 
in each data set. The PCS prediction can be done automatically for all atoms after 
fitting of the Δχ tensors. The quality of the fitting can easily be evaluated by the 
correlation between the experimental and calculated PCS values. The PCS predictions 
made for atoms, for which PCSs are not provided in the input, are useful to guide 
additional PCS assignments (de la Cruz et al. 2011) or to validate the fit by 
comparison with the experimental PCSs that are not included in the fit (described in 
Paper 2) (Chen et al. 2014). 
 
1.4.3 Δχ-tensors fitting and structure calculation by PCS-Rosetta and GPS-Rosetta 
 
A breakthrough in 3D structure determinations of proteins was obtained by Shen et al. 
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(2008) who developed a protocol that combines the structure prediction program 
Rosetta with experimental 13Cα, 13Cβ, 13C’, 15Ν, 1Hα and 1HN NMR chemical shifts to 
assist in the initial fragment selection step of Rosetta. The resulting program, CS-
Rosetta, has been shown to successfully yield structures closely similar to X-ray or 
NMR structures determined primarily from nuclear Overhauser effects (NOEs) (Shen 
et al. 2008). In a later step, PCS-Rosetta was developed, which incorporates the long-
range distance information inherent in PCSs in the fragment assembly step to fit Δχ 
tensors and thus yield models in agreement with experimental PCSs. This was shown 
to improve the yield of near-native structures over CS-Rosetta as measured by Cα 
rmsd values to the target structures (Schmitz et al. 2012). Recently, PCS-Rosetta was 
developed further into a version called GPS-Rosetta, which uses a similar algorithm 
as PCS-Rosetta but accepts amide proton PCSs generated by paramagnetic centres at 
multiple sites (Yagi et al. 2013). Remarkably, GPS-Rosetta can determine complete 
3D structures of proteins from backbone amide PCSs only, which can readily be 
measured in 15N-HSQC spectra (Pilla et al. 2015). GPS-Rosetta has also proved a 
powerful tool for the determination of protein-ligand complexes, which is described in 
Paper 4. 
 
1.5 A two-component drug target: the dengue virus NS2B-NS3 protease  
 
The four serotypes of dengue virus (DENV) constitute most significant mosquito-
borne viral pathogens. Each of the four DENV serotypes produces acute, self-limited 
infections. The first infection with any of the serotypes typically produces a mild 
fever, rash or muscle/joint pain, and patients subsequently gain a lifelong immunity to 
that serotype. A second infection by another serotype, however, can cause deadly 
diseases due to dengue haemorrhagic fever and shock syndrome (DHF/DSS). It is 
estimated that there are 390 millions new dengue infections per year, of which 
roughly 96 million produce clinically apparent symptoms (Bhatt et al. 2013).  
 
Recent reports of phase IIb and III trials with the candidate dengue vaccine CYD-
TDV indicate that the vaccine is more serotype-specific than hoped, providing only 
limited protection against dengue 2 and no effective protection for children below the 
age of six (Sabchareon et al. 2012; Capeding et al. 2014; Villar et al. 2014). Drugs 
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against dengue are thus still of undiminished interest. As evidenced by the clinical 
availability of ten human immunodeficiency virus (HIV) protease inhibitors (PIs) (De 
Clercq 2009) and two hepatitis C virus (HCV) PIs (Kwong et al. 2008), viral 
proteases are proven drug targets, thus making the DENV protease one of the most 
attractive drug targets to overcome dengue.   
 
1.5.1 Roles of NS3pro and the NS2B cofactor 
 
In the polyprotein translated from the DENV genome (Figure 9), the N-terminal 180 
amino acids of NS3 constitute a protease domain (NS3pro), which mediates the 
cleavage at several protein boundaries, including capsid protein/precursor of the viral 
membrane protein (prM), NS2A/NS2B, NS2B/NS3, NS3/NS4A, NS4A/NS4B and 
NS4B/NS5 junctions (Falgout et al. 1991; Cahour et al. 1992; Amberg and Rice 1999; 
Muñoz-Jordán et al. 2005). Deletion of NS2B abolishes the NS3 protease activity 
(Falgout et al. 1991) and further study revealed that the conserved hydrophilic domain 
of 40 amino acids from NS2B, with deletion of its hydrophobic region, is essential for 
the proteolytic activity of NS3pro (Falgout et al. 1993; Clum et al. 1997). Thus, the 
dengue virus NS3pro in complex with its NS2B cofactor was established as an 
attractive therapeutic target for the rational design of dengue drugs (Yusof et al. 2000; 
Leung et al. 2001). 
 
Figure 9. Schematic diagram of the DENV genome organization and polyprotein 
processing. The top depicts the viral genome including the 5’-cap, 5’UTR, the 
structural and non-structural protein coding regions, and the 3’UTR. The bottom 
shows the genome-translated polyprotein, which is processed by the viral NS2B/NS3 
protease, host signalases and unknown proteases. C, prM and E denote the capsid 
protein, precursor of the viral membrane protein, and envelope protein on the viral 
surface, respectively. Reproduced from Lim et al. (2013).  
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The proteases from all four serotypes of DENV share high sequence identity as well 
as similar substrate specificity (Li et al. 2005). As infection by DENV2 has been 
reported to be more serious than the other three serotypes (Vaughn et al. 2000), 
DENV2 NS2B-NS3pro has become the target of particularly intensive efforts in drug 
development. The construct that used in this thesis consists of 47 residues from 
DENV2 NS2B, a cleavable linker (EVKKQR) and 185 residues from DENV2 
NS3pro (de la Cruz et al. 2014). 
 
1.5.2 Structural studies of dengue virus NS2B-NS3pro 
 
Molecular structure determination plays an important role in the structure-based 
strategies for drug discovery (Kuntz 1992). To understand the role of the NS2B 
cofactor in DENV NS3pro activation from a structural point of view, many efforts 
have been made to determine the structure of the complex between NS2B and NS3pro. 
 
Crystal structures of the highly homologous NS2B-NS3pro from West Nile virus 
(WNV), which shares 56% sequence identity with DENV NS2B-NS3pro, revealed 
two distinct conformations, open and closed (Figure 10), in the apo and substrate-
bound states, respectively (Erbel et al. 2006; Aleshin et al. 2007). However, NMR 
studies could only confirm the closed conformation of the WNV protease irrespective 
of the presence or absence of low-molecular-weight inhibitors (Su et al. 2009a; Su et 
al. 2009c). Similarly, a high quality crystal structure of DENV2 NS2B-NS3pro 
showed an open conformation without inhibitor (Figure 10) (Erbel et al. 2006). The 
N-terminal part of the NS2B cofactor (residues 49-66), which is sufficient to stabilize 
NS3pro, forms a β strand and inserts into the N-terminal β barrel of NS3pro. 
Unfortunately, the electron density of the C-terminus of NS2B (NS2Bc), which is 
enzymatically essential, was discontinuous and located far away from the active site 
of NS3pro. Crystallization of DENV NS2B-NS3pro is difficult and the question of 
open and closed conformation is more easily addressed by NMR spectroscopy. Early 
NMR studies of a DENV NS2B-NS3pro construct with a covalent linker between 
NS2B and NS3pro indicated that NS2B was unfolded in the absence of inhibitor (Wu 
et al. 2007). A subsequent NMR analysis of this construct in the presence of a low-
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molecular-weight inhibitor clearly demonstrated the closed conformation, which 
proved to be similar to the closed conformation of WNV protease (de la Cruz et al. 
2011). Subsequently, a crystal structure of DENV3 NS2B-NS3pro in complex with a 
peptide inhibitor confirmed the closed conformation, showing that NS2Bc forms a β 
hairpin and wraps around the core of NS3pro to line the substrate binding site (Figure 
11) (Noble et al. 2012).  
 
Figure 10. Structure of NS2B-NS3pro in the absence and presence of an inhibitor. (a) 
DENV NS2B-NS3pro. Gray, NS3pro; yellow, NS2B. PDB code: 2FOM. (b) WNV 
NS2B-NS3pro in complex with Bz-Nle-Lys-Arg-Arg-H (orange).  PDB code: 2FP7. 
Reproduced from Erbel et al. (2006). 
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Figure 11. Structure of DENV3 NS2B-NS3pro, highlighting the S2 and S3 pockets, 
with the bound nKRR-H inhibitor shown as sticks (PDB code: 3U1I). The structure is 
shown in cartoon representation, with NS3 in pink and NS2B in green. Reproduced 
from Lim et al. (2013).  
 
In contrast, more recent NMR studies indicated that the open conformation in the 
absence of any inhibitor may be an artefact of the Gly4-Ser-Gly4 linker between NS2B 
and NS3pro, as constructs without a covalent linker overwhelmingly populate the 
closed conformation in solution, even in the absence of inhibitor (Kim et al. 2013; de 
la Cruz et al. 2014). In addition, narrow resonances previously thought to represent 
the open state were reassigned as protein degradation signals (de la Cruz et al. 2014).  
 
The two distinct confirmations of DENV NS2B-NS3pro evident by both 
crystallographic and/or NMR studies compromised early structure-guided approaches 
for drug discovery. In this thesis, the study on the unlinked construct of DENV2 
confirmed that the closed conformation of DENV NS2B-NS3pro is the best model for 
structure-guided drug design (chapters 2 and 3).  
 
1.5.3 Inhibitors targeting NS2B-NS3pro 
 
After more than a decade of research, there still is no dengue virus protease inhibitor 
that has advanced into clinical trials. The big challenges of the inhibitor design are the 
shallow active site and the difficulty to replace the two basic P1 and P2 residues 
(Figure 11) (Lim et al. 2013).  
 
Over the years, many research groups have focused on developing DENV inhibitors. 
Numerous non-peptidic inhibitors were identified via high-throughput library 
screening or in silico docking. However, none of the non-peptidic inhibitors reported 
showed inhibition constants in the nanomolar range. False positives and non-drug-like 
properties of the hits were major problems slowing down the progress (Lim et al. 
2013; Nitsche et al. 2014). In contrast, using the substrate recognition sequence as 
starting point for the design of protease inhibitors, quite a number of peptidic 
inhibitors have been developed with low micromolar inhibition constants (Figure 12) 
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(Nitsche et al. 2014). The most potent peptidic inhibitor, a tetra-peptide derived from 
Bz-Nle-Lys-Arg-Arg (6, Figure 12) with an electrophilic boronic acid warhead, is 
unsuitable for oral dosing and also not DENV-specific (Yin et al. 2006). It is 
interesting that the sequence WYCW-NH2 (24, Figure 12), which successfully 
removed Arg residues from the nonprime positions, exhibited a promisingly low Ki 
value against DENV2 (4.8 µM), indicating that there is no absolute requirement for 
basic side chains in the dengue virus inhibitors. The binding mode of this peptidic 
inhibitor, however, remains unknown (Prusis et al. 2013). 
 
The key assumption of structure-based design is that good inhibitors must possess 
significant chemical as well as structural complementarity to their target receptors 
(Dean 1987). Due to the difficulties in co-crystallizing the dengue virus protease with 
any inhibitors, the binding modes of the dengue virus protease inhibitors relies mostly 
on computer docking algorithms. Even when molecular dynamic simulations were 
applied to explore conformational changes of the protein induced by specific 
interactions with inhibitors, the reliability of the resulting complex models remains a 
concern. Clearly, experimentally confirmed models of the complex between NS2B-
NS3pro and inhibitors are needed to help with the development of lead compounds 
and thus guide lead optimisation. It is the central aim of this thesis to use information 
obtained by paramagnetic NMR spectroscopy as structural restraints for the modelling 
of protein-ligand complexes to provide a guide for rational drug design against 
dengue (Paper 4). 
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Figure 12. Selected peptidic inhibitors of the dengue virus protease. Reproduced from 
Nitsche et al. (2014).  
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Conclusion and Outlook 
 
2.1 Additional lanthanide tagging sites on the dengue virus protease  
 
2.1.1 Site B is not an ideal site for inhibitor binding studies 
 
When studying the conformation of the C-terminal segment of NS2B (NS2Bc) in the 
complex between the dengue virus protease and BPTI, the bulky lanthanide tag at site 
B, which produces the largest PCSs for residues of NS2Bc (Paper 1), was noted to be 
fairly close to ligands at the active site, which could lead to clashes between ligand 
and tag, in particular for bulky ligands like BPTI. Therefore, only site C was chosen 
to generate PCSs for the complex with BPTI. In hindsight, PCSs induced from a 
single site were sufficient to position NS2Bc in that particular study (Paper 2). In the 
subsequent small-molecule binding study, large PREs resulted from tags at site B, 
which hampered the unambiguous assignment of PCSs in 1D 1H NMR spectra (Paper 
4). This indicated an unexpectedly short distance between the paramagnetic centre 
and the nuclei of interest, which may be attributed to tag flexibility. PREs are 
exquisitely sensitive to the presence of minor species, even with populations as low as 
1%, if the distances between the paramagnetic centre and the protons of interest are 
much shorter in the minor than in the major species (Tang et al. 2007). At site B, the 
tag has the chance to move as close as 15 Å to the tert-butyl group, which would 
produce a large PRE effect and render the observation of PCSs in 1D 1H NMR spectra 
more difficult (Figure 13). 
 
Very recently, Koh-Stenta et al. (2015) reported an NMR study of the complex of the 
dengue virus protease with another covalently bonded inhibitor carrying a ester 
warhead (Koh-Stenta et al. 2015). They presented a docking model, which showed a 
4-methoxyphenyl group interacting with residue 34 in the P2’ site. Unfortunately, 
residue 34 is also site B. In other words, a bulky lanthanide tag ligated at site B could 
easily interfere with the binding of ligands in the P2’ pocket. 
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Consequently, site B may need to be abandoned in future ligand binding studies of the 
dengue virus protease, and at least one or more alternative solvent-exposed sites 







Figure 13. Stereo view of the metal position distribution at site B on the dengue virus 
protease complex. NS2B is coloured orange, while NS3pro is shown in grey. Ligand 1 
and Ser34 are shown in sticks. Three examples of distances are drawn as black dotted 
lines. The positions of the metal were sampled from 100,000 rotamers. The most 
highly populated distances were between 18-20 Å, but the tag also has the chance to 
move towards the tert-butyl group of ligand 1 as close as 15 Å and as far as 33 Å. 
Minor populations of short distances easily dominate the line broadening effect for the 
tert-butyl group. 
 
2.1.2 Possible new sites for lanthanide tag conjugation 
 
In theory, the more tagging sites are available the better, since each of them would 
provide unique and helpful 3D restraints. Previously, three single cysteine mutations 
were established for the introduction of C1 and C2 lanthanide tags to study the 
conformation of NS2B: Ala57*Cys (site A), Ser34Cys (site B) and Ser68Cys (site C) 
(labelled as A-C in Figure 14) (de la Cruz et al. 2011). Based on the known ligand 
binding pockets, the following sites may possibly be suitable as well: Lys42, Thr45, 
Val109 and Leu115 (labelled as 1-4 in Figure 14). The rational for this proposal is 
based on a number of observations. Firstly, the conformation of NS2Bc needs to be 
monitored in any ligand binding study, making NS2B unsuitable for tagging. In 
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addition, the mutation sites should be sufficiently far from the catalytic triad to avoid 





















Figure 14. Proposed tagging sites mapped on the dengue virus protease. NS2B is 
coloured orange, while NS3pro is shown in grey. The new proposed tagging sites are 
numbered 1-4. They correspond to the sites of Lys42, Thr45, Val109 and Leu115. 
The catalytic triad (consisting His51, Asp75 and Ser135) is identified by black 
spheres. The three established sites A (Ala57*), B (Ser34) and C (Ser68) for single 
cysteine mutations are shown as yellow spheres. Two other sites (D: Thr122 and E: 
Ser189), which proved unsuitable for conformational studies of NS2B (de la Cruz, 
2013) are identified by green spheres.  
 
Lys42 is located in the same β-strand as Ser34 (site B), but it is on a different face of 
the protein and opposite to the active site. It must be noted, however, that charged 
residues may not the best choice for mutation, as charge-charge interactions can be 
important for protein stability. Thr45, the first residue of the next β-strand, is located 
close to Lys42 and may be equally suitable as a tagging site. A cysteine residue 
replacing Val109 has a good chance of directing a lanthanide tag to point in a 
direction parallel to the binding pocket, thus avoiding clashes with NS2B. Lys42, 
Thr45 and Val109 are all at similar distances to NS2Bc as the sites B and C, 
suggesting that all of these sites might be suitable for assessing the conformation of 
NS2Bc even when inhibitors bind to the active site of NS3pro.  
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In the Ph.D. thesis of Dr L. de la Cruz, Thr122 and Ser189 (labelled as C and E in 
Figure 14) were shown to be unsuitable tagging sites for conformational studies of 
NS2Bc (de la Cruz, 2013). When re-evaluated, Ser189 is still considered an unsuitable 
tagging site, since it is too close to the binding pocket. Leu115 (labelled 4 in Figure 
14) is near Thr122, is opposite to the binding site and highly solvent exposed. 
Lanthanide tags at Leu115 may induce sizeable PCSs for ligands binding at the active 
site. Like Thr122, however, Leu115 is very close to NS2Bc. Nevertheless, using a 
more rigid tag and a less strongly paramagnetic metal ion like Ce3+, PREs on NS2Bc 
can provide distance information to help assess its conformation. Therefore, Leu115 
might serve as a useful supplemental tagging site for ligand binding studies using both 
PREs and PCSs. 
 
2.2 The potential of tert-butyl substitutions  
 
2.2.1 Multiple tert-butyl substitutions on the same small-molecule ligand 
 
The usefulness of tert-butyl groups for the structural analysis of proteins and protein-
ligand complexes by NMR spectroscopy is a key result of this thesis (Chapters 4 and 
5).  
 
For small-molecule ligands, the introduction of a tert-butyl group would significantly 
increase the overall size. However, free rotations of a tert-butyl group could reduce 
the impact from the change in size as long as it is solvent-exposed (i.e. points out 
from the binding pocket or away from the protein surface). A ligand with tert-butyl 
group should be capable of binding in generally the same location as the ligand 
without substitution. Clearly, the chemical properties of this group may still affect the 
protein-ligand affinity. For example, the dengue virus protease ligand analogue with a 
tert-butyl group exhibited a slightly decreased binding affinity compared with the 
original ligand. The effect on affinity would depend on the position of the substitution 
on the ligand and the chemical and structural properties of the binding pocket. 
Therefore, the site for introduction of a tert-butyl group on the ligand must be 
carefully designed and its effect on inhibition and/or binding affinity should be 
evaluated prior to structural studies. Furthermore, similar to fluorine substitutions, the 
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tert-butyl substitutions could be varied chemically (Figure 15), which would result in 
different chemical shifts. For example, the 1D 1H NMR signal of a O-tert-butyl group 
typically appears near 1.2 ppm, while a tert-butyl-benzyl group exhibits a small 
downfield shift by about 0.05 ppm. Boc groups display signals even further downfield 
due to the electron withdrawing effect of the ester group, i.e. at 1.4 ppm. These 
features can be helpful for assignment, when multiple tert-butyl substitutions are 
introduced are different sites on the same ligand. Indeed, ligands exist that feature a 
tert-butyl group and a Boc group at the same time, e.g. asunaprevir (Scola et al. 
2014).  
O O
             O-tert-butyl group                    tert-butyl-benzyl group
O



















Figure 15. Chemical structures of various tert-butyl substitutions. 
 
2.2.2 Tert-butyl substitutions on natural amino acids 
 
A number of natural amino acids bearing tert-butyl substitutions have been developed 
and commercialised (Figure 15). O-tert-butyl substitutions could be introduced to 
modify Tyr, Ser and Thr. Boc substitutions could be performed on Cys, His, Lys, Arg, 
Asp and Glu. Different tert-butyl substitutions are possible. Chemical peptide 
synthesis uses tert-butyl containing unnatural amino acids, making it possible to 
simply retain tert-butyl groups during removal of the N-Boc protecting group (Gibson 
et al. 1994). Notably, the tert-butyl group is used as a common protection group 
because it can easily be removed; nonetheless, deprotection under mild NMR buffer 
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conditions (usually pH 6-8) is not easy. There is an increased interest in peptides in 
pharmaceutical research and development (R&D) and approximately 140 peptide 
therapeutics are currently being evaluated in clinical trials (Fosgerau and Hoffmann 
2014). Therefore, peptides with tert-butyl substitutions may be straightforward to 
obtain and could produce useful structural information in interaction studies with the 
target proteins. Tert-butyl groups thus present a bright future for NMR spectroscopy 
in lead compound development.  
 
2.3 Concluding remark 
 
This thesis focuses on the development of paramagnetic NMR spectroscopy for 
structural analysis of proteins (Paper 1), protein-protein complexes (Paper 2) and 
protein-ligand complexes (Papers 3 and 4). Special tools used in these studies are 
pseudocontact shifts, lanthanide tags, unnatural amino acids, cell-free protein 
synthesis, as well as the programs Numbat and Rosetta. In particular, the combination 
of the highly NMR-sensitive tert-butyl label with PCSs broadens the scope of 
paramagnetic NMR spectroscopy in drug discovery to provide structural information 
for rational ligand design in situations, when atomic-resolution structural data of the 
protein-ligand complex cannot easily be obtained by other techniques.  
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The two-component dengue virus NS2B–NS3 protease (NS2B–NS3pro) is
an established drug target but inhibitor design is hampered by uncertainties
about its 3D structure in solution. Crystal structures reported very different
conformations for the functionally important C-terminal segment of the
NS2B cofactor (NS2Bc), indicating open and closed conformations in the
absence and presence of inhibitors, respectively. An earlier NMR study in
solution indicated that a closed state is the preferred conformation in the
absence of an artificial linker engineered between NS2B and NS3pro. To
obtain direct structural information on the fold of unlinked NS2B–NS3pro
in solution, we tagged NS3pro with paramagnetic tags and measured
pseudocontact shifts by NMR to position NS2Bc relative to NS3pro.
NS2Bc was found to bind to NS3pro in the same way as reported in a pre-
viously published model and crystal structure of the closed state. The struc-
ture is destabilized, however, by high ionic strength and basic pH, showing
the importance of electrostatic forces to tie NS2Bc to NS3pro. Narrow
NMR signals previously thought to represent the open state are associated
with protein degradation. In conclusion, the closed conformation of the
NS2B–NS3 protease is the best model for structure-guided drug design.
Introduction
Dengue virus is a health burden that sends almost
100 million people to clinics every year [1] with an esti-
mated 40% of the world’s population at risk, espe-
cially in the tropical and subtropical regions [2,3]. The
infection involves translation of the flavivirus RNA
genome into a poly-protein that must be cleaved into
several individual components. The N-terminal part of
the nonstructural protein 3 (NS3) encodes a serine
protease, NS3pro, which is required for cleavage of
the poly-protein. This makes NS3pro a prime drug tar-
get [4]. Its activity towards peptide substrates is
boosted ~3300–7600-fold by the presence of a second
viral protein, NS2B, which comprises ~40 residues [5].
The NS2B–NS3 proteases of dengue serotypes 1–4 are
closely related to each other (Fig. S1) and to the
NS2B–NS3 protease from the West Nile virus (WNV;
~40% sequence identity). This study focuses on the
NS2B–NS3 protease of dengue virus serotype 2, which
is the most studied serotype.
The wild-type poly-protein contains a recognition
site for the NS2B–NS3 protease between NS2B and
NS3 [6]. To stabilize the protein, the most widely used
construct of the NS2B–NS3 protease contains a 47-res-
idue segment of NS2B fused to the N-terminus of
Abbreviations
NS3, nonstructural protein 3; PCS, pseudocontact shift; PRE, paramagnetic relaxation enhancement; WNV, West Nile virus.
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NS3pro via an artificial Gly4–Ser–Gly4 linker. This
and similar constructs retain the activity of the
protease [7] and have been used for crystal structure
determinations [8,9], NMR spectroscopic studies
[10,11] and ligand-binding studies [12–28]. In the fol-
lowing, we refer to this construct as DENpro (WNV-
pro for the corresponding construct from WNV). We
use the name DENp for an alternative construct that
is devoid of the covalent linkage between NS2B and
NS3pro. The distinction is important, because the
functionally important NS2B cofactor has been
reported to assume very different conformations in
DENpro and DENp (Fig. 1).
The crystal structures of DENpro and WNVpro in
the absence of inhibitors revealed an open conforma-
tion [8,29], in which the N-terminal part of the NS2B
cofactor inserts into the N-terminal b-barrel of the
NS3 protease, but the C-terminal segment of NS2B
(NS2Bc, corresponding to the segment Glu66-Leu95 in
DENpro serotype 2) is located far from the substrate-
binding site of NS3pro. We refer to the structures with
NS2Bc far from the active site of NS3pro as the ‘open
state’ (Fig. 1A). By contrast, structures determined in
the presence of inhibitors displayed NS2Bc forming a
b-hairpin that lines the substrate-binding site [8,29–32].
We refer to this conformation as the ‘closed state’
(Fig. 1B). In view of the importance of NS2Bc for full
proteolytic activity of the proteases [5,33–37], the
closed conformation is assumed to represent the enzy-
matically active structure. As expected for homologous
proteins, the closed conformations reported for DEN-
pro and WNVpro in the presence of inhibitors are
very similar [8,30]. Remarkably, the crystal structures
of the open conformations without inhibitors are also
very similar [8,29].
In solution, NMR experiments unambiguously
showed that DENpro can assume the closed confor-
mation in the presence of inhibitor 1 (Fig. S2A) [11].
In the absence of an inhibitor, however, not all signals
could be observed, indicating extreme broadening of
the NMR resonances of DENpro due to conforma-
tional exchange. A similar situation was observed in
the case of WNVpro: the protein assumes the closed
A
B
Fig. 1. Open and closed conformations observed in crystal
structures of the NS2B–NS3 protease from dengue virus
serotypes 2 and 3, respectively. In the orientation shown, the C-
and N-terminal b‐barrels of the protease are in the left and right
halves, respectively. The parts from NS2B and NS3 are shown in
orange and grey, respectively, and their N- and C-termini are
labeled. Spheres identify the Ca atoms of the single cysteine
residues for the attachment of lanthanide binding tags in the
mutants A–C. Dotted lines indicate missing electron density in
the crystal structure. (A) Open conformation (PDB ID 2FOM [8]).
The C-terminal segment of NS2B, NS2Bc, is far from the active
site. (B) Closed conformation (PDB ID 3U1I [30]). NS2Bc wraps




Fig. 2. Expression constructs of the dengue virus protease with
and without covalent linker between NS2B and NS3. (A) Schematic
representation of the protease construct with NS2B (orange) linked
to NS3pro (black) via a flexible Gly4–Ser–Gly4 linker. We refer to
this construct as DENpro. (B) Same as (A), except that the Gly4–
Ser–Gly4 linker is replaced by the natural cleavage site between
NS2B and NS3 in dengue virus serotype 2 (EVKKQR). We refer to
this construct as DENp. The autoproteolytic cleavage site is
identified by a red triangle. See Fig. S1 for the detailed amino acid
sequence. (C) SDS/PAGE of DENp with Coomassie Brilliant Blue
staining. (Left) Result from cell-free expression (S: supernatant, C:
crude reaction mixture). (Right) Purified product from in vivo
expression. In both cases, soluble DENp was obtained without
covalent linkage between NS2B and NS3pro. The bands of NS2B
and NS3pro are indicated.
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conformation in the presence of inhibitors, but the
disappearance of signals in the absence of inhibitors
indicates conformational exchange. NMR experiments
showed that, also without inhibitor, the closed confor-
mation is more highly populated [38].
A recent study investigated a construct of DENp
produced by coexpression of NS2B and NS3pro with-
out a covalent link between both proteins [39]. Signifi-
cant differences from earlier results obtained with
DENpro were found. Importantly, no NMR signals
were reported to be missing in the absence of inhibi-
tors, allowing more complete resonance assignments
and thus the measurement of secondary chemical
shifts, 15N-relaxation rates and paramagnetic relaxa-
tion enhancements (PREs) from a spin-label attached
to NS2Bc. These data indicated that NS2B may exist
in a conformation similar to the closed form of DEN-
pro, but structural details were not obtained.
This study presents direct structural information for
a related unlinked NS2B–NS3pro construct, using
pseudocontact shifts induced by different paramagnetic
lanthanide ions attached at different sites. The data
fully support the structure of the closed state detected
previously in the presence of inhibitors [11,30], but
NS2Bc is found to undergo conformational exchange
that becomes more pronounced at increased pH and
ionic strength, without appreciably dissociating from
NS3pro even under conditions of high salt. Evidence is
presented that a set of very narrow signals at chemical
shifts characteristic of random coil conformations
previously attributed to open conformations [10,38]
instead signifies degraded protein. The results show
that the structure and dynamics of the dengue NS2B–
NS3 protease are much more closely related to the cor-
responding protease from the West Nile virus than
implied by previous analyses.
Results
Protein production
DENp was expressed as a single polypeptide chain to
produce NS2B and NS3pro in an equimolar ratio.
SDS/PAGE showed that the autoproteolytic cleavage
site was quantitatively cleaved in the course of protein
expression and purification, regardless of whether the
protein was produced by cell-free synthesis or in vivo
(Fig. 2). ESI-MS of DENp selectively labelled with
15N-isoleucine showed two peaks of molecular mass
6670 and 20 753 Da (calculated: 6671 and 20 757 Da
for NS2B and NS3pro, respectively). DENp was enzy-
matically active (Fig. S3).
DENp assumes the closed conformation
The 15N-HSQC spectrum of DENp selectively labelled
with 15N-isoleucine (Fig. 3A) was strikingly similar to
that of DENpro in the presence of inhibitor 1
A B C
Fig. 3. Chemical shift conservation suggests that DENp predominantly assumes the closed conformation in the absence of an inhibitor. The
spectra show the spectral region of the backbone amides in 15N-HSQC spectra recorded of selectively 15N-isoleucine-labelled samples of
DENp and DENpro. All spectra were acquired using 0.2 mM protein solutions in 90% H2O/10% D2O with 20 mM MES, pH 6.5, 50 mM NaCl
at 25 °C on a Bruker 800 MHz NMR spectrometer. Assignments of NS2B are identified by stars. (A) 15N-HSQC spectrum of DENp. The
circle indicates the position of the cross-peak of Ile86* which was observed with very weak intensity in a spectrum of a different sample.
(B) As (A), except for DENpro. Weak narrow cross-peaks of NS2B appearing at random coil chemical shifts are from a minor species of
variable intensity between different sample preparations. (C) As (B), except that a fivefold excess of inhibitor 1 was added to induce the
closed conformation.
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(Fig. 3C). The improved spectral quality of DENp is
in line with earlier observations, in which a similar
unlinked construct of the NS2B–NS3 protease was
shown to produce better NMR spectra than the DEN-
pro construct [39]. We previously established using
pseudocontact shifts from multiple lanthanide binding
sites [11], that the structure of DENpro with bound
inhibitor 1 assumes the closed conformation, as
observed in the crystal structure 3U1I [30]. The conser-
vation of chemical shifts observed for the isoleucine
residues in DENp without inhibitor (Fig. 3A) and
DENpro with inhibitor 1 (Fig. 3C) thus indicates that
DENp assumes the closed conformation too. Apart
from small differences in chemical shifts expected to
arise from the presence or absence of the inhibitor and
the covalent linker peptide (e.g. Ile36, which is close to
the active site and changes its chemical shift between
DENp without inhibitor and DENpro with inhibi-
tor 1), there are pronounced differences in peak inten-
sities. For example, the cross-peaks of Ile78* and
Ile86* in NS2B and Ile165 in NS3pro were unexpect-
edly weak. Effects of this magnitude can only be
explained by exchange broadening, which we attribute
to conformational exchange of the b-hairpin of
NS2Bc. Ile165 is buried in the C-terminal b-barrel of
NS3pro which binds NS2Bc in the closed conforma-
tion. Sensitivity of the C-terminal b-barrel to the state
of NS2Bc has been reported earlier [11].
Remarkably, greater spectral differences are
observed between DENpro without inhibitor (Fig. 3B)
and either DENpro with inhibitor 1 (Fig. 3C) or
DENp without inhibitor (Fig. 3A). For example, the
resonance of Ile123 is strongly affected in DENpro
(Fig. 3B) and there are no signals of Ile165, Ile67* and
Ile73* that would be expected for the closed conforma-
tion. Another notable feature of the spectra of
DENpro (Fig. 3B,C) is a set of narrow signals for
isoleucine residues of NS2B at 1H chemical shifts
characteristic of an unfolded polypeptide chain (8.1–
8.3 ppm). In early NMR studies of DENpro, these
signals were very intense and assigned to NS2B by sys-
tematic site-directed mutagenesis [10]. In the present
spectra (Fig. 3B,C), however, these cross-peaks are
much weaker than those of NS3pro. Having repeated
these preparations and NMR measurements multiple
times, we found the intensity of these NS2B signals to
vary between different sample preparations and not to
change when inhibitor 1 was added to the sample.
Furthermore, previous experiments of selectively
15N-Ser-labelled samples of DENpro without inhibitor
displayed weak 15N-HSQC cross-peaks of the serine
residues of NS2B at the chemical shifts of the closed
conformation, with little evidence of serine residues at
random coil chemical shifts [11]. We conclude that the
cross-peaks of isoleucine residues of NS2B at random
coil chemical shifts stem from degradation of the
NS2B–NS3pro complex, possibly resulting in free
NS2B, which is known to be soluble, whereas NS3pro
is insoluble. In agreement with this interpretation, the
corresponding set of narrow peaks in selectively 15N-
isoleucine-labelled DENp grew noticeably in height
after 4 h at 25 °C, in step with protein precipitation.
This conclusion supersedes our earlier interpretation
that the random coil signals of NS2B represent the
open conformation of NS2B in the NS2B–NS3pro
complex [11,38].
Discounting the signals from the degraded protease,
there is no second set of isoleucine cross-peaks that
would indicate the existence of the open conformation
in either DENp or DENpro. Instead, the open confor-
mation may be manifested in the apparent absence and
weakness of some of the isoleucine cross-peaks in the
15N-HSQC spectrum, which indicates excessive line
broadening arising from conformational exchange. To
rule out line broadening due to chemical exchange of
the amide protons with the water, we performed a con-
trol experiment to assess the amide proton exchange
rates. The experiment used selective excitation of the
water resonance followed by a mixing time to allow
magnetization transfer by chemical exchange followed
by the 15N-HSQC pulse sequence to record the amide
cross-peaks arising from chemical exchange with water.
The spectrum of selectively 15N-Ile/15N-Ser-labelled
DENp was recorded. The scarcity of observable cross-
peaks (Fig. 4C) confirmed that exchange with the water
resonance was unimportant, even at pH 7.5, where
exchange with water is more pronounced than at lower
pH [40]. Weak cross-peak intensities in the 15N-HSQC
spectra of Fig. 3 are thus indicative of conformational
rather than chemical exchange broadening.
Structural analysis of DENp by pseudocontact
shifts
Although the overall conservation of chemical shifts
between DENp and DENpro indicates structural con-
servation, we sought more direct evidence by measur-
ing pseudocontact shifts (PCS) in DENp. To do this
without mutations in the critical NS2Bc segment, we
prepared three different single-cysteine mutants for
labelling with paramagnetic C1- and C2-lanthanide
tags. The mutation sites corresponded to the sites A, B
and C (Ala57*Cys, Ser34Cys and Ser68Cys, respec-
tively) used previously to establish the closed confor-
mation of DENpro in the presence of the inhibitor 1
[11]. In the study of DENpro [11], on average, larger
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PCSs were obtained with the C2 tag than with the C1
tag. Therefore, we recorded data with the C1 tag only
for mutant B, which delivered the largest number of
PCSs for NS2B. For all three mutants, PCSs were
measured with Tm3+ and Tb3+ tags. Figure 5 shows
examples of PCSs measured for mutant B with the
C2–Tb3+ tag in DENp without inhibitor and com-
pares them with corresponding PCSs measured for
DENpro with inhibitor 1. Figure 6 shows an overview
of all the PCSs that could be resolved for both DENp
and DENpro with different tags. Clearly, the PCSs
measured for DENp and DENpro were very similar
throughout, including, in particular, resonances of
NS2Bc. The PCSs thus provide very clear evidence
that both NS3pro and NS2B predominantly assume
the closed conformation in DENp. The model of the
closed conformation of DENpro established by PCSs
[11] is very similar to the crystal structure of the sero-
type 3 NS2B–NS3 protease determined in the presence
of an inhibitor [30] with a backbone rmsd of 0.7 !A.
Conformational exchange of NS2B
DENp and DENpro display more intense 15N-HSQC
cross-peaks in the presence of the inhibitor 1. Figure 7
shows a quantitative assessment of the relative peak
heights of samples selectively labelled with 15N-Ser and
15N-Ile in the absence and presence of inhibitor.
Clearly, signals from NS2B are more strongly affected
than those of NS3, and DENpro suffers more from
exchange broadening than DENp, including residues
123–165 of NS3pro. This observation reinforces the
conclusion that the C-terminal b-barrel, which har-
bours those residues, senses the conformational
exchange of NS2B. Notably, residual exchange broad-
ening persists in DENp in the absence of inhibitor for
NS2B and also for Ile139 in NS3.
Although it is common that binding of an inhibitor
rigidifies a protein structure, it is remarkable that the
low-molecular mass inhibitor used here achieves this
for NS2B, because the inhibitor is too small to form
direct contacts with NS2B. Based on mutation and
MS data, the inhibitor hydrolyses upon binding, leav-
ing behind only a p-guanidino-benzoyl moiety that is
covalently bound to Ser135 [11]. We hypothesized that
the positive charge of the guanidino group helps to tie
NS2Bc to NS3, because the C-terminal b-hairpin of
NS2B is highly negatively charged owing to the pres-
ence of Glu80 and Asp81 and four additional gluta-
mates at the C-terminus of NS2B (Fig. S1). If
electrostatic interactions are important, the association
of NS2B to NS3 should be weakened by high salt con-
centrations. Furthermore, the association should be
weakened at higher pH, when His51 in the active site
loses its positive charge.
Figure 4 shows that the 15N-HSQC cross-peaks of
many residues became significantly weaker at pH 7.5
compared with pH 6.5 and that this loss in intensity
was not due to fast proton exchange with the water.
As expected, the effect was observed equally for
A B C
Fig. 4. Reduced peak intensities in the 15N-HSQC spectra are caused by conformational, not chemical exchange. All spectra were recorded
of selectively 15N-Ser- and 15N-Ile-labelled DENp, using the same sample condition and spectrometer as in Fig. 3. See Fig. S4 for resonance
assignments. (A) 15N-HSQC spectrum at pH 6.5. (B) As (A), except that the pH was 7.5. (C) 15N-HSQC exchange spectrum at pH 7.5. The
experiment was recorded with the CLEANEX‐PM‐FHSQC pulse sequence [62], in which selective water excitation by a 7.5 ms 180° pulse
sequence was followed by 60 ms CLEANEX-PM mixing prior to the conventional HSQC pulse sequence. Cross-peaks in this spectrum arise
from magnetization transfer from water to amide protons by proton exchange.
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DENp and DENpro, whereas the signals retained their
intensities in the presence of inhibitor 1 (Fig. 8). The
presence of 300 mM NaCl at pH 6.5 weakened the sig-
nal of Ile78* in a selectively 15N-Ile-labelled sample
(Fig. S5). A uniformly 15N-labelled sample confirmed
this result, i.e. most cross-peaks of NS2Bc were signifi-
cantly weaker or absent at 300 mM NaCl, whereas the
cross-peaks from NS3pro were much less affected
(Fig. 9B), except for some cross-peaks of amides in
NS3pro that are sufficiently close to NS2B to sense its
conformational exchange (Fig. 9C). These results indi-
cate that the association of NS2Bc to NS3pro is
indeed stabilized by electrostatic attraction.
In view of the open conformations found in crystal
structures of DENpro and WNVpro [8,29], it is plausi-
ble that the pH- and salt-dependent conformational
exchange of NS2B in DENp arises from temporary
dissociation of NS2Bc from NS3pro, leading to the
open conformation. As stated above, however, the
PCSs measured for NS2B were in full agreement with
the closed conformation. PCSs readily average to zero
for flexible polypeptide chains, so that any disordered
open conformation would not contribute to PCSs of
NS2B and, therefore, the average PCSs of closed and
open conformations would become smaller for increas-
ing populations of open conformations. The similarity
in PCSs observed in DENp without inhibitor and
DENpro with inhibitor 1 (Fig. 6) indicates that, at
pH 6.5 and low ionic strength, DENp does not popu-
late open conformations to any significant extent.
In a fast equilibrium between open and closed con-
formations, a minor population of open conformation
should be manifested in changes in chemical shifts,
whereas a slow equilibrium would result in new cross-
peaks for the open conformation. Because the protein
chemical shifts are very highly conserved between
pH 6.5 and pH 7.5 without any new peaks appearing
at pH 7.5 (Fig. 4A,B), open conformations cannot be
highly populated at the higher pH. Nonetheless, many
signals broaden significantly at pH 7.5. A more com-
plete picture was obtained by using uniformly 15N-
labelled DENp. Comparison of Figs 9 and 10 shows
that high pH and high salt predominantly affect the
residues of NS2Bc and nearby residues of NS3pro, sug-
gesting that the electrostatic attraction of NS2Bc to
NS3pro is weakened at increased pH. This result may
be explained by a loss of charge of the side chain of
His51. If the exchange broadening observed at high salt
and high pH arises from small populations of open
conformations, DENpro would be expected to be more
sensitive than DENp. This is indeed the case (Fig. 8).
The chemical shifts of DENp changed slightly in the
presence of high salt, raising the possibility that this
effect could be attributed to a greater population of open
conformations. It was difficult, however, to assess the
amount of open population, because all NS2Bc reso-
nances were too broad to be observable (Fig. 9A) and
Ser70* and Ser71* were the last residues of NS2B for
which amide cross-peaks could be detected in uniformly
15N-labelled DENp at high salt (Fig. 9B). Their PCSs
A
B
Fig. 5. Similar PCSs are observed for NS2B of DENp without
inhibitor as for DENpro with inhibitor 1. The spectra were recorded
on a 600 MHz NMR spectrometer using the same conditions as in
Fig. 3. (A) Superimpositions of selected spectral regions of 15N-
HSQC spectra of mutant B of DENp without inhibitor (left) and
DENpro with inhibitor 1 (right). The samples were tagged with the
C2 tag loaded with paramagnetic Tb3+ (cyan peaks) or diamagnetic
Y3+ (red peaks). (B) Cartoon representation of the dengue virus
protease in the closed conformation (PDB ID 3U1I [30]), showing
NS2B in orange and NS3pro in grey. The locations of the residues
analysed in (A) are highlighted by balls and the site of the C2-tag is
indicated by a green sphere.
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generated by the C2–Tb tag attached to a cysteine residue
at site B (Fig. S6) changed slightly at high salt, but other
PCSs in NS3pro also changed, reflecting a small change
in the average location and orientation of the paramag-
netic tag relative to the protein. This effect is not unex-
pected, because the lanthanide tags used were charged
Fig. 6. PCSs demonstrate that DENp assumes a closed conformation very similar to that reported in the crystal structure of DENpro with
bound inhibitor [30]. Figure plots of the PCSs measured with different tags and metal ions for mutants A, B and C of DENp in the absence
of inhibitor (red symbols) and DENpro in the presence of inhibitor 1 (black symbols). Squares identify the PCSs of NS3pro and NS2B
residues that form part of the N-terminal b-barrel of NS3pro; these residues are structurally similar between open and closed conformations
(see Fig. 1). PCSs for NS2Bc are shown as circles. For clarity, data are shown only for residues for which PCSs could be measured both for
DENp and DENpro. The close similarity between the PCSs indicates closely similar structures.
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and thus sensitive to attractive and repulsive forces from
the charged amino acid side chains on the protein
surface. Using all observable PCSs to fit Dv tensors
yielded good correlations between back-calculated and
experimental PCSs, including for residues 70* and 71*
(Fig. S7, Tables S1 and S2). The PCS data thus indicate
that Ser70* and Ser71* of NS2Bc retain their closed-state
association with NS3pro even at high ionic strength. By
contrast, the more C-terminal residues of NS2Bc are
subject to substantial conformational exchange, which
may or may not include dissociation from NS3pro.
Clearly, however, the open conformation observed in the
crystal structure [8] can be populated to a very small
extent only (< 10%).
Discussion
Open and closed conformations
The question of open and closed conformations in the
dengue virus and West Nile virus proteases has been
vexed ever since their first observation in crystal struc-
tures [8]. Because NS2B greatly increases the activity
of the proteases [5,41], it would be attractive to pre-
vent the association of NS2Bc with the substrate-bind-
ing site by a drug molecule. Inhibitor designs for
DENpro have used either conformation as template
[14,17,19,20,23,26,42–52]. For both WNVpro and
DENpro, the presence of low molecular mass inhibi-
tors greatly improves the quality of the NMR spectra
[11,38,44,53–55]. For WNVpro, however, the NMR
experiments clearly showed that the closed conforma-
tion is predominant in solution regardless of the pres-
ence of an inhibitor [38]. The situation was thought to
be different for DENpro, because very narrow signals
indicative of NS2Bc in a random coil conformation
were observed with high intensities in the absence of
inhibitors [10]. In the course of this study, these signals
proved to be little reproducible in intensity, with some
sample preparations showing hardly any evidence for
them at all. Furthermore, they were insensitive to the
addition of inhibitor 1. These observations clearly
A
B
Fig. 7. Ratios of cross-peak heights in 15N-HSQC spectra of DENp and DENpro without and with inhibitor 1 provide evidence for
conformational exchange. All spectra were measured at pH 6.5 under the same sample conditions as in Fig. 3. In each spectrum, the cross-
peak intensities were determined relative to the intense cross-peak of Ile172. Error ranges were estimated from the reproducibility of the
peak heights in spectra recorded with two different samples, taking into account the level of white noise. Data for residues of NS2B and
NS3 are shown in orange and grey, respectively. Residues, for which cross-peaks at or near the position characteristic of the closed
conformation could not be observed in the absence of inhibitor are reported with a peak intensity ratio of zero. (A) Data for DENp. (B) Data
for DENpro.
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identify these signals as degradation products and elim-
inate them as evidence for a predominantly open con-
formation, in contrast to our previous interpretation
[38]. Heterogeneity in DENpro sample preparations
has been reported previously [56] but the evidence for
open conformations in solution is not clear-cut.
Kim et al. [39] reported recently that an unlinked
construct of the NS2B–NS3 protease yields better
NMR spectra than the original linked DENpro con-
struct. They also used NMR spectroscopy to establish
that the unlinked protease most likely assumes the
closed conformation. The key observations were: (a)
that the 15N-relaxation times of the NS2Bc resonances
were overall comparable to those of NS3pro, showing
that the mobility of NS2Bc is not greatly enhanced
compared to that of NS3pro in agreement with the
closed state; and (b) that PREs could be resolved for
seven of the backbone amides in the globular part of
the protease in a cysteine mutant with a nitroxide rad-
ical attached to residue 75 of NS2B. The PREs were
also in agreement with the closed conformation and
could not be explained by the open conformation of
the crystal structure 2FOM [8]. In addition, approxi-
mate boundaries of secondary structure were derived
from the chemical shifts of NS2B that are in agree-
ment with the b-hairpin structure found for NS2Bc in
the crystal structure 3U1I of the closed conformation
[30].
The crystal structures of DENpro and WNVpro
indicate that the association between NS2Bc and
NS3pro is weak, because the closed conformation has
only ever been observed in the presence of an inhibi-
tor. Even with the strongly binding inhibitor aprotinin,
a co-crystal structure of DENpro showed no electron
density for NS2Bc, indicating that it is disordered [30].
Nonetheless, the crystal structures of WNVpro [29]
and DENpro from serotype 1 [9] showed that the b-
hairpin structure of NS2Bc forms readily also when
NS2Bc is dissociated from NS3pro. It is thus conceiv-
able that, in solution, the b-hairpin structure forms
and associates nonspecifically with NS3pro. The NMR
data of Kim et al. [39] could not discern this situation
from the well-defined closed conformation observed
with inhibitors [11,30], because distance restraints to
nitroxide tags are difficult to quantify. In addition, the
hydrophobicity of the tag could influence the interac-
tion with NS3pro.
The PCSs observed in this study using multiple tags
at multiple sites unambiguously establish that the den-
gue virus NS2B–NS3pro enzyme from serotype 2
assumes the closed conformation as observed in the
crystal structure 3U1J [30], when the covalent linkage
between NS2B and NS3pro is broken. At the same
time, however, broad and missing NMR signals show
that NS2Bc retains increased dynamics which increase
with increasing salt and pH.
Conformational exchange
All backbone amide groups with the same relaxation
times should display 15N-HSQC cross-peaks of the
same intensity, whereas increased relaxation rates
reduce the cross-peak intensities by broadening the sig-
nals and because of loss of magnetization by fast
relaxation during the spin-echo periods of the experi-
ment. Because no relaxation mechanism can compete
with the line broadening effects from chemical
exchange, the weak signal intensities observed in the
spectra of DENpro and DENp must arise from
exchange broadening. Because hydrogen exchange with
Fig. 8. The conformational equilibria in
DENp and DENpro are pH dependent.
(Upper) Superimposition of a selected
spectral region from 15N-HSQC spectra of
DENp (red) and DENpro (black) recorded
without inhibitor at different pH. Except
for the pH, the sample conditions were
the same as in Fig. 3. The decrease in
peak intensities with increasing pH
indicates the increasing population of
alternative conformations with chemical
shifts different from the closed state of
the protease. (Lower) Corresponding
region of DENpro in complex with inhibitor
1, providing a reference for the closed
conformation.
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water is inefficient at pH 7.5, conformational exchange
remains the only plausible mechanism for the loss of
cross-peak intensities.
It is tempting to identify the exchange broadening
with an exchange between open and closed conforma-
tions. Our results show that the broadening becomes
more pronounced by increasing the pH or the salt con-
centration, showing that the interaction between
NS2Bc and NS3pro has a significant electrostatic
component. Even in the presence of 300 mM NaCl,
however, when most signals of NS2Bc become unob-
servable, the PCSs of the last backbone amides of
NS2Bc that we were able to resolve (Ser70* and
Ser71*), induced by a C2–Tb tag at site B, were not at
all reduced, contrary to expectations when NS2Bc fully
dissociates from NS3pro and assumes a random
A
B C
Fig. 9. High ionic strength weakens the association between NS2Bc and NS3pro. (A) 15N-HSQC spectra of uniformly 15N-labelled DENp at
300 mM NaCl (red spectrum) and 50 mM NaCl (black spectrum). All other sample conditions were the same as in Fig. 3. Circles identify
peaks that broadened beyond detection after the addition of sodium chloride. (B) Cross-peak heights observed in the spectra of (A) plotted
versus the amino acid sequence. Red and black symbols correspond to the data measured at high and low salt concentrations, respectively.
A horizontal line indicates the level of white noise in the spectrum at high salt. Circles and squares refer to NS2B and NS3, respectively.
The peaks in DENp displaying intensity reductions > 20% after the addition of salt are highlighted by filled red symbols. (C) Cartoon
representation of the NS2B–NS3 protease in the closed conformation with NS2B and NS3 shown in orange and grey, respectively. Spheres
identify the residues highlighted in (B) for greatly reduced peak intensities upon addition of salt.
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position relative to the tag. This suggests that the
exchange broadening arises from exchange between
different conformations of the b-hairpin of NS2Bc
while it is bound or from its selective dissociation from
NS3pro. In either case, the fully open conformations
reported in crystal structures are not the predominant
form in solution even under conditions that promote
conformational exchange of NS2Bc.
The 15N-Ile-labelled DENpro construct shows no
cross-peaks of NS2Bc in the closed conformation
A
B C
Fig. 10. High pH weakens the association between NS2Bc and NS3pro. The figure corresponds to Fig. 9, except that the peaks affected by
pH rather than salt are analysed. (A) 15N-HSQC spectra of uniformly 15N-labelled DENp at pH 7.5 (blue spectrum) and pH 6.5 (black
spectrum). All other sample conditions were the same as in Fig. 3. Circles identify peaks that broadened beyond detection at pH 7.5. (B)
Cross-peak heights observed in the spectra of (A) plotted versus the amino acid sequence. Red and black symbols correspond to the data
measured at high and low pH, respectively. A horizontal line indicates the level of white noise in the spectrum at high pH. Intensities are in
arbitrary units and the spectra were scaled to give similar intensities for the peaks with highest intensities. The peaks in DENp displaying
intensity reductions > 40% at high pH are highlighted by filled red symbols. (C) Cartoon representation of the NS2B–NS3 protease in the
closed conformation with NS2B and NS3 shown in orange and grey, respectively. Spheres identify the residues highlighted in (B) for
substantial reductions in peak intensities at pH 7.5.
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(Fig. 3B), indicating that the Gly4–Ser–Gly4 linker
enhances the conformational exchange of NS2Bc.
Nonetheless, weak cross-peaks at chemical shifts char-
acteristic of the closed conformation have been
observed in 15N-Ser-labelled samples [11], showing that
the closed conformation is populated even in DENpro.
Because there are no cross-peaks of NS2Bc in the
spectrum of Fig. 3(B) that can be assigned to the
intact NS2B–NS3 protease, it is hard to tell whether
the closed or open state is more highly populated in
DENpro. Certainly, the conformational state of DEN-
pro is more sensitive to high pH, because cross-peaks
from NS3pro disappear more readily at pH 7.5 than
the corresponding signals in DENp (Fig. 8).
Pseudocontact shifts for structure analysis
This study illustrates the power of PCSs induced by
lanthanide tags. Traditionally, most NMR studies col-
lect long-range structure restraints by measuring
PREs from site-specifically attached nitroxide spin-
labels. PREs, however, can also arise from intermo-
lecular interactions and artificial interactions can be
promoted by the hydrophobic nature of conventional
nitroxide spin-labels. By contrast, the PCS effect can
be measured over greater distances, allowing attach-
ment of the tag at a site far from the site of interest
where it causes minimal perturbations, and nonspe-
cific intermolecular interactions do not generate PCSs
[57]. The PCSs proved particularly valuable in the
case of DENp at high salt, where the signals of
NS2Bc were either missing or strongly attenuated due
to conformational exchange. This demonstrates how
PCSs can provide structural information even under
adverse conditions, where NMR signals can be
observed only for isolated residues because of peak
broadening, low protein concentrations or unstable
preparations.
Dissociation of NS2Bc from NS3pro
In contrast to DENpro, which is stable against degra-
dation at room temperature, our DENp construct
precipitated rapidly during the NMR measurements.
Precipitation was even faster at high ionic strengths,
limiting the measurement time for each sample to
~4 h. A possible explanation for this effect is that the
absence of the linker between NS2B and NS3pro facil-
itates the dissociation of NS2B, as NS3pro on its own
is insoluble.
Could the open conformations observed in crystal
structures be caused by the crystallization conditions
used? It is well known that exchange with small popula-
tions of alternate conformations may be sufficient to
broaden NMR signals beyond detection and that crystal-
lization conditions can select unusual conformations.
Notably, serotype 2 DENpro without inhibitor was
crystallized at pH 8.5 and 48 °C [8], conditions which
could promote dissociation of NS2Bc from NS3pro. The
open conformation of WNVpro crystallized at pH 7.5
and 25 °C [29], but it was obtained of the His51Ala
mutant, which might have weakened the binding of
NS2Bc to NS3pro. The open conformation of serotype 1
DENpro was of the wild-type protein crystallized at
pH 7.5 and 20 °C [9]. Based on our data, these condi-
tions would not promote dissociation of NS2Bc from
NS3pro, but the difference in amino acid sequence may
confer different properties to this particular protein,
favouring the association between the NS2Bc segments
from different protein molecules as observed in the
crystal structure.
Conclusion
Our results unequivocally demonstrate that the sero-
type 2 dengue virus NS2B–NS3 protease in solution
predominantly assumes the closed conformation in the
absence of inhibitors and that any open conformation
is hardly populated. This has obvious and important
implications for the choice of structural templates in
the rational design of inhibitors.
Experimental procedures
Materials
Two different dengue 2 NS2B–NS3pro constructs were
used. The first was the traditional construct used earlier for
structural and functional work [7,8,11], comprising 255 resi-
dues with a (Gly)4–Ser–(Gly)4 linker between NS2B (47 res-
idues) and NS3pro (185 residues). In addition, it contained
a His6-tag at the C-terminus and the T7 gene 10 N-terminal
peptide MASMTG at the N-terminus followed by a two-
residue cloning artefact (Leu–Glu), resulting in a 27 kDa
protein. In this construct, NS2Bc comprises the segment
from Glu66* to Leu95* (to discriminate between NS2B
and NS3 residues, residue numbers of NS2B are marked by
an asterisk throughout this text). We refer to this construct
as DENpro. The second construct was the same as the first,
except that the (Gly)4–Ser–(Gly)4 sequence in the linker
between NS2B and NS3pro was replaced by the protease
recognition sequence EVKKQR that precedes NS3 in the
wild-type poly-protein (Fig. 2A,B). We refer to this con-
struct as DENp.
DENpro and DENp samples were prepared either by
cell-free protein synthesis from PCR-amplified DNA [10] or
by high-cell density in vivo expression [58]. Cell-free protein
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synthesis used the high-copy number plasmid pRSET-6d-
DEN2 CF40GlyNS3pro as the template for PCR-amplifica-
tion [8,59]. S30 cell extracts were prepared in-house from
Escherichia coli strains Rosetta::kDE3/pRARE and BL21
Star::kDE3 [42], including concentration with poly(ethylene
glycol) 8000. 15N-labelled amino acids were purchased from
Cambridge Isotope Laboratories (Andover, MA, USA) and
ISOTEC (St. Louis, MO, USA). Synthetic oligonucleotides
were purchased from IDT (Coralville, IA, USA) and Gene-
works (Thebarton, SA, Australia). PCRs were performed
using Vent DNA polymerase (New England Biolabs, Ips-
wich, MA, USA). PCR products were purified using the
QiaQuick PCR purification kit (Qiagen, Hilden, Germany).
Single-cysteine mutants were prepared by in vivo expres-
sion experiments using the same gene constructs as cell-free
expression but inserted into the pETMCSI T7 expression
vector [60] and transformed into the E. coli strain Rosetta::
kDE3/pRARE.
The C1- and C2-compounds for tagging with lanthanides
were synthesized as described [61].
Cell-free protein synthesis
Production by cell-free synthesis allowed selective labelling
with 15N-labelled amino acids without significant isotope
scrambling [62] and the rapid production of site-specific
mutants [10]. Samples of DENp were synthesized in a cell-
free E. coli coupled transcription–translation system using
a previously described protocol [63,64]. 15N-labelled isoleu-
cine was used in the cell-free reaction mixture. Wild-type
DENpro was synthesized using the pRSET-DEN2
CF40GlyNS3pro plasmid at a concentration of 16 lg!mL"1
of reaction mixture. Mutant DENpro was synthesized using
reannealed DNA at a concentration of 20 lg!mL"1 of
reaction mixture. Each synthesis was performed in two
identical parallel reactions, each using a reaction volume of
2 mL in 20 mL of outer buffer and proceeding for 14–15 h
at 30 °C. Typical protein yields were 1.6 mg per reaction.
The S30 extract used for the expression of selectively
15N-serine-labelled samples was reduced with sodium boro-
hydride to suppress cross-labelling by transaminases as
described previously [65].
Protein purification
Following synthesis, the protein samples were purified
using IMAC Ni-NTA spin columns. The columns were
equilibrated with binding buffer (50 mM HEPES, 300 mM
NaCl, 10 mM imidazole at pH 7.5), loaded with the sam-
ple, washed five times with wash buffer (50 mM HEPES,
300 mM NaCl, 30 mM imidazole, pH 7.5) and eluted with
elution buffer (50 mM HEPES, 300 mM NaCl, 300 mM
imidazole, pH 7.5). The purified protein was dialysed
extensively against NMR buffer (20 mM MES, pH 6.5,
50 mM NaCl or 20 mM Tris/HCl, pH 6.9 or pH 7.5,
50 mM NaCl). Samples at higher salt concentrations
(300 mM NaCl) were prepared by dialysis against buffers
with correspondingly increased salt concentration. Samples
were concentrated using a Centricon-4 ultrafilter MWCO-
10 kDa concentrator (Amicon, Billerica, MA, USA) to
final volumes of 0.5 mL for samples at low salt concentra-
tion in 5 mm NMR tubes and 0.2 mL for samples at high
salt concentration in 3 mm NMR tubes. The protein
concentrations at low and high salt were 0.2 and 0.7 mM,
respectively.
Tagging reaction
C1 and C2 tags loaded with Tb3+, Tm3+ or Y3+ (Fig. S2)
were attached to the single-cysteine mutants of DENp by
adding the protein to a threefold excess of the respective
metal complexes of C1 or C2 and incubating at room tem-
perature for several hours. Excess low-molecular mass reac-
tants and products were removed by washing with NMR
buffer.
NMR spectroscopy
All NMR spectra were recorded at 25 °C on Bruker 600
and 800 MHz NMR spectrometers equipped with cryop-
robes. NMR spectra were recorded in NMR buffer unless
indicated otherwise. p-Nitrophenyl-p-guanidino benzoate
(1; Fig. S2A) was used as the inhibitor [66]. The inhibitor
was added in fivefold molar excess to the protein using a
100 mM stock solution in dimethylsulfoxide-d6. A spectrum
for measuring chemical exchange between water and amide
protons was recorded using the CLEANEX-PM pulse
sequence [67].
Pseudocontact shifts
PCSs were measured as the 1H chemical shifts of backbone
amides observed in 15N-HSQC spectra of paramagnetic
samples minus those observed for diamagnetic samples.
The PCSs were generated by a lanthanide ion with noniso-
tropic magnetic susceptibility. For each nuclear spin, the
PCS (measured in ppm) depends on its polar coordinates












where Dvax and Dvrh denote, respectively, the axial and
rhombic components of the magnetic susceptibility tensor v
[68], and the Dv tensor is defined as the v tensor minus its
isotropic component. Equation (1) shows that PCSs can be
positive or negative, depending on the position of the
nuclear spin with respect to the coordinate system defined
by principal axes of the Dv tensor. For mobile polypeptide
chains, PCSs easily average to zero.
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Figure S1. Sequence alignment of the NS2B-NS3pro in the dengue virus serotypes 
1-4 (NCBI taxonomy IDs 11053, 11070, 408693 and 408688). Positively and negatively 
charged amino acids are shown in blue and red, respectively. Residues of NS2B are 
displayed in italics and identified by an asterisk. NS2B contains a hydrophilic domain 
acting as a cofactor (residues 49*-95*) followed by a hydrophobic transmembrane 
 2 
domain and a C-terminal hydrophilic segment containing the autoproteolytic cleavage 
site (residues 125*-130*) leading to NS3. In previous studies of the dengue virus 
protease, the NS2B cofactor was linked to NS3pro via a covalent Gly4-Ser-Gly4-linker, a 
construct referred to as DENpro [1]. The construct presented here, referred to as DENp, 
uses the autoproteolytic cleavage site (residues 125*-130*) instead of the 
Gly4-Ser-Gly4-linker to connect NS2B and NS3pro. The resulting amino acid sequence 
of the DENp construct is shown in bold, underlined residues form the catalytic triad. 








Figure S2. Chemical structures of inhibitor 1 and C1 lanthanide tag. (A) Inhibitor 
used in the present work. It is a generic inhibitor of serine proteases [2,3], which reacts 
with the protease with formation of an ester bond to Ser135, releasing yellow 
p-nitrophenolate [4]. (B) Structure of the C1 tag with bound lanthanide ion [5]. The tag 
is activated by a pyridin-2-yldisulfanyl group for spontaneous reaction with a cysteine 
thiol group to form a disulfide bond. The C2-tag is the opposite enantiomer of the 
C1-tag with ((R)-1-phenylethyl)acetamide pendants instead of 
((S)-1-phenylethyl)acetamide pendants throughout.   
 3 
 
Figure S3. DENp is enzymatically active. The activities of DENp (triangles) and 
DENpro (circles) were compared using 10 µM Bz-norleucine-lysine-arginine- 
arginine-AMC [6] in 50 mM Tris.HCl (pH 7.5), 50 mM NaCl and 1 mM CHAPS in a 
final volume of 50 µL at 25 °C. The proteolytic reaction was monitored by the increase 
in fluorescence (relative fluorescence units per second, exciting at 380 nm and 
monitoring the emission at 450 nm) observed during 30 mins on a SpectraMax 
microplate reader. Each measurement was performed in three different wells and the 




Figure S4. 15N-HSQC spectrum of DENp selectively labelled with 15N-serine and 












Figure S5. 15N-HSQC spectra of DENp selectively labelled with 15N-isoleucine at 
different ionic strengths. Both spectra were acquired using 0.2 mM protein solutions in 
90% H2O/10% D2O with 20 mM MES, pH 6.5, at 25 oC on a Bruker 800 MHz NMR 
spectrometer. (A) 15N-HSQC spectrum recorded in the presence of 50 mM NaCl. The 
spectrum is the same as the spectrum in Figure 3A. (B) Same as (A), except that the 
buffer contained 300 mM NaCl.  
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Figure S6. PCSs observed for NS2B of DENp at 50 mM and 300 mM NaCl. The 
spectra were recorded using the same conditions as in Figure 3. (A) Superimpositions of 
selected spectral regions of 15N-HSQC spectra of mutant B of DENp with the C2 tag at 
50 mM NaCl (left panels) and 300 mM NaCl (right panels). The samples were tagged 
with the C2-tag loaded with paramagnetic Tb3+ (cyan peaks) or diamagnetic Y3+ (red 
peaks). The resonance assignments of the selected cross-peaks are indicated. (B) 
Cartoon representation of the dengue virus protease in the closed conformation (PDB ID 
3U1I [7]), showing NS2B in orange and NS3pro in grey. The locations of the residues 





Figure S7. Correlations between back-calculated and experimental PCSs of DENp 
at low and high salt. The PCSs were measured for the backbone amide protons of a 
uniformly 15N-labelled cysteine mutant of DENp with the cysteine positioned at site B 
(see Figure 1) and ligated with either a paramagnetic C2-Tb3+ or a diamagnetic C2-Y3+ 
tag. The PCSs of NS2B and NS3pro are shown as red squares and black circles, 
respectively. NS2B appears to be located in the same position at high and low salt, as 
this point fits equally well to the correlation line under both conditions. (A) Data at 50 





Table S1. PCSs of backbone amide protons of 15N-labelled DENp mutant B with C2-tag 
loaded with Tb3+ at 50 mM and 300 mM NaCl concentrationsa 
Residueb  
PCS in low 
salt (ppm) 
PCS in high 
salt (ppm) 
Arg55* -0.578 -0.722 
Ala57* -0.220 -0.361 
Glu62* 0.075 0.026 
Glu63* 0.056 0.026 
Gln64* 0.070 0.056 
Ala65* 0.096 0.078 
Ser70* 0.169 0.183 
Ser71* 0.119 0.140 
Ser75* 0.108 - 
Gly21 -0.200 -0.280 
Gly39 -0.413 -0.640 
Thr41 -0.265 -0.340 
Thr48 -0.128 -0.220 
His51 1.219 1.020 
Gly62 -0.748 -0.710 
Asp71 0.254 0.200 
Ile77 0.092 0.060 
Tyr79 -0.308 -0.330 
Gly82 -0.088 -0.110 
Leu98 0.175 0.090 
Ala108 0.142 0.080 
Gln110 0.166 0.140 
Thr111 0.158 0.130 
Gly114 0.179 0.130 
Phe116 0.195 0.160 
Gly121 0.141 0.140 
Thr122 0.130 0.120 
Ile123 0.181 0.170 
Val140 0.135 0.090 
Lys142 0.073 0.050 
Gly148 0.143 0.080 
a Other parameters were 20 mM MES, pH 6.5, 800 MHz 1H NMR frequency. PCSs were 
calculated as the difference in chemical shifts measured with paramagnetic Tb3+ minus 
the chemical shifts with diamagnetic Y3+. 
b NS2B residues are identified by an asterisk. 
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Table S2. Δχ tensor parameters of DENp mutant B with C2-Tb3+ taga 





































a The tensor parameters of NS2B-NS3pro complex were calculated with the program 
Numbat [8], using the PCSs of Table S1 and the model of the closed conformation 
established previously [4]. This model deviates from the crystal structure of serotype 3 
DENpro 3U1I [7] with a backbone RMSD of 0.7 Å. The axial and rhombic components 
of the Δχ tensors are given in 10-32 m3 and the Euler angles in degrees, using the zyz 
convention and unique tensor representation [8]. Error estimates (in brackets) were 
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a b s t r a c t
The C-terminal b-hairpin of NS2B (NS2Bc) in the dengue virus NS2B–NS3 protease is required for full
enzymatic activity. In crystal structures without inhibitor and in the complex with bovine pancre-
atic trypsin inhibitor (BPTI), NS2Bc is displaced from the active site. In contrast, nuclear magnetic
resonance (NMR) studies in solution only ever showed NS2Bc in the enzymatically active closed con-
formation. Here we demonstrate by pseudocontact shifts from a lanthanide tag that NS2Bc remains
in the closed conformation also in the complex with BPTI. Therefore, the closed conformation is the
best template for drug discovery.
Structured summary of protein interactions:
NS2B, BPTI and NS3 physically interact by nuclear magnetic resonance (View interaction)
! 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
1. Introduction
Dengue virus (DENV) is the most important mosquito-borne
pathogen in terms of human suffering and cost, with a high rate
of hospitalization and potentially deadly outcome [1]. There are
four different closely related serotypes (DENV-1–DENV-4). To date,
no approved vaccine or drug is available for any of them, but an
established drug target is presented by the NS2B–NS3 protease
(NS2B–NS3pro) formed from segments of the non-structural virus
proteins NS2B and NS3 [2,3]. For a long time, however, develop-
ment of an inhibitor of NS2B–NS3pro has been hampered by diffi-
culties to ascertain the correct structure of the protein.
The first crystal structure of NS2B–NS3pro, determined for a
construct from DENV-2, displayed an open conformation in which
the C-terminal segment of NS2B (NS2Bc; residues 66⁄–95⁄;
throughout this text, residue numbers of NS2B are identified by
asterisks) was located far from the active site in an inactive confor-
mation (Fig. 1) [4]. Subsequent NMR studies showed, however, that
the protease assumes a closed conformation in solution, where
NS2Bc lines the substrate binding site [5–7], in complete analogy
to the structure of the related West Nile virus protease [4,8,9]. A
crystal structure of NS2B–NS3pro from DENV-3 in complex with
a peptide inhibitor confirmed the closed conformation [10], but
the same protein in complex with the high-affinity (Ki = 26 nM
[11]) trypsin inhibitor bovine pancreatic trypsin inhibitor (BPTI)
lacked any electron density for NS2Bc, indicating once again an
open conformation [10].
In the absence of firm information about the correct target struc-
ture in solution, computational ligand binding studies targeting the
active site used either closed or open conformations of the NS2B–
NS3 protease [12–28]. Unfortunately, the actual three-dimensional
(3D) structure in solution cannot readily be determined by conven-
tional NMR methods due to poor spectral resolution, line broaden-
ing by conformational exchange and limited protein stability. In the
case of the NS2B–NS3pro complex with BPTI, its high molecular
weight (35 kDa) further impedes NMR analysis.
Here we show that, in solution, the closed conformation pre-
vails also in the presence of BPTI. This result was obtained by mea-
suring pseudocontact shifts (PCS) of 15N-HSQC cross-peaks of
backbone amides in uniformly and selectively 15N-labelled sam-
ples with a paramagnetic lanthanide tag attached to NS3pro. The
PCSs provide a clear picture of the binding mode of BPTI at the
active site and of the location of the b-hairpin of NS2Bc.
http://dx.doi.org/10.1016/j.febslet.2014.05.018
0014-5793/! 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
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2. Materials and methods
2.1. Expression plasmids
The DENV-2 NS2B–NS3 protease was produced without a cova-
lent link between NS2B and NS3pro, using a previously described
construct in which NS2B is separated from NS3pro by the natural
protease recognition sequence EVKKQR [7]. The entire construct
consists of the T7 gene 10N-terminal peptide MASMTG followed
by a two-residue cloning artifact (Leu-Glu), 47 residues from
NS2B, the cleavage sequence EVKKQR, 185 residues from NS3pro
and a C-terminal His6-tag. The gene was inserted into the pETMCSI
expression vector [29] and the plasmid was transformed into the
Escherichia coli strain Rosetta::kDE3/pRARE. An additional con-
struct contained the single-cysteine mutation S68C in NS3pro for
subsequent ligation with lanthanide tags [5]. The nucleotide
sequence of BPTI [30] was also subcloned into the pETMCSI T7
expression vector and transformed into the E. coli strain TOP10
(Life Technologies, Carlsbad, CA, USA). The N-terminus was pre-
ceded by a His6-tag followed by the tobacco etch virus (TEV) pro-
tease cleavage sequence ENLYFQG.
2.2. Protein sample preparation
Uniformly and selectively 15N-labelled samples of the protease
weremade by high-cell density in vivo expression [31] and cell-free
synthesis [32–34], respectively, andpurifiedas describedpreviously
[7]. BPTI samples selectively labelledwith 15N-labelled Ala, Arg, Lys,
Thr, Leu, Phe and Ile (Cambridge Isotope Laboratories, Andover, MA,
USA; ISOTEC, St. Louis, MO, USA) were prepared by cell-free synthe-
sis at 30 "C overnight following a published protocol that includes
His6-tagged disulfide bond isomerase C (DsbC) to catalyze correct
disulfide bond formation [30]. The reaction volume was 1 mL in a
dialysis tube of Spectra/Por 2 (MWCO: 12–14 kDa) suspended in
10 mL outer buffer. The protein was purified by diluting the super-
natant of the cell-free reactionwith 2 times buffer A (50 mMHEPES,
pH 7.5, 300 mM NaCl), loading the mixture onto a Ni-NTA agarose
spin column (Qiagen, Hilden, Germany), washingwith buffer A plus
30 mM imidazole and elutingwith buffer A plus 300 mM imidazole.
BPTI was separated from DsbC by a spin column containing SP-
650 M resin (TOSOH, Minato, Japan), using buffer B (50 mM HEPES,
pH 8.0)with 50 mMNaCl for loading, buffer Bwith 100 mMNaCl for
washing and buffer Bwith 1 MNaCl for elution. All purified proteins
were exchanged into NMR buffer (20 mMMES, pH 6.5, 50 mMNaCl,
10% D2O). Protein concentrations were determined by their UV
absorbance at 280 nm.
Samples of the protease–BPTI complex were prepared either
with 15N-labelled protease and unlabelled BPTI or vice versa. Tag-
ging of the S68C mutant of the protease was performed after for-
mation of the 1:1 complex with BPTI by addition to a 3-fold
excess of the C2 tag loaded with either Y3+ or Tb3+ [35,5]. Following
5 h incubation at room temperature, the complex was washed with
NMR buffer using a centrifugal filter unit (Amicon Ultra with a
MWCO of 3 kDa; Millipore, Billerica, USA).
2.3. NMR spectroscopy
All NMR spectra were recorded of 0.1–0.2 mM solutions of
the protease-BPTI complex in NMR buffer at 25 "C, using a
Bruker 800 MHz NMR spectrometer equipped with a TCI
cryoprobe. PCSs were measured in ppm as the amide proton
chemical shifts measured in the presence of a paramagnetic
lanthanide minus the chemical shift observed in the presence
of diamagnetic Y3+.
2.4. Dv-tensor fitting
The PCS of a nuclear spin, DdPCS, is measured in ppm as the dif-
ference in chemical shift between a sample with a paramagnetic
ion (Tb3+ in the present work) and a sample with a diamagnetic
ion. PCSs arise from an anisotropic magnetic susceptibility (Dv)
tensor associated with the unpaired electrons of the paramagnetic
ion. PCSs follow the equation [36]:
DdPCS ¼ 1=ð12pr3Þ½Dvaxð3 cos2 h% 1Þ þ 1:5Dvrh sin2 h cos 2/' ð1Þ
where DdPCS is the PCS, r is the distance of the nuclear spin from the
metal ion, Dvax and Dvrh are the axial and rhombic components of
the Dv tensor, and h and / are the polar angles describing the posi-
tion of the nuclear spin with respect to the principal axes of the Dv
tensor. PCSs from lanthanide tags can be measured for nuclear spins
over 40 Å from the metal ion [37].
The PCSs measured for the complex of NS2B–NS3pro with BPTI
were used to determine the position and orientation of the mag-
netic susceptibility anisotropy (Dv) tensors of the paramagnetic
ions relative to the protein structure. The program Numbat [38]
was used to fit the Dv tensors to the crystal structure of the com-
plex with BPTI (PDB ID: 3U1J [10]). As no electron density of NS2Bc
was observed in the structure 3U1J, the coordinates of NS2Bc in the
crystal structure with the peptide inhibitor Bz-nKRR-H (PDB ID:
3U1I [10]) were grafted onto the 3U1J structure for a complete
model of the closed conformation.
Fig. 1. Ribbon drawings of the dengue virus NS2B–NS3 protease as observed in crystal structures. NS3pro is shown in grey and NS2B in orange. The active site is located near
the centre top in the orientation shown. The N-terminal segment of NS2B (NS2Bn, residues 49⁄–65⁄) includes a structurally conserved b-strand that inserts into the N-
terminal b-barrel of NS3pro. The C-terminal segment of NS2B (NS2Bc, residues 66⁄–95⁄) differs greatly between the open (panel A, PDB ID: 2FOM) and closed (panel B, PDB ID:
3U1I [10]) conformations detected by X-ray crystallography [4,10]. The arrow identifies the last residue of NS2B, for which electron density was observed in the complex with
BPTI (PDB ID: 3U1J [10]). The positions of selected residues are indicated.
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3. Results
3.1. The complex of the protease with BPTI is stable
Producing the protease as a single polypeptide chain with a
self-cleavage site between NS2B and NS3pro ensured a precise
1:1 ratio of both components in the final protease. Cell-free synthe-
sis of BPTI produced correctly folded, selectively 15N-labelled
protein (Fig. S1), yielding well-resolved 15N-HSQC cross-peaks that
were straightforward to assign to individual residues by compari-
son with resonance assignments of the free protein (Fig. 2B).
In our hands, samples of the protease without covalent link
between NS2B and NS3pro are stable for only a few hours at room
temperature in the absence of inhibitor. Sample degradation
results in additional narrow cross-peaks from NS2B at random coil
chemical shifts which, previously, had erroneously been attributed
to open conformations [39,40,5]. Notably, 15N-HSQC spectra of the
complex with BPTI were free of these additional cross-peaks and
stable for at least a month, indicating that BPTI inhibits the
degradation of the protease (Fig. S2).
3.2. The binding mode of BPTI in solution is the same as in the crystal
Fig. 2 illustrates the PCSs observed for the complex of the S68C
mutant of the protease with BPTI, with the C2-Tb3+ tag ligated to
Cys68. The same construct ligated with diamagnetic C2-Y3+ served
as the diamagnetic reference. PCSs of NS2B–NS3pro were observed
in the sample of 15N-labelled protease with unlabelled BPTI
(Fig. 2A), while PCSs of BPTI were observed in the sample of selec-
tively 15N-labelled BPTI with unlabelled protease (Fig. 2B). Using
the previously established assignment of the protease [5], 21 PCSs
could be resolved for NS3pro and residues 55⁄–65⁄ of NS2Bn, and 8
PCSs for NS2Bc (Table S1). Owing to the better spectral resolution
in the selectively 15N-labelled BPTI sample, PCSs could be assigned
and accurately measured for 23 residues of the BPTI construct.
To verify that BPTI binds to the protease in solution as reported
by the crystal structure 3U1J, we used the PCSs from NS3pro and
NS2Bn to fit an initial Dv tensor to the crystal structure (Fit 1 in
Table 1). The good quality of the fit is illustrated by the close cor-
relation between experimental and back-calculated PCSs (Fig. 3A).
Using the fitted Dv tensor together with the crystal structure coor-
dinates of the DENV-3 protease-BPTI complex (PDB ID: 3U1I [10])
to predict the PCSs of BPTI reproduced the expected trend (Fig. 3C).
This shows that the inhibitor binds in solution as reported by the
crystal structure (Fig. 3E). This conclusion is unaffected by the
observation that the back-calculated PCSs of BPTI were consis-
tently more positive than the experimental PCSs (Fig. 3C). Discrep-
ancies of this magnitude are common for mobile tags like the C2
tag, as translational motions of the metal ion compromise the
accuracy with which the PCS data can be approximated by a single
effective Dv tensor [41].
3.3. NS2Bc retains the closed conformation in the presence of BPTI
To obtain more accurate predictions for the PCSs of NS2Bc in the
closed conformation, we accepted the correctness of the crystal
structure 3U1I [10] with regard to the position of BPTI and deter-
mined a new Dv tensor using amide PCSs of residues from NS3pro,
NS2Bn and, in addition, BPTI, so long as they were within 30 Å of
the metal ion position determined by Fit 1. The resulting fit (Fit 2
in Table 1) still produced good agreement between back-calculated
and experimental PCSs (Fig. 3B) and accurately predicted the PCSs
also for BPTI residues located further than 30 Å from the metal cen-
tre (Fig. S3B). Most important, however, the PCSs predicted for
NS2Bc in the closed conformation of the crystal structure (3U1I
[10]) very closely matched the experimental data (Fig. 3D). This
indicates that NS2Bc is in the closed conformation as in the crystal
Fig. 2. PCSs observed for the complex of NS2B–NS3 protease with BPTI. (A) Superimposition of 15N-HSQC spectra of uniformly 15N-labelled protease S68C, tagged with either
C2-Tb3+ (red spectrum) or C2-Y3+ (black spectrum), in complex with unlabelled BPTI. PCSs of NS2Bc residues are labelled. (B) Same as (A), except that the protease is at natural
isotopic abundance and BPTI is selectively labelled with 15N-Ala, Arg, Lys, Thr, Leu, Phe and Ile. PCSs of BPTI are identified by lines. Cross-peaks of residues 15 (circle) and 17
were observable only at the noise level. Asterisks identify unassigned resonances attributed to the modified N-terminus and the nearby C-terminus.
Table 1
Dv-tensor parameters of the protease–BPTI complex with the C2-Tb3+ tag attached to
residue 68 of NS3proa.
Dvax Dvrh x y z a b c
Fit 1b %12.3 %4.0 %16.098 %34.428 3.681 146.1 48.9 30.1
(0.1) (0.6) (0.3) (0.3) (0.2) (2.5) (1.2) (4.7)
Fit 2c %12.9 %1.9 %16.800 %33.423 3.582 144.0 50.9 67.7
(0.2) (0.3) (0.1) (0.3) (0.1) (1.5) (0.6) (3.1)
a Dv-tensor parameters determined by the program Numbat using the crystal
structure 3U1J. The axial and rhombic components of the Dv tensors are given in
10%32 m3 and the Euler angles in degrees, using the zyz convention and unique
tensor representation [38]. Uncertainties (in brackets) were estimated by randomly
omitting 10% of the PCS data in multiple tensor fits.
b Fit 1 used only PCSs from NS3pro and residues 55⁄–65⁄ of NS2B. The root mean
square deviation (rmsd) between the experimental and back-calculated PCSs was
0.014 ppm for the residues included in the fit.
c Fit 2 used only PCSs from NS3pro, residues 55⁄–65⁄ of NS2B, and PCSs from
those BPTI amides, which are within 30 Å from the paramagnetic metal centre
determined by Fit 1. The rmsd between the experimental and back-calculated PCSs
was 0.029 ppm for the residues included in the fit.
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structure with the peptide inhibitor (3U1I [10]) and as determined
by NMR in the absence of an inhibitor [7]. Using the PCSs to fit a
Dv tensor to NS2Bn and NS3pro in the open conformation of
Fig. 1A (2FOM [4]) predicted completely wrong PCSs for NS2Bc,
confirming that this conformation cannot be populated to any sig-
nificant extent in the complex with BPTI (Fig. S4).
Our results suggest that the open conformation observed in the
crystal structure of the protease–BPTI complex could be a crystal-
lization artifact. Indeed, inspection of intermolecular contacts in
the crystal lattice show that a symmetry-related molecule occupies
much of the space where the b-hairpin of NS2Bc would be
expected to be in the closed conformation (Fig. S5).
4. Discussion
The present work demonstrates that the C-terminal b-hairpin of
NS2B retains the closed conformation in solution also when BPTI is
bound to the dengue virus NS2B–NS3 protease. Previous solution
NMR data showed that the protease assumes the closed conforma-
tion also in the absence of an inhibitor [6,7]. Without exception,
the closed conformation thus is the overwhelmingly predominant
conformation in solution, regardless of the presence or absence of
inhibitors of high or low molecular mass. These results are in stark
contrast to the crystal structure determinations of the NS2B–NS3
protease, which reported NS2Bc exclusively in open conformations
except for a single case in which a small peptide inhibitor was
bound to the protease [4,42,10]. Our results have important impli-
cations for rational drug design: while the crystallizations indicate
that the association between NS2Bc and NS3pro may be weak, the
closed conformation, as observed in the crystal structure with a
small peptide inhibitor [10], is the most faithful representation of
the protease structure to use in drug development efforts.
Notably, the NS2B–NS3 protease is subject to conformational
changes, as indicated by non-uniform peak intensities in the
Fig. 3. Correlation between experimental and calculated PCSs for the complex of NS2B–NS3pro with BPTI. (A) Back-calculated versus experimental PCSs produced by Fit 1 of
Table 1. Data of NS2B (residues 55⁄–65⁄) and NS3pro are shown as red squares and black circles, respectively. (B) Same as (A), except showing the data from Fit 2. PCSs from
BPTI are shown as blue triangles. (C) PCSs of BPTI predicted by the Dv tensor of Fit 1 versus the amino-acid sequence of BPTI. Experimental and calculated data are shown as
black and white triangles, respectively. (D) PCSs of NS2Bc predicted by the Dv tensor of Fit 2 versus the amino-acid sequence of NS2Bc. Experimental and calculated data are
shown as black and white squares, respectively. (E) Cartoon representation of the structure 3U1J with NS2Bc copied from the structure 3U1I [10]. The N-terminal segment of
NS2B is shown in orange, NS2Bc in light orange, NS3pro in grey and BPTI in cyan. The link between residues 69⁄ and 70⁄ is indicated by dots. The green sphere highlights the
site of the cysteine residue carrying the lanthanide tag (residue 68). (F) PCS isosurfaces (±0.5 ppm) generated by the Dv tensor of Fit 2 (Table 1) plotted on the structure of the
protease–BPTI complex. Blue and red surfaces identify, respectively, positive and negative PCSs. The amides for which PCSs were measured and used in the fit are identified by
spheres. Light orange balls illustrate amides of NS2Bc for which experimental PCSs were measured. The same data are displayed in two different orientations.
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15N-HSQC spectra (Fig. 2A). High pH (7.5 versus 6.5) or high concen-
trations of NaCl (300 mM) in the absence of any inhibitor have been
observed to broaden the signals of NS2Bc after Ser71⁄ beyond detec-
tion, which can be attributed to an equilibrium between open and
closed conformations (with residues preceding Ser71⁄ retaining
their location in the closed state) or to conformational changes
within the closed state [7]. The non-uniform peak intensities in
the presence of BPTI indicate that the inhibitor does not eliminate
all conformational exchange processes in the protease. As the PCSs
ofNS2Bc closelymatch the expectations for the closed conformation
and we could not observe signals of an additional conformation, we
estimate that at most 10% of NS2Bc in an open conformation could
have escaped detection.
On a technical note, our data illustrate the power of pseudocon-
tact shifts for the structure analysis of proteins and protein–ligand
complexes in aqueous solution, even if the lanthanide tag is attached
via a fairly flexible linker. An earlier analysis of the C1 tag (which is
the opposite enantiomer of the C2 tag used here) attached to the
NS2B–NS3 protease concluded that themobility of the tag can com-
promise the prediction of accurate PCSs of a ligand, if a single effec-
tive Dv tensor is fitted to all experimental PCS data of the protein
[41]. This effect arises from the fact that, in principle, displacements
of the metal requires the fitting of multipleDv tensors for accurate
PCS back-calculations. Much improved PCS predictions are already
expected, however, if a single effectiveDv tensor is fitted to a subset
of PCSs measured for nuclear spins in the vicinity of the ligand. This
expectation is borne out by the experimental data of the present
work, as the PCSs predicted for NS2Bc matched the experimental
results much better, when PCSs from nuclear spins of BPTI were
included to fit theDv tensorwhile excluding those BPTI amides that
were located far from themetal site. In this way, the approximation
of the PCSdata by a single effectiveDv tensor resulted in a goodfit of
PCSs for nuclear spins in the vicinity of NS2Bc (Fig. 3F), producing a
meaningful prediction of PCSs for NS2Bc and comparison with
experimental PCSs.
In conclusion, our results stress the stability of the closed con-
formation of the dengue virus NS2B–NS3 protease, at least for sero-
type 2 which is the serotype with the highest global growth rate
over the last decade [43]. NMR studies of the other serotypes will
be required to assess the effect of sequence differences on the
prevalence of open conformations. Our results also highlight the
way in which PCSs induced by fairly mobile lanthanide tags can
be used to obtain useful structural information in solution for pro-
tein systems that are difficult to analyse in detail by conventional
techniques.
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Supplementary Material 
The dengue virus NS2B-NS3 protease retains the closed conformation in 
the complex with BPTI 






Fig. S1. BPTI produced by cell-free synthesis is correctly folded. The figure shows 
1D 1H NMR spectra of BPTI produced by cell-free synthesis on the top and of 
commercial BPTI (Sigma, derived from bovine lung) at the bottom. Peaks from 
solvent and buffer are truncated. The NMR buffer (90% H2O/10% D2O) contained 20 
mM MES, pH 6.5, and 50 mM NaCl. The spectra were recorded of 0.2 mM protein 





Fig. S2. BPTI protects the NS2B-NS3 protease against degradation. The figure shows 
15N-HSQC spectra of 0.1 mM solutions of selectively 15N-Ile-labelled wild-type 
NS2B-NS3pro in the presence and absence of BPTI. Same sample conditions and 
temperature as in Fig. S1. (A) Sample purified in the presence of BPTI. The spectrum 
was recorded following addition of BPTI to a nominal ratio of about 1.1:1 (BPTI to 
protease). (B) Spectrum recorded of NS2B-NS3pro in the absence of inhibitor. The 
resonance assignment is taken from ref. [1]. The circles highlight weak narrow cross-
peaks absent from the spectrum in (A), indicating sample degradation. The cross-
peaks of I178 and I182 from the unstructured C-terminal segment of NS3pro were 
very weak in the spectrum in (A) for unknown reasons. The same experiment 
performed with the mutant S68C displayed these cross-peaks with usual intensities 






Table S1. PCSs of backbone amide protons in the complex between NS2B-NS3pro 













NS2B     
 
Arg55* -0.66 -0.65  21.6 -0.61 22.4 
Ala57* -0.39 -0.41  24.6 -0.40 25.2 
Glu62* -0.08 -0.09  34.5 -0.10 34.9 
Glu63* -0.08 -0.07  38.4 -0.08 38.8 
Ala65* -0.06 -0.06  38.6 -0.07 38.8 
Ser71*   0.02  0.01  40.4  0.01 40.1 
Ile73*   0.04  0.04  39.6  0.04 39.1 
Ser75*   0.08  0.07  37.4  0.07 36.8 
Thr77*   0.16  0.12  31.7  0.13 30.9 
Ile 78*  0.19  0.19  28.5  0.19 27.7 
Gly82*   0.50  0.39  21.8  0.45 20.9 
Ser83*   0.38  0.30  23.0  0.37 22.2 
Ile86*   0.12  0.09  33.0  0.11 32.3 
NS3pro     
 
Lys28 -0.48 -0.48 16.2 -0.49 16.7 
Tyr41 -0.69 -0.69 19.1 -0.70 19.7 
His51  0.38  0.37 16.1  0.42 15.7 
Val52 -0.02 -0.01 15.5  0.01 15.3 
Thr53 -0.28 -0.28 13.1 -0.30 13.0 
Gly62 -0.64 -0.64 15.7 -0.67 16.8 
Trp89  0.08  0.07 28.7  0.03 28.5 
Leu98 -0.12 -0.15 27.7 -0.16 27.9 
Thr111 -0.05 -0.03 35.5 -0.04 35.5 
Phe116  0.10  0.09 32.3  0.07 31.8 
Thr120  0.16  0.15 31.3  0.14 30.4 
Gly121  0.14  0.16 30.8  0.14 30.0 
Thr122  0.15  0.12 32.1  0.10 31.5 
Ile123  0.12  0.11 31.3  0.10 30.7 
! S4 
Val140 -0.08 -0.07 29.1 -0.09 29.2 
Gly148 -0.03 -0.02 24.8 -0.08 24.8 
BPTI      
Phe4   0.10  0.04 35.7  0.08 35.1 
Leu6   0.10  0.04 37.0  0.07 36.4 
Thr11  0.08  0.03 30.0  0.07 29.6 
Ala16  0.02 -0.05 21.8  0.00 21.6 
Arg17 -0.13 -0.22 20.8 -0.17 20.8 
Ile18 -0.08 -0.08 22.5 -0.01 22.4 
Arg20  0.07 -0.01 25.5  0.06 25.4 
Phe22  0.07  0.03 30.2  0.07 30.0 
Ala25   0.06  0.02 38.3  0.05 37.9 
Lys26   0.06  0.02 40.5  0.04 40.2 
Ala27   0.04  0.01 40.5  0.03 40.3 
Leu29   0.04  0.02 38.3  0.04 38.1 
Thr32  0.02 -0.00 31.7  0.03 31.7 
Phe33  0.05 -0.00 28.2  0.05 28.0 
Arg39  0.35  0.20 23.1  0.31 22.4 
Ala40  0.31  0.17 23.4  0.30 22.8 
Lys41  0.18  0.09 27.2  0.17 26.6 
Arg42  0.20  0.08 29.7  0.15 29.0 
Phe45  0.16  0.07 26.3  0.15 25.9 
Lys46  0.26  0.12 23.3  0.24 22.9 
Ala48  0.11  0.06 27.1  0.11 27.0 
Arg53   0.13  0.06 31.4  0.10 31.0 
Thr54   0.15  0.05 31.5  0.10 31.0 
 
a Samples contained either uniformly 15N-labelled NS2B-NS3pro with unlabelled 
BPTI or unlabelled NS2B-NS3pro with selectively 15N-labelled Ala, Arg, Lys, Thr, 
Leu, Phe, Ile labelled BPTI. In each case, NS2B-NS3pro was the S68C mutant tagged 
with either C2-Tb3+ (paramagnetic sample) or C2-Y3+ (diamagnetic reference). PCSs 
were measured as the chemical shifts observed with C2-Tb3+ minus the chemical 
shifts observed with C2-Y3+.  
b Fit 1 was obtained from fitting a Δχ tensor to the crystal structure 3U1J [2], using 
the PCSexp values of backbone amide protons of NS3pro and NS2B (residues 55*–
! S5 
65*).  The Δχ tensor determined by Fit 1 was subsequently used to back-calculate 
PCS data, PCScal, for the same protein structure. Data in bold are PCSs back-
calculated for nuclear spins, the PCSexp data of which were not used for the tensor 
determination by Fit 1. To back-calculate PCScal values for NS2Bc residues without 
electron density in the structure 3U1J, their coordinates were generated by crafting the 
corresponding coordinates from 3U1I [2] onto 3U1J, following superimposition of the 
NS2Bn and NS3pro residues of both crystal structures.  
c Fit 2 was performed like Fit 1, except using the PCSexp data of NS2B (residues 55*–
65*), NS3pro, and BPTI residues within 30 Å from the metal centre determined by Fit 
1. PCScal values of NS2Bc and BPTI are highlighted in bold if they were not used in 
Fit 2.  
d Distance of the nuclear spin from the metal centre determined by the Δχ-tensor 
determination of Fit 1. 
e Distance of the nuclear spin from the metal centre determined by the Δχ-tensor 







Fig. S3. Comparison of back-calculated and experimental PCSs for residues that were 
excluded from the Δχ-tensor fits. (A) Experimental PCSs and PCSs predicted by Fit 1 
for backbone amide protons of NS2Bc. Filled and open squares indicate experimental 
and calculated PCSs, respectively. The PCScal values match the PCSexp data less well 
than in Fig. 3D, because Fit 1 did not include PCSs from BPTI. This demonstrates the 
importance of determining the Δχ-tensor from PCS data of nuclei located near NS2Bc 
[3]. (B) Experimental PCSs (filled triangles) and PCSs predicted by Fit 2 (open 
triangles) for backbone amide protons of BPTI. Data of residues further than 30 Å 
from the metal center (determined by Fit 1) are highlighted in red; they were not used 
in the Δχ-tensor determination of Fit 2. By including a number of amides from BPTI 
in the Δχ-tensor fit, Fit 2 resulted in better agreement between predicted and 





Fig. S4. Correlation between back-calculated and experimental PCSs for backbone 
amide protons, using the open conformation of Fig. 1A (2FOM [4]) and the PCSs of 
Table S1 to fit a Δχ tensor to NS2Bn and NS3pro. The data of NS2Bn (residues 55*–
65*), NS2Bc (residues 66*–95*) and NS3pro are shown as red, blue and black points, 
respectively. The structure 2FOM contains electron density for only four of the 
NS2Bc residues, for which PCSs could be measured. For these residues, negative 
PCSs are predicted by the Δχ tensor but positive PCSs were measured, demonstrating 
that this or similar conformations of NS2Bc are not highly populated in solution in the 
complex with BPTI. 
! S8 
 
Fig. S5. Stereo view of crystal contacts at the NS2B binding site in the structure 
3U1J. Grey: NS3pro; cyan: BPTI; orange: NS2B; light orange: NS2Bc copied from 
the crystal structure with the peptide inhibitor Bz-nKRR-H (3U1I, [2]); red: residues 
6–13 from a neighboring NS3pro molecule in the crystal lattice of 3U1J, which 
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ABSTRACT: O-tert-Butyltyrosine (Tby) is an unnatural amino acid
that can be site-speciﬁcally incorporated into proteins using
established orthogonal aminoacyl-tRNA synthetase/tRNA systems.
Here we show that the tert-butyl group presents an outstanding NMR
tag that can readily be observed in one-dimensional 1H NMR spectra
without any isotope labeling. Owing to rapid bond rotations and the
chemical equivalence of the protons of a solvent-exposed tert-butyl
group from Tby, the singlet resonance from the tert-butyl group generates an easily detectable narrow signal in a spectral region
with limited overlap with other methyl resonances. The potential of the tert-butyl 1H NMR signal in protein research is illustrated
by the observation and assignment of two resonances in the Bacillus stearothermophilus DnaB hexamer (320 kDa), demonstrating
that this protein preferentially assumes a 3-fold rather than 6-fold symmetry in solution, and by the quantitative measurement of
the submicromolar dissociation constant Kd (0.2 μM) of the complex between glutamate and the Escherichia coli aspartate/
glutamate binding protein (DEBP, 32 kDa). The outstanding signal height of the 1H NMR signal of the Tby tert-butyl group
allows Kd measurements using less concentrated protein solutions than usual, providing access to Kd values 1 order of magnitude
lower than established NMR methods that employ direct protein detection for Kd measurements.
■ INTRODUCTION
NMR spectroscopy oﬀers structural information on biological
macromolecules at a level of detail that is unsurpassed by any
other solution method. The resolution of the solution NMR
spectrum of a large protein, however, is compromised both by
the number of NMR resonances as well as by line widths that
increase with molecular mass.1 These problems are routinely
addressed by labeling with 15N and 13C to facilitate the
recording of multidimensional NMR spectra. In addition,
perdeuteration of the protein leads to narrower NMR signals of
the remaining 1H spins, permitting in exceptional cases two-
dimensional (2D) NMR spectra to be recorded of protein
multimers approaching total molecular masses of 500 kDa and
beyond.2−4 In particular, methyl groups are relatively easy to
observe in such systems because methyl groups rotate rapidly,
which results in chemical shift degeneracy of the three methyl
protons and favorable 1H relaxation properties.5 It is a quite
general phenomenon that enhanced mobility produces
narrower, more easily observable NMR signals. For example,
highly ﬂexible polypeptide segments are typically found at the
N- and C-termini of a protein and their NMR resonances can
often be observed without perdeuteration even when the
molecular weight of the system is large.6
These observations prompted us to investigate the potential
of an unnatural amino acid containing a mobile tert-butyl group.
Methods have recently been established for the genetic
encoding of O-tert-butyltyrosine (Tby),7,8 but NMR spectra
of proteins with Tby incorporated in this way have not been
reported, although the value of monitoring the NMR signal of a
site-speciﬁcally incorporated chemical “spy” is well established.
For example, Geierstanger and co-workers have shown that the
NMR resonances of the methyl- and CF3-groups of p-
methoxyphenylalanine (OMePhe) and p-triﬂuoromethoxyphe-
nylalanine (OCF3Phe) can readily be observed after site-
speciﬁc incorporation at diﬀerent locations of a 33 kDa
protein.9 The signals of the newly introduced 13CH3- and CF3-
groups were readily observed in two-dimensional (2D) 13C
HSQC and 1D 19F NMR spectra, respectively. Similarly, Mehl
and co-workers demonstrated that site-speciﬁc incorporation of
triﬂuoromethylphenylalanine (CF3Phe) produced 1D
19F NMR
spectra that allowed distinction of diﬀerent ligand- and metal-
bound states in 48 and 98 kDa homodimers.10 While the 1H
NMR resonances of methyl groups are diﬃcult to resolve
without additional labeling with 13C, the main drawback of 19F
NMR is the large chemical shift anisotropy (CSA) associated
with 19F spins which leads to broad NMR resonances. As CSA
relaxation rates increase with the square of the magnetic ﬁeld
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strength, 19F NMR spectra are best recorded at relatively low
NMR frequencies, compromising sensitivity. In contrast, the
tert-butyl group of Tby can be observed by 1H NMR with
increasing sensitivity at increasing magnetic ﬁelds. We
hypothesized that, owing to the intensity of the methyl
resonance (corresponding to nine degenerate 1H spins) and the
decreased relaxation rate associated with a mobile, solvent
exposed tert-butyl group, its observation by high-ﬁeld NMR
should be straightforward without any stable isotope labeling.
In the following we show that Tby indeed produces a 1H
NMR signal that is readily observable in proteins without
isotope labeling, including a 320 kDa system. Furthermore, we
show that the outstanding sensitivity of the tert-butyl resonance
allows its detection in dilute protein solutions, eﬀectively
reducing the protein demand by 1 order of magnitude. Finally,
we show that Tby is an excellent probe for direct NMR
measurements of submicromolar ligand binding aﬃnities.
■ RESULTS
Incorporation of Tby. For site-speciﬁc incorporation of
Tby into proteins, we chose the p-cyanophenylalanyl-tRNA
synthetase (pCNF-RS) evolved from the Methanocaldococcus
jannaschii tyrosyl-RS encoded in the pUltra system together
with the requisite tRNACUA for recognition of TAG stop
codons.11 Bacillus stearothermophilus (Bst) DnaB was produced
in fusion with the solubility enhancer GB1 by in vivo expression
in Escherichia coli (Supporting Information Figures S1 and
S2A), whereas Staphylococcus aureus sortase A (SrtA) and the E.
coli aspartate/glutamate binding protein (DEBP) were
produced from linear PCR ampliﬁed DNA in a cell-free system
based on an E. coli cell extract, from which the release factor 1
had been selectively removed by tagging with chitin-binding
domains and ﬁltration over chitin (Figure S2B).12 The fusion
with GB1 did not signiﬁcantly change the 1D 1H NMR
spectrum of the Bst DnaB hexamer (Figure S3A).
NMR Spectroscopy of DnaB-Tby. Figure 1A compares
the 1D 1H NMR spectrum of the mutant Tyr104Tby with the
corresponding spectrum of wild-type DnaB. As expected for a
high-molecular-weight system, the proteins display very broad
signals, whereas very narrow signals arise from buﬀer or low-
molecular-weight impurities. Two new signals at about 1.2
ppm, however, are observed for DnaB-Tby but not wild-type
DnaB. Their chemical shifts agree with the chemical shift of the
tert-butyl group in free Tby (1.26 ppm in 25 mM Tris-HCl, pH
7.5). The observation of two resonances is in agreement with
the two diﬀerent chemical environments of the Tby site in
crystal structures of the Bst DnaB hexamer in complex with
DnaG (Figure 1B and C).13 Previous electron microscopy
studies of E. coli DnaB had reported hexamers with 3-fold and
6-fold symmetries.14−16 The observation of two, rather than
one, tert-butyl resonances identiﬁes the 3-fold symmetry as the
symmetry prevailing for the Bst helicase in solution.
To assign the local environments which the two resonances
belong to, we introduced the additional mutations Cys253Val,
Ala303Cys, and Cys305Val to enable site-speciﬁc ligation with a
lanthanide tag at position 303. At the same time, the natural
amino acids of the protein were perdeuterated to conﬁrm the
assignment of the tert-butyl signals. The mutations did not alter
the appearance of the tert-butyl signals (Figure 1A). Following
ligation of the cysteine residue with a C1-tag17 loaded with
Ce3+ (Figure S4A), one of the two Tby resonances broadened
signiﬁcantly, assigning it to the site, which is within 15 Å of Ala
303 in the crystal structure. This result presents further
Figure 1. Conformational study of Bst DnaB helicase. (A) 1D 1H
NMR spectra of wild-type and mutant Bst DnaB. The spectra were
recorded in a buﬀer of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl at 25
°C, using a Bruker 600 MHz NMR spectrometer. Protein
concentrations were about 20−40 μM and the total recording time
per spectrum was 0.5−2 h. (i) Wild-type DnaB. (ii) DnaB with Tby at
site 104. The tert-butyl group displays two peaks (highlighted by a
frame). Unassigned narrow signals are from impurities in the buﬀer.
(iii) Perdeuterated DnaB (70% deuteration) with Tby at site 104 and
containing the additional mutations Cys253Val, Ala303Cys, and
Cys305Val. The reduced intensity of the background conﬁrms the
identiﬁcation of the Tby tert-butyl resonances. (iv) Same as (iii),
except with a C1-Ce tag ligated to Cys 303. The downﬁeld, but not the
upﬁeld, tert-butyl peak is aﬀected, assigning the downﬁeld peak to the
Tby residue near residue 303 of the neighboring DnaB molecule, and
conﬁrming that residue 104 exists in two diﬀerent chemical
environments as expected for a hexamer with C3 symmetry. (B)
View of the crystal structure of the DnaB hexamer along the C3
symmetry axis (PDB: 2R6A).13 Each monomer is colored diﬀerently,
showing the N-terminal domains in a cartoon representation, while the
linker segments and the C-terminal domains are in a surface
representation. The sites of Tyr 104, which was replaced by Tby in
this work, are highlighted by red spheres. The sites of residue 303,
mutated to a cysteine for subsequent ligation with the C1-Ce tag, are
identiﬁed by yellow spheres. (C) The C1-Ce tag modeled at Cys 303
(yellow) is close to Tyr 104 in the blue monomer, but far from Tyr
104 in the green monomer in the crystal structure 2R6A. The N- and
C-terminal domains are shown in cartoon and surface representations,
respectively, as in (B). Tyr 104 is shown in red.
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conﬁrmation that the crystal structure of the Bst hexamer
reﬂects its predominant three-dimensional (3D) structure in
solution.
Most importantly, the result clearly demonstrates the
possibility to detect the Tby tert-butyl resonance in systems
of high molecular mass at low concentration without any
isotope labeling. For comparison, we also incorporated a
triﬂuoromethyl-phenylalanine residue in position 104 and
recorded a 19F NMR spectrum at a 1H NMR frequency of
500 MHz. The line width of the 19F NMR resonance was about
160 Hz at half height and thus too broad to resolve two
diﬀerent signals (Figure S5).
NMR Spectroscopy of Sortase A with Tby. Figure 2A
and B compares the 1D 1H NMR spectra obtained with the
Thr150Tby mutant of S. aureus sortase A and the eﬀects of
calcium and inhibitor binding on the chemical shift of the tert-
butyl resonance of Tby. The chemical shift of the tert-butyl
group is unusually high-ﬁeld, which can be attributed to ring
current eﬀects arising from its proximity to the side chain of
Phe 144. Despite the distance of the Tby residue from the
active site marked by Cys 184 (about 25 Å) and the calcium
binding site (about 20 Å, Figure 2C), the chemical shift of the
tert-butyl resonance was sensitive to the presence of Ca2+ or
inhibitor, or both. Therefore, the Tby residue can be used for
remote sensing of changes in the substrate binding site of the
enzyme. Although the presence of calcium causes many spectral
changes in the 1H NMR spectrum of the protein, the tert-butyl
resonance is easily picked out as the tallest resonance in the
range between 0 and 1.7 ppm (Figure 2A). The size of the
resonance greatly facilitates monitoring its chemical shift in
titration experiments, and its narrow line width magniﬁes the
signiﬁcance of even small chemical shift changes. The inhibitor
used here (Figure S4B) is known to bind irreversibly by
formation of a covalent bond to the active-site cysteine.18 As
expected for a system with slow or no chemical exchange, the
tert-butyl resonances of the inhibitor bound and unbound states
of the protein appeared simultaneously at half-saturation
(Figure 2B). A control experiment conﬁrmed that the dimethyl
sulfoxide (DMSO) of the inhibitor stock solution caused much
smaller chemical shift changes than the ligand (Figure S3B).
Measuring Submicromolar Dissociation Constants. E.
coli DEBP is a periplasmic transport protein that reversibly
binds aspartate or glutamate. It binds glutamate with a binding
aﬃnity of 260 nM, as measured by isothermal calorimetry
(ITC; B. Clifton and C. J. Jackson, personal communication).
Despite the high molecular mass of the protein (32 kDa), the
tert-butyl resonance is clearly visible in the 1D 1H NMR
spectrum of the mutant Val140Tby and over 1 order of
magnitude taller than any other signal of the protein (Figure
3A). Therefore, NMR spectra of good sensitivity can be
recorded at low protein concentrations, which is a prerequisite
for determining small dissociation constants from chemical shift
changes of protein resonances. Titration of glutamate into the
protein solution indeed led to small changes in chemical shifts,
indicating fast exchange between the bound and free state of
the protein (Figure 3B).
Figure 2. Ligand binding study of S. aureus sortase A. The spectra were
recorded at 25 °C using a Bruker 800 MHz NMR spectrometer. (A)
1D 1H NMR spectra of sortase A with Tby incorporated at position
150. Top trace: 20 μM protein in 20 mM MES buﬀer, pH 6.5, 50 mM
NaCl, 5 mM CaCl2. Bottom trace: same as above, but without CaCl2
and with 1 mM EDTA. (B) 1D 1H NMR spectra of a sortase A/
inhibitor complex with (top) and without (bottom) calcium. The
protein concentration was 20 μM. Black: inhibitor-free state. Red: half-
saturation with inhibitor. Blue and magenta: inhibitor-bound state with
50% excess inhibitor. The inhibitor18 was added from a 5 mM stock
solution in DMSO-d6. The ﬁnal concentration of DMSO in the
protein solution was always less than 1%. Arrows indicate the direction
of chemical shift change upon addition of inhibitor. (C) Cartoon
representation of sortase A (PDB: 1IJA19). Inhibitor, calcium, and the
mutation site for Tby are shown as red sticks, a white sphere, and an
orange sphere, respectively. The ligand and calcium coordinates were
taken from the PDB ﬁles 2MLM18 and 2KID,20 respectively.
Figure 3. Binding aﬃnity measurement of E. coli DEBP for glutamate.
The 1D 1H NMR spectra were recorded in 20 mM phosphate buﬀer,
pH 7.5, 100 mM NaCl at 25 °C, using a Bruker 800 MHz NMR
spectrometer. (A) NMR spectra of 50 μM solutions of DEBP. The top
and bottom traces show the spectra of the mutant with Tby at position
140 and of wild-type DEBP, respectively. The signal of the tert-butyl
group appears at about 1.24 ppm. Other narrow signals are from low-
molecular weight impurities. (B) Titration of glutamate (1 mM stock
solution in H2O) into a 2 μM solution of DEBP. The tert-butyl
resonance shifts upﬁeld with increasing concentration of glutamate
(indicated by the arrow). Each spectrum was acquired with a total
recording time of 30 min on a 800 MHz NMR spectrometer equipped
with a cryoprobe. (C) Fit of the binding aﬃnity curve by eq 1. For best
accuracy, the chemical shifts were determined by ﬁtting Lorentzian line
shapes to the tert-butyl resonances in (B). Kd was calculated as 0.20
μM with a standard error of 0.08 μM.
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The observed chemical shift changes can be described by eq
1:
Δ = Δ + +
− + + −
K L P
K L P PL P
{( )
[( ) 4 ] }/(2 )






where Δobs is the observed change in chemical shift, Δmax is the
maximal chemical shift change observed when the protein is
fully saturated with ligand, Lt and Pt are the total concentrations
of ligand and protein, respectively, and Kd is the dissociation
constant. The Kd value obtained by ﬁtting the observed changes
in chemical shifts by eq 1 was 0.20 μM (Figure 3C), in close
agreement with the value determined by ITC measurement.
Near-Isotropic Bond Reorientation in Tby. The tert-
butyl group of Tby produces an exceptionally narrow line
because of its motional freedom. When it is fully solvent
exposed, three diﬀerent bond rotations contribute to the
reorientation of the C−H bonds of the methyl groups. First,
each methyl group rotates about its axis of symmetry. Second,
the tert-butyl group reorientates by rotation about the C−O
bond, that projects from the aromatic ring. Finally, the
following O−C bond to the tert-butyl group is free to rotate.
Crystal structures of compounds with tert-butyl-phenyl groups
show dihedral angles of about 90° for the C−O bond,
positioning the tert-butyl group outside the plane of the
aromatic ring (Figure 4A). Assuming dihedral angles of 90° or
270° for the C−O bond, and 60°, −60°, or 180° for the O−C
bond and the methyl group rotamers, an individual C−H group
of a methyl can access 2 × 3 × 3 = 18 diﬀerent rotameric states.
Assuming equal probability of each dihedral angle combination
owing to unrestricted motions of a solvent-exposed tert-butyl
group, the C−H bond populates a remarkably isotropic
distribution of orientations (Figure 4B). As a measure of the
degree of isotropy, concatenation of all C−H bond vectors
produced by the 18 rotameric states yields a sum vector of a
length of only about 1 Å. Although each rotamer may be
associated with diﬀerent opportunities for dipole−dipole
relaxation depending on the location of other protein protons
in the vicinity, the remarkably slow relaxation of the tert-butyl
resonance is fundamentally due to its exceptionally high degree
of mobility.
■ DISCUSSION
The present work shows that tert-butyl-tyrosine is an
outstanding probe for the study of small and large proteins at
natural isotopic abundance by NMR spectroscopy. The intense
1H NMR signal of the tert-butyl group is easily detected in one-
dimensional NMR spectra due to its narrow line width and
chemical shift that is well separated from the NMR resonances
of most organic buﬀers, the water resonance, and the usually
dominant methyl signals of valine, leucine, and isoleucine. The
system for genetic encoding of Tby is well established,7
allowing its incorporation at any site of a protein. Importantly,
the 1H chemical shift of the tert-butyl resonance is still sensitive
to changes in the chemical environment of the protein, even if
the tert-butyl group is solvent exposed. Therefore, it can be
used to monitor the state of a protein, which is of particular
interest for studies of ligand binding.
Measurements of Dissociation Constants. The results
obtained with DEBP demonstrate the outstanding advantage of
Tby for ligand binding studies, in particular for the measure-
ment of tight binding aﬃnities. Measurements of small
dissociation constants by direct observation of protein signals
require a protein concentration in the order of the Kd value.
The intensity of the tert-butyl resonance provides the sensitivity
required to measure dilute solutions even of large proteins.
A graphical representation of titration curves for diﬀerent Kd
values illustrates the diﬃculty to measure dissociation constants
that are much smaller than the protein concentration (Figure
5). To obtain Kd values with reasonable accuracy, a practical
recommendation is to aim for protein concentrations that
produce saturation ratios of ligand-bound protein to total
protein between 0.2 and 0.8, when ligand and protein are
present in 1:1 ratio.22 Figure 5 shows that this condition is
fulﬁlled for Kd values that are 10 times smaller than the protein
concentration, but not if they are 100 or 1000 times smaller
(see also Figure S6). Therefore, the measurement of
submicromolar Kd values requires the ability to measure at
protein concentrations in the low micromolar range. Such low
concentrations pose a serious challenge in sensitivity for
contemporary NMR spectrometers, especially if the NMR
resonances of the protein are broad due to high molecular
weight or chemical exchange broadening. As a result, NMR
Figure 4. Methyl groups of O-tert-butyl-tyrosine can change their
orientation in multiple directions. (A) Stick representation of the O-
tert-butyl-tyrosine residue as determined by X-ray crystallography.21
(B) Diﬀerent orientations of a single methyl C−H bond produced by
rotations around bonds of the O-tert-butyl group, including dihedral
angles of 90° or 270° for the C−O bond, and 60°, −60°, or 180° for
the O−C bond and the methyl groups. The variability in the resulting
C−H bond orientations is highlighted by superimposing the carbon
atom of each of the 18 rotameric states. The carbon and hydrogen
atoms of the C−H group are represented by black and white spheres,
respectively. Some of the rotamers produce degenerate orientations.
Figure 5. Titration curves calculated for diﬀerent dissociation
constants Kd. The curves were calculated using eq 1. The vertical
axis plots the saturation of the protein with ligand (ratio of bound
protein, PL, relative to total protein, Pt). The horizontal axis plots the
ratio of total ligand concentration, Lt, to total protein concentration.
The curves are labeled with the respective dissociation constants
normalized by the total protein concentration, Kd/Pt.
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spectroscopy is traditionally regarded as a unique tool for
detecting complexes with weakly binding ligands, whereas Kd
values much smaller than about 10 μM are practically
inaccessible by direct observation of protein resonances even
in the case of small proteins,23 let alone proteins of the
molecular mass of DEBP. The exceptional peak height of the
1H NMR resonance of the tert-butyl group of Tby changes this
situation and lowers the detection limit by more than an order
of magnitude. In principle, ligand detected competition
experiments are a viable alternative for determining nanomolar
binding aﬃnities by NMR spectroscopy, but these experiments
are less straightforward than the direct monitoring of an NMR
resonance of the target protein in a protein observed
experiment because they require the availability of an
additional, diﬀerent ligand, for which the dissociation constant
must be determined independently.24
Tight binding aﬃnities are invariably associated with slow
dissociation rates, as the dissociation constant can be calculated
from the ratio of dissociation versus association rates and
diﬀusion poses an upper limit on the rate of complex formation.
In the limit of slow chemical exchange between bound and free
protein, separate NMR signals are observed and eq 1 no longer
applies. Importantly, however, the limit between the fast and
slow chemical exchange regimes depends on the frequency
diﬀerence of the NMR resonances in the respective states, with
small frequency diﬀerences extending the fast exchange regime
to slower exchange rates. For the measurement of small
dissociation constants, it is thus an advantage if the NMR signal
which is monitored displays only small chemical shift changes
upon titration with ligand, as in the case of a solvent-exposed
tert-butyl group. As the examples of sortase A and DEBP show,
the narrow line shape of the 1H NMR resonance of the tert-
butyl group of Tby permits accurate measurements also of
small changes in chemical shift, allowing the positioning of the
Tby probe suﬃciently far from the ligand binding site to avoid
any interference with ligand binding. In practice, we found that
narrow NMR signals from buﬀer or low-molecular weight
impurities provide excellent internal controls to conﬁrm the
accurate alignment of the NMR spectra recorded in a titration
experiment.
Tby as a Probe in High-Molecular-Weight Systems.
Established strategies for solution NMR spectroscopy of high-
molecular weight systems employ isotope labeling strategies, in
particular per-deuteration to reduce dipolar relaxation rates of
the remaining 1H spins.25,26 Selective labeling or unlabeling of
all amino acid residues of a certain type, however, usually labels
more than a single site, making it challenging to obtain site-
speciﬁc information. In contrast, the incorporation of a single
unnatural amino acid naturally produces a label at a
predetermined site, which is deﬁned by the amber stop
codon placed in the gene of interest.
In the case of Bst DnaB, the Tby probe positioned at a
solvent exposed site of the N-terminal domain of the protein
not only revealed clear 1H NMR resonances of the tert-butyl
group, but also provided clear evidence for the C3 symmetry of
the hexamer as two diﬀerent chemical environments of the tert-
butyl group were apparent. Considering the molecular mass of
the hexamer (320 kDa), it is remarkable that this could be
achieved without isotope labeling, highlighting the substantial
line narrowing associated with a mobile tert-butyl group of Tby.
Once a site-speciﬁc signal can be observed, it oﬀers a
convenient probe for further structural analysis. In the case of
Bst DnaB we were able to verify the crystal structure of the
hexamer by the selective line broadening observed for one of
the signals, when an intermonomer contact with a paramagnetic
tag was produced in a cysteine mutant of the protein. The C1-
tag is a cyclen-based lanthanide-binding tag designed to induce
pseudocontact shifts (PCS). In the case of the Bst DnaB mutant
with Tby residue and C1-Ce tag, the observation of line
broadening rather than PCS can be attributed to paramagnetic
relaxation enhancement, which becomes more severe with
increasing molecular weight,27 or to reduced motional freedom
of the tert-butyl group due to interactions with the tag. For
protein systems of lower molecular mass, where the tert-butyl
signal is more readily observable, it will be possible to use a
lanthanide tag to gain further structural information by
inducing pseudocontact shifts in the tert-butyl resonances of
Tby residues positioned at diﬀerent sites of the protein.
■ CONCLUSION
In conclusion, the Tby probe oﬀers superior sensitivity in 1H
NMR spectra, which makes larger and less soluble proteins
amenable to NMR analysis than hitherto possible. The NMR
signal of the tert-butyl group can be observed with minimal
interference from the protein background. The robustness with
which the tert-butyl group can be detected also in the presence
of large concentrations of buﬀer and ligands could be enhanced
further by 13C labeling. While, in principle, isotope labels can be
deployed to study wild-type proteins, the introduction of a Tby
residue requires a point mutation. Notably, however, the
capacity to study proteins without perdeuteration is important
too, as perdeuterated proteins can be signiﬁcantly less stable
than their unlabeled forms, which can result in slightly diﬀerent
structures.28,29 Unlabeled Tby is commercially available and
inexpensive. We anticipate that the Tby probe will become an
extremely valuable tool in structural biology and drug discovery.
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O-tert-Butyltyrosine, an NMR tag for high-molecular weight systems and 
measurements of submicromolar ligand binding affinities 
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Expression constructs 
The DNA nucleotide sequence of the Bacillus stearothermophilus (Bst) gene for DnaB was 
codon optimized for expression in E. coli using the program OPTIMISER.1 The construct of 
the wild-type protein included a protein G B1 domain as a N-terminal solubility enhancement 
tag,2 preceded by a MASMTG sequence (coded by 5’ nucleotides of the bacteriophage T7 
gene 10) and a His6-tag. A tobacco etch virus (TEV) protease cleavage site was inserted 
between the GB1 domain and the DnaB (Figure S1).  
 
The S. aureus sortase A (SrtA) construct used in this study is the catalytic domain (residues 
60-206) of the full-length protein without the signal polypeptide. The catalytic core has been 
reported to retain the enzymatic activity.3,4 The sequence was preceded by a MASMTG tag at 
the N-terminus, and contained a TEV cleavage site and a His6-tag at the C-terminal end.  
 
The expression construct for the wild-type E. coli aspartate/glutamate binding protein 
(DEBP) was preceded by a MHHHHHHMENLYFQG sequence, resulting in 291 residues.  
 
The genes were cloned into the T7 expression plasmid pETMCSI,5 which was transformed 
into the E. coli strain TOP10 for plasmid progression. Sites for the incorporation of O-tert-
butyl-tyrosine (Tby) were selected by inspection of the three-dimensional protein structures 
to make sure that the tert-butyl group would be solvent exposed, using the structures with the 
PDB accession codes 2R6A for Bst DnaB,6 1IJA and 2KID for S. aureus SrtA,4,7 and 2VHA 
for E. coli DEBP.8 Site-directed mutations were generated by two pairs of primers (IDT-
DNA Technologies) using Q5 DNA polymerase (New England Biolabs), following a 
modified overlap extension protocol as described.9 The PCR amplified products were 
digested with the restriction enzymes NdeI and EcoRI for insertion into pETMCSI.  
 
 S2 
Protein expression and purification 
Bst DnaB proteins containing Tby were produced by using a published pUltra vector10 to 
express p-cyanophenylalanyl-tRNA synthetase (pCNF-RS) and the requisite tRNACUA. The 
pUltra vector was co-transformed into E. coli BL21 (DE3) together with the pETMCSI T7 
vector harbouring the target Bst DnaB mutant. The proteins were produced in a high-cell 
density protocol to minimize the usage of unnatural amino acid.11 After the 1L cell culture 
reached OD600 0.5-1.0, the cells were spun down at 5,000 g at 10 oC and then resuspended in 
250 mL fresh Luria-Bertani medium containing 1 mM Tby (Sigma-Aldrich). Following a 
recovery period of 1-2 h shaking at 37 oC, isopropyl-β-D-thiogalactopyranoside (IPTG) was 
added to a final concentration of 1 mM for protein overexpression. Perdeuterated DnaB 
samples were prepared in a similar way, except that the cells from a 1 L culture were washed 
twice using 25 mL minimal medium made from 70% D2O and 99% D2O prior to 
resuspension in minimal medium prepared in 99% deuterium oxide. Unlabeled ammonium 
chloride and glucose were used as nitrogen and carbon source, respectively. Following 
overnight expression at 25 oC, the cells were lysed by sonication and the lysate was loaded 
onto a 5 mL Ni-NTA column (GE Healthcare, USA). The target protein was then eluted 
using a gradient buffer mixture of buffer A (50 mM Tris-HCl, pH 7.5, 300 mM NaCl) and 
buffer B (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 300 mM imidazole). To separate the 
truncation product from the full-length DnaB, the protein was dialyzed into buffer C (25 mM 
Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM DTT), concentrated to 500 µL using a centrifugal 
filter unit with molecular weight cut-off (MWCO) of 10 kDa (Amicon Ultra, Millipore, 
Billerica, USA), and loaded onto a Superdex 200 column (GE Healthcare, USA). The protein 
was eluted with buffer C. Finally, the buffer was exchanged to NMR buffer (25 mM Tris-
HCl, pH 7.5, 150 mM NaCl) using a centrifugal filter device (MWCO 10 kDa).  
To explore the effect of the GB1 domain fusion to DnaB on 1D 1H NMR spectra, TEV 
protease was added after the gel filtration step at 1:100 weight ratio and the solution dialyzed 
into buffer D (25 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM 2-mercaptoethanol) at 4 oC for 
14 h. The digested mixture was passed onto a 1 mL Ni-NTA gravity column (GE Healthcare, 
USA) and the flow-through fraction was exchanged into NMR buffer using a centrifugal 
filter unit (MWCO 10 kDa).  
To minimize sample losses, the perdeuterated DnaB samples were applied to a centrifugal 
filter unit (MWCO 100 kDa) with NMR buffer instead of using gel filtration to separate the 
truncation product from the hexamer.  
 
 S3 
S. aureus SrtA and E. coli DEBP were produced by continuous exchange cell-free protein 
synthesis using PCR amplified DNA as template.9,12-14 RF1-depleted S30 extract was 
prepared from an engineered E. coli BL21(DE3) strain.13,15 The proteins were purified by 
diluting the reaction mixture with buffer A, loading the mixture onto a 1 mL Ni-NTA gravity 
column, washing with buffer A plus 30 mM imidazole, and eluting with buffer B. S. aureus 
SrtA was subsequently dialyzed into NMR buffer (20 mM MES buffer, pH 6.5, 50 mM 
NaCl). Following the Ni-NTA purification and prior to exchange into NMR buffer, E. coli 
DEBP was unfolded by incubation for 2 h at room temperature in the presence of 6 M 
guanidinium hydrochloride to release any bound substrate. Protein refolding and removal of 
denaturant were achieved by dialysis against NMR buffer (20 mM phosphate buffer, pH 7.5, 
100 mM NaCl). Finally, the protein samples were concentrated using centrifugal filter units 
(MWCO 10 kDa). 
 
Ligation with a lanthanide binding tag 
The Bst DnaB Ala303Cys mutant was ligated with the C1 tag loaded with Ce3+ 16 by 
incubation for 14 h at room temperature with a three-fold excess of C1-Ce tag. Excess tag 
was removed by washing with NMR buffer using a centrifugal filter unit (MWCO 10 kDa). 
 
NMR spectroscopy and measurements of Kd values 
All 1D 1H NMR spectra were recorded of 2-50 µM protein solutions in aqueous buffer 
containing 10% D2O at 25 oC, using a Bruker 600 MHz or 800 MHz NMR spectrometers 
equipped with TCI cryoprobes. The spectra of DnaB were recorded using the jump-and-
return pulse sequence,17 while a double spin echo18 was used to record the spectra of SrtA 
and DEBP. For accurate determination of peak positions in the titration experiment of DEBP 
with glutamate, line shape fits were performed for the tert-butyl resonance using TopSpin 2. 
The chemical shifts were fitted by the program Origin 8.0 using equation 1.   
 
 
Figure S1. Bst DnaB expression construct used. The N-terminal fusions increased the 
molecular mass of the monomeric protein to 58.7 kDa. Due to the flexibility of the linker 
between GB1 domain and DnaB, this increase in molecular mass is not expected to influence 
the NMR spectrum of the hexamer very much. 
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Figure S2. Protein production and purity analyzed by 15% SDS-polyacrylamide gel 
electrophoresis. The gels were stained with Coomassie blue. The positions of the expected 
full-length and truncated samples are indicated. (A) Bst DnaB produced in vivo with Tby 
incorporated at position 104. Lane 1: Crude protein fraction after IPTG induction. Lane 2: 
Elution from Ni-NTA affinity purification. Lane 3: Elution at 8 mL from Superdex 200 gel 
filtration. Lane 4: Elution at 12 mL from Superdex 200 gel filtration. Lane 5: Sample after 
Ni-NTA column and filtration with a centrifugal filter unit (MWCO 100 kDa), without using 
gel filtration. (B) Samples of SrtA and DEBP produced by cell-free synthesis. The expected 
positions of the truncation products are indicated. Left panel: cell-free reaction mixture 
containing SrtA with Tby (denoted Y*) at position 150. There is no evidence for truncation 
product. Right panels: DEBP with Tby at position 140 and wild-type protein. Notably, 
although the amber stop codon at site 140 was followed by a thymidine in the DNA sequence 
(Figure S7), the expression level of the Val140Tby mutant was not much reduced compared 
with the wild-type protein, with only little evidence of truncation in contrast to expectations 









Figure S3. Control experiments to assess the effect of the fusion with GB1 on the structural 
integrity of wild-type Bst DnaB and the effect of DMSO on the chemical shift of the tert-
butyl resonance in SrtA. (A) 40 µM solution of Bst DnaB in 25 mM Tris-HCl, pH 7.5, 150 
mM NaCl. Top: after cleavage of the GB1 domain with TEV protease; bottom: before TEV 
protease cleavage. A few more signals can be observed in the uncleaved product, suggesting 
that the GB1 moiety is mobile relative to the DnaB. The conservation of the overall 
appearance of the spectrum suggests that the hexamer remains unaffected by the fusion with 
GB1. (B) tert-butyl resonance measured of a 20 µM solution of SrtA with Tby incorporated 
at position 150. Black: SrtA in 20 mM MES buffer, pH 6.5, 50 mM NaCl, 5 mM CaCl2; 
brown: same as the black spectrum, but with 1% DMSO; red: SrtA in 20 mM MES buffer, 
pH 6.5, 50 mM NaCl, 1 mM EDTA; magenta: same as red spectrum, but with 1% DMSO. 
The chemical shift changes induced by DMSO are much smaller than the chemical shift 





Figure S4. Chemical structures of compounds used. (A) C1-Ce tag.16 (B) SrtA inhibitor N-














Figure S5. 19F NMR spectra of 70 µM solutions of Bst DnaB with trifluoromethyl-
phenylalanine (tfmF) incorporated at site 104. The samples were prepared using the same 
protocol as for the preparation of the Tby samples described above, except that Tby was 
replaced by 1 mM tfmF. The buffer used contained 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 
mM DTT, and 200 mM NaCl. The spectra were recorded at room temperature on a Varian 
Inova 500 MHz NMR spectrometer in 4 h each. Spectrum calibration was relative to external 
tfmF (-62.1 ppm). Black: after TEV protease cleavage of the GB1 solubilization domain. 





Figure S6. Binding affinity measurement of 10 µM E. coli DEBP for glutamate. The spectra 
were recorded in 20 mM phosphate buffer, pH 7.5, 100 mM NaCl at 25 oC, using a Bruker 
600 MHz NMR spectrometer. The fit yielded a Kd value of 0.16 µM with a standard error of 
























Figure S7. Nucleotide sequence of the construct of E. coli DEBP used in the present work. 
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ABSTRACT: Structure-guided drug design relies on detailed structural
knowledge of protein−ligand complexes, but crystallization of cocomplexes
is not always possible. Here we present a sensitive nuclear magnetic
resonance (NMR) approach to determine the binding mode of tightly
binding lead compounds in complex with diﬃcult target proteins. In
contrast to established NMR methods, it does not depend on rapid
exchange between bound and free ligand or on stable isotope labeling,
relying instead on a tert-butyl group as a chemical label. tert-Butyl groups
are found in numerous protein ligands and deliver an exceptionally narrow
and tall 1H NMR signal. We show that a tert-butyl group also produces
outstandingly intense intra- and intermolecular NOESY cross-peaks. These
enable measurements of pseudocontact shifts generated by lanthanide tags attached to the protein, which in turn allows
positioning of the ligand on the protein. Once the ligand has been located, assignments of intermolecular NOEs become possible
even without prior resonance assignments of protein side chains. The approach is demonstrated with the dengue virus NS2B-
NS3 protease in complex with a high-aﬃnity ligand containing a tert-butyl group.
■ INTRODUCTION
Structure-guided ligand design is a powerful approach in drug
discovery. Usually, the approach relies on X-ray crystallography
to obtain the 3D structural information on the protein−ligand
complexes required to guide further ligand development. NMR
spectroscopy is often used to aid this process when single
crystals of the protein−ligand complexes cannot be obtained.
As the NMR resonances of ligand molecules are often diﬃcult
to discriminate against the background of protein NMR signals,
however, NMR spectroscopic methods tend to perform best for
weakly binding and rapidly exchanging ligands that can be used
in large excess over the protein.1 In the case of tightly binding
ligands, the ligand molecule can, for all intent and purpose, be
considered to act like an integral part of the protein.
The most common NMR approaches to characterize the
complexes between proteins and tightly binding ligands involve
chemical shift perturbations2 and nuclear Overhauser eﬀects
(NOE).3 Both methods rely on the assignment of a large
number of NMR signals. In particular, reliable assignments of
intermolecular NOESY cross-peaks require either near-
complete resonance assignments of the target protein, which
are diﬃcult to obtain for large target proteins irrespective of the
availability of 15N or 13C-labeled protein samples, or
information from independent data, such as site-directed
mutagenesis experiments.4 Detailed structural interpretation
of chemical shift perturbations is diﬃcult and requires
measurements with a series of ligand derivatives.
In recent years, paramagnetic NMR methods have
increasingly been recruited for structural analysis of protein−
ligand complexes, in particular by making use of paramagnetic
relaxation enhancements (PRE) and pseudocontact shifts
(PCS) generated by site-speciﬁcally attached tags.5 While
much work has focused on these parameters for the analysis of
weakly binding complexes,6−12 the ligand PCSs are exceedingly
small if a large excess of ligand is used. The reverse experiment,
generating PCSs in the target protein by attaching a
paramagnetic metal complex to the ligand, requires a signiﬁcant
chemical modiﬁcation of the ligand and comprehensive
resonance assignments of the protein for data interpreta-
tion.13,14 Examples are rare where PCSs have been used to
establish the structure and orientation of a tightly binding
ligand at its binding site on the protein.11,15−17 The
fundamental problem in these cases arises from the diﬃculty
in identifying the resonances of the tightly bound ligand. In the
special situation of a protein−protein complex, isotope labeling
allows selective observation of either protein component, which
has been used for structure analysis of high-aﬃnity protein−
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protein complexes using PCSs induced by paramagnetic
lanthanide ions.15,17 In the case of a small-molecule ligand,
however, synthesis of an isotope-labeled version would usually
be prohibitively laborious. An alternative strategy employs
selective suppression of the 1H NMR spectrum of the protein
by isotope labeling, either using 15N/13C-labeling in combina-
tion with half-ﬁlter pulse sequences,18 or by perdeuteration of
the protein.19 Either approach is imperfect, as the half-ﬁlters
achieve only incomplete suppression of the protein NMR
signals, due to nonuniform one-bond coupling constants, and
are associated with signiﬁcant signal decay by relaxation, while
very high deuteration levels are required to reduce the residual
protein 1H NMR signals to a level below those of the ligand.
Instead of relying on costly isotope labeling, the present
approach makes use of the unique NMR properties of tert-butyl
groups.
The 1H NMR signal of a tert-butyl group is an intense singlet
with a chemical shift in the range of about 1.0 to 1.5 ppm
depending on the chemical environment. Owing to rapid
methyl rotation and methyl reorientation within this ﬂexible
group, the signal of a solvent-exposed tert-butyl group is much
narrower than protein 1H NMR signals, enabling its detection
even in protein complexes of high molecular mass without any
isotope labeling.20 In experiments aimed at probing chemical
exchange phenomena, we observed that the tert-butyl group
also produces NOESY cross-peaks that are much more intense
than anticipated and can be observed even under conditions
where cross-peaks of the protein are barely detectable. This
opens a new route to characterize the binding mode of a ligand
labeled with a tert-butyl group. First, the NOESY cross-peaks
with the tert-butyl signal enable measurements of PCSs induced
by paramagnetic tags attached to the protein at diﬀerent sites.
These data position the tert-butyl group with respect to the
protein. If intraligand NOEs with the tert-butyl group can be
observed, the PCSs of additional ligand protons can be used to
orient the ligand in its binding site. Finally, intermolecular
NOEs with the tert-butyl group further pinpoint its location on
the protein.
We demonstrate the approach with the structure determi-
nation of the complex between the two-component dengue
virus NS2B-NS3 protease (NS2B-NS3pro) from serotype 2 (in
the following referred to as DENpro) and a newly developed
ligand that contains a boronic acid warhead, binds with high
aﬃnity, and contains a tert-butyl group (C. Nitsche and C. D.
Klein, manuscript in preparation). Although a dengue vaccine
has been developed that is eﬀective against all serotypes, the
vaccine oﬀers only incomplete protection and is ineﬀective in
children below the age of 6, who need it most.21 Dengue causes
severe complications and is spreading rapidly,22 making
DENpro a drug target of high priority.23−25 Despite intense
eﬀorts over many years, however, crystallization of DENpro
remains diﬃcult and only a single structure has been published,
which proved to be of an inactive conformation (PDB code
2FOM).26 Co-crystal structures with inhibitors are available of
serotype 3 (PDB code 3U1I and 3U1J)27 and of the
homologous West Nile virus protease,26 which allow modeling
of the structure of DENpro. In the absence of exact structural
information, the development of high-aﬃnity inhibitors has
been slow. An eﬀective inhibition constant of 43 nM was
reported for the peptidic inhibitor Bz-Nle-Lys-Arg-Arg-B(OH)2
owing to the presence of the electrophilic boronic acid warhead
which is thought to form a covalent bond to Ser135 at the
active site of DENpro.28 A range of further inhibitors lacking a
boronic acid warhead has been developed,25,29,30 but their
binding modes remain uncertain in the absence of experimental
conﬁrmation for any of the computational models built.
DENpro has a molecular mass of about 27 kDa and degrades
readily in the absence of high-aﬃnity ligands. Its NMR
spectrum shows broad resonances and strong signal overlap,
and varies between diﬀerent constructs and inhibitors.31−35 The
well-resolved 15N-HSQC cross-peaks comprise about half of
the backbone amides (Figure S3). We identiﬁed three single-
cysteine mutants of DENpro for the attachment of para-
magnetic lanthanide tags, which generate pronounced PCSs in
the NMR spectrum of the protein.31 Using the resolved 15N-
HSQC cross-peaks, PCS measurements are straightforward and
allowed characterization of the conformation of DENpro in
isolation and in complex with a small-molecule and a protein
inhibitor, respectively.20,31 Assessing the binding mode of the
synthetic nonprotein inhibitor, however, proved intractable
because of the diﬃculty in observing and assigning
intermolecular NOEs.
In the following we report the binding mode of the high-
aﬃnity ligand 1 (Figure 1) to DENpro. This is the ﬁrst time
that the complex between DENpro and a small-molecule ligand
Figure 1. 1D 1H NMR spectra of ligand 1 without and with DENpro.
(A) Chemical structure of ligand 1. Ligand 2 is structurally identical
except for the absence of the tert-butyl group. (B) 1D 1H NMR
spectrum of ligand 1 in the absence of DENpro. The spectrum was
recorded at 25 °C in NMR buﬀer (20 mM MES, pH 6.5, 50 mM
NaCl) using a 800 MHz NMR spectrometer. The downﬁeld region of
the spectrum was scaled up 8-fold relative to the upﬁeld part of the
spectrum. The open arrow marks the 1H NMR resonance of the tert-
butyl group. The star identiﬁes the signal from an impurity. (C) 1D 1H
NMR spectra of 50 μM solutions of DENpro in deuterated NMR
buﬀer without ligand (bottom trace) and in a 1:1 complex with ligand
1 (top trace). The spectral appearance of the aromatic region was
simpliﬁed by perdeuteration of Tyr, Phe, and Trp. Signals at 7.3 and
8.0 ppm are from the C-terminal His6-tag. The low-ﬁeld region was
scaled up 2-fold relative to the high-ﬁeld region. The resonance of the
tert-butyl group of ligand 1 is marked by a ﬁlled arrow. The star
identiﬁes the signal of a nonbinding impurity.
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has been modeled at atomic resolution using experimental
NMR data. Importantly, the new protocol succeeded with a
limited set of 15N-HSQC cross-peaks of backbone amides,
which are suﬃciently well resolved to enable a straightforward
transfer of their assignments between the free protein and
complexes with diﬀerent inhibitors.
■ MATERIALS AND METHODS
Sample Preparation. Three single-cysteine mutants of DENpro
were prepared. The mutants were Ala57*Cys (site A; the asterisk
marks residues in NS2B), Ser34Cys (site B), and Ser68Cys (site C).
Uniformly 15N-labeled protein samples were produced by over-
expression in E. coli and selectively isotope-labeled samples by cell-free
synthesis as described previously.31 The samples were ligated with C2-
Ln3+ tags (Figure S1) as described,31,35,36 where Ln3+ is either Y3+,
Tm3+, or Tb3+.
Ligands 1 and 2 were synthesized as described elsewhere (C.
Nitsche and C. D. Klein, manuscript in preparation).
NMR Measurements. All NMR spectra were measured on a
Bruker 800 MHz NMR spectrometer equipped with a 5 mm TCI
cryoprobe, using 3 mm NMR tubes. 15N-HSQC spectra were recorded
with t1max = 26.2 ms and t2max = 160 ms. NOESY spectra were recorded
with a mixing time of 200 ms, t1max = 58 ms, and t2max = 232 ms. The
total recording times of the NOESY spectra varied from 4 h for
diamagnetic samples to 8 h for paramagnetic samples.
PCSs were measured as 1H chemical shifts observed for DENpro
tagged with C2−Tm3+ or C2−Tb3+ tags minus the corresponding
chemical shifts measured with DENpro tagged with diamagnetic C2−
Y3+. PCSs are through-space eﬀects that follow the equation37





where ΔδPCS is the PCS measured in ppm, r is the distance of the
nuclear spin from the metal ion, Δχax and Δχrh are the axial and
rhombic components of the magnetic susceptibility anisotropy tensor
Δχ, and θ and φ are the polar angles describing the position of the
nuclear spin with respect to the principal axes of the Δχ tensor. We
used the PCSs of backbone amide protons (Table S1) to ﬁt the Δχ
tensors to the coordinates of DENpro models generated by Rosetta.38
PREs of the tert-butyl resonance were measured by comparing its
1H NMR line widths in resolved NOESY cross-peaks recorded for
samples tagged with paramagnetic and diamagnetic tags.
Modeling of the Protein−Ligand Complex. A structural model
of DENpro in the catalytically active conformation was obtained using
the program Modeller39 and the crystal structure 3U1I27 of the
protease from serotype 3 as the template. A total of 100 models were
generated following the advanced modeling protocol,40 and the best
model was selected based on the discrete optimized potential energy
(DOPE) score.41
The program AutoDock-Vina42 was used to generate 20 diﬀerent
poses of the docked ligand. Each pose was checked for agreement with
the ligand PCSs using six diﬀerent Δχ tensors, which had been
determined from the PCSs of the backbone amides of DENpro with
C2−Tm3+ and C2−Tb3+ tags at three sites. The best-ﬁtting pose was
selected for further reﬁnement by the software suite Rosetta43 to
model a covalent bond between the boron and the side chain oxygen
of Ser135. Further restraints were introduced to ensure tetrahedral
coordination of the boron, as detected in boronic acid complexes of
other serine proteases such as the hepatitis C virus protease,44 and
planarity of the guanidinum groups. The all-atom Relax module of
Rosetta43 was used to reﬁne the amino acid side chain conformations
in the substrate binding site, following the protocol available in the
protocol demonstrations (demos directory) of the Rosetta software
suite.45 From the models generated by the all-atom Relax module, the
model that best fulﬁlled the backbone PCSs of DENpro was selected
as the ﬁnal structure. New Δχ tensors were ﬁtted to each model to ﬁnd
the structure with the lowest PCS score.46
■ RESULTS
1H NMR Resonance of the tert-Butyl Group of Ligand
1 in the Absence and Presence of DENpro. In the
DENpro construct used in the present work, the linker between
NS2B and NS3 contained the natural recognition site
EVKKQR, leading to autoproteolytic cleavage at this site. We
have shown previously that the resulting product assumes the
enzymatically active closed conformation of the protease.35 The
unlinked construct degraded during NMR measurements in
less than a day, but was stable for months in the presence of
ligand 1.
The 1D 1H NMR spectrum of the free ligand shows four
prominent resonances for the aromatic rings between 7 and 8
ppm, and a particularly intense NMR signal for the tert-butyl
group (Figure 1). The signal of the tert-butyl group is also easily
discernible in the 1:1 complex with DENpro, whereas the
aromatic resonances of the ligand are diﬃcult to identify even
in a sample prepared with a high level of perdeuteration of
aromatic residues (Tyr, Phe, and Trp). The chemical shift of
the tert-butyl group of ligand 1 in the bound state is slightly
downﬁeld compared with the chemical shift in the free state. In
the presence of excess ligand, the signals of bound and free
ligand were observed simultaneously, indicating that any
chemical exchange is slow as expected for a tightly bound
ligand (data not shown).
PCS Measurements. The strategy of the present work
relies on PCS measurements of the protein (to determine the
Δχ tensors) and of the ligand (to determine the position of the
ligand relative to the Δχ tensors and thus relative to the
protein). To account for possible conformational changes
caused by ligand binding, PCSs of DENpro were measured in
15N-HSQC spectra recorded of the complex between 15N-
labeled DENpro and ligand 1, using C2−Tm3+ and C2−Tb3+
tags at sites A−C, with C2−Y3+ tagged samples as diamagnetic
reference (Figures S2−S4). The PCSs were very similar, but
not identical, to PCSs measured previously for samples without
inhibitor35 and with the protein inhibitor BPTI.17 A total of 222
PCSs (Table S1) were measured and used to determine the
Δχ-tensor parameters (Table S3).
PCSs of the bound ligand 1 sometimes proved diﬃcult to
determine from simple 1D 1H NMR spectra. The intense 1H
NMR resonance of the tert-butyl group was readily detected in
the diamagnetic samples, but PREs combined with changes in
the NMR spectrum of the protein can make it diﬃcult to
identify the resonance in the paramagnetically tagged samples
(Figure S5).
In contrast, NOESY spectra turned out to yield intense cross-
peaks with the tert-butyl resonance that could easily be followed
even when the tert-butyl resonance was broadened by PRE. In
addition, the NOESY spectra yield PCSs not only for the tert-
butyl resonance itself but also for the protons involved in the
NOEs with the tert-butyl group. Figure 2B illustrates the
intensity of the tert-butyl cross-peaks with the wild-type protein.
The cross-peaks are readily identiﬁed by their narrow line shape
in the detection dimension. As expected, they were absent from
the corresponding NOESY spectrum recorded with ligand 2,
which is the same as ligand 1 but without the tert-butyl group
(Figure 2A). Particularly intense cross-peaks are observed with
protons at about 7.5 ppm, which were assigned to the aromatic
ligand protons in the positions ortho and meta to the tert-butyl
group labeled 1, 1′, 2, and 2′ in Figure 1A. (Using a sample
prepared with 15N-labeled DENpro, a NOESY spectrum
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b00416
J. Am. Chem. Soc. 2016, 138, 4539−4546
4541
recorded without 15N-decoupling conﬁrmed that these NOEs
are not with amide protons of the protein.) Additional cross-
peaks at about 0.7 and 1.7 ppm cannot be explained as
intraligand NOEs and, based on the chemical shifts, include
NOEs with methyl groups.
Figure 3 illustrates the measurement of PCSs from the
NOESY cross-peaks with the tert-butyl resonance. The cross-
peaks were preserved between wild-type DENpro and DENpro
tagged with diamagnetic C2−Y3+ tags, and were displaced by
PCSs in the samples containing paramagnetic tags. Diﬀerent to
backbone amides, where PCSs displace 15N-HSQC cross-peaks
along mostly parallel lines owing to the close spatial proximity
of 1H and 15N spins, the PCSs observed for the protons
involved in NOEs with the tert-butyl resonance were mostly
diﬀerent from the PCS of the tert-butyl resonance itself, as
expected for spins that are located at more disparate positions
relative to the Δχ tensors of the paramagnetic tags.
Importantly, the C2−Tm3+ and C2−Tb3+ tags produced
PCSs of opposite sign31,36 and the NOESY cross-peaks of the
three samples tagged with C2−Tm3+, C2−Y3+, and C2−Tb3+
tags could be connected by almost straight lines. This greatly
aids the identiﬁcation of the paramagnetically shifted cross-
peaks, even when the cross-peaks were signiﬁcantly broadened
by PREs, as for the paramagnetic samples tagged at site B
(Figure 3B).
Altogether, the NOESY cross-peaks observed with the tert-
butyl resonance delivered 18 ligand PCSs together with 14
protein PCSs (Table S2). The ligand PCSs immediately enable
a qualitative structural interpretation regarding the orientation
of the tert-butylphenyl group relative to the Δχ tensors. For
example, the PCSs obtained with the tags at site B decrease in
magnitude in moving from the protons at positions 2/2′ to
those at positions 1/1′ to the tert-butyl group (Figure 3B),
suggesting that the tert-butyl group faces away from the tag at
site B. This conclusion is conﬁrmed by the broad line widths of
cross-peaks observed for the H-2/2′ resonances in the
paramagnetic samples which can be attributed to PREs due
to proximity to the tag.
PRE Measurement. As the tert-butyl resonance is a singlet,
PREs can simply be measured as the diﬀerence in line width
observed in paramagnetic and diamagnetic samples. The
NOESY cross-peaks of Figure 3 clearly show that the tert-
butyl resonance is broader in the samples with paramagnetic
Figure 2. NOESY spectra of DENpro in complex with ligands 1 and 2.
The spectra were recorded at 25 °C of 150 μM solutions of unlabeled
wild-type DENpro in NMR buﬀer containing 10% D2O, using 3 mm
NMR tubes in a 5 mm TCI cryoprobe. Experimental parameters: 200
ms mixing time, t1max = 58 ms, t2max = 232 ms, total recording time per
spectrum 4 h. The spectral region shown captures the NOE cross-
peaks of the tert-butyl resonance. (A) NOESY spectrum of the
complex with ligand 2. (B) NOESY spectrum of the complex with
ligand 1. Five cross-peaks with the tert-butyl resonance are labeled.
Note that these cross-peaks were readily detected, while other cross-
peaks, e.g., with amide protons, were much weaker or unobservable.
Figure 3. PCSs observed in 2D NOESY spectra of DENpro with C2
tags at three diﬀerent sites. The spectra were recorded of 150 μM
solutions of 15N-labeled DENpro complexes with ligand 1 in NMR
buﬀer at 25 °C. The ﬁgure shows superimpositions of NOESY spectra
for samples tagged with C2−Y3+ (black), C2−Tm3+ (blue) and C2−
Tb3+ (red). The spectral regions shown contain cross-peaks between
the tert-butyl resonance and protons in the aromatic and methyl
regions of the NMR spectrum. PCSs are identiﬁed by lines drawn
between cross-peaks of the diamagnetic samples and their correspond-
ing peaks in the paramagnetic samples. (A) NOESY spectra of the
complex tagged at site A. (B) Same as (A), but for the complex tagged
at site B. (C) Same as (A), but for the complex tagged at site C. NOEs
with two initially unassigned methyl groups are labeled as CH3-1 and
CH3-2. The NOEs with two aromatic protons were attributed to the
protons 1/1′ and 2/2′ of the ligand (Figure 1A).
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versus diamagnetic tags, and broader with Tb3+ tags than with
Tm3+ tags, as expected from the greater paramagnetic moment
of Tb3+.47 It is diﬃcult, however, to convert the PREs into
quantitative distance restraints from the metal ions. First, the
signiﬁcant anisotropy of the magnetic susceptibility tensors
associated with Tb3+ and Tm3+ needs to be taken into
account.48 Second, the PREs can be compromised by cross-
correlation eﬀects with nuclear chemical shift anisotropies.49
Most importantly, however, the linker of the C2 tag is not
entirely rigid, resulting in multiple possible metal positions. For
a conservative estimate of the distance restraint indicated by a
PRE, we calculated the largest distance compatible with the Δχ
tensor anisotropies determined from the PCSs using the
anisotropic Curie-spin relaxation equations48 with a rotational
correlation time of 10 ns. We only used the data from site B,
which showed the greatest PRE eﬀects (Figure 3). In this
construct, the C2−Tb3+ and C2−Tm3+ tags broadened the tert-
butyl signal by 22 and 13 Hz, respectively, relative to the
diamagnetic sample with the C2−Y3+ tag. Both measurements
correspond to a distance from the paramagnetic center of about
15.5 Å. To account for the uncertainty in metal position, we
converted the PREs observed for mutant B into an upper
distance restraint of 20 Å.
PCS-Guided Modeling of the Protein−Ligand Com-
plex. As no crystal structure of DENpro in the active
conformation is available and the amino acid sequences of
NS2B-NS3pro of serotypes 2 and 3 are 66% sequence identical,
we modeled the structure of DENpro on the crystal structure
3U1I of serotype 3.27 Among 100 very similar homology
models, we selected the best model based on the DOPE
score,41 which had a Cα-RMSD of 0.7 Å relative to the crystal
structure 3U1I.
The Δχ tensors associated with the C2−Tm3+ and C2−Tb3+
tags at sites A−C produce diﬀerent PCSs at diﬀerent sites of
the DENpro-ligand complex. Using the Δχ tensors determined
for the best-ﬁtting model of DENpro, we predicted the PCSs
for every point of a dense grid placed over the structural model
of DENpro to identify all the points that were in agreement
with the PCSs generated by the C2−Tm3+ and C2−Tb3+ tags
at sites A−C.
Allowing for an uncertainty range of ±0.02 ppm for the
experimental PCSs, the PCSs of the tert-butyl group of the
ligand identiﬁed a continuous space in the vicinity of NS2B,
where the tert-butyl group could be located. We refer to this
PCS-supported grid point volume as localization space. The
localization space of the tert-butyl group was in full agreement
with its expected position upon formation of a covalent bond
between Ser135 and the boronic acid moiety of the ligand, as
anticipated in the design of the ligand. The localization space
shown in Figure 4 was also restricted by imposing the 20 Å
distance restraint for the tertbutyl group from the metal
position of the tag at site B, which had been derived from PREs.
To generate a complete model of the ligand, 20 poses of
ligand 1 were generated on the structural model of DENpro
using the program AutoDock-Vina.42 The diﬀerent poses
produced dramatically diﬀerent ligand structures and orienta-
tions (with a pairwise RMSD of about 10 Å) with very similar
calculated binding energies (ranging from −7.5 to −7.9 kcal/
mol). The two top-ranked and seven further poses approx-
imately positioned the tert-butyl group in the localization space
deﬁned by the PCSs. Furthermore, the top-ranked pose
positioned the boronic acid group in the vicinity of Ser135
and the direction of the tert-butylphenyl group was also in
general agreement with the localization spaces of the 1/1′ and
2/2′ protons (Figure 4). To reﬁne this model of the protein−
ligand complex, we used the Rosetta software suite38,43 to form
a covalent bond between the boron of the ligand and the side
chain oxygen of Ser135, and allowed small structural adjust-
ments by the all-atom “Relax” reﬁnement protocol of Rosetta.
The protocol generated 1000 structures of the complex, all with
conserved protein conformations and similar ligand conforma-
tions (over 90% within 1.3 Å of the structure with the lowest
PCS energy, Figure S6). The protein structure with the lowest
PCS score showed an excellent correlation between the
experimental and back-calculated PCSs (Figure S7). Figure 4
shows the structure best fulﬁlling the PCSs of DENpro, which
was chosen as the ﬁnal representation of the DENpro-ligand 1
complex.
The localization spaces of protons 1/1′ and 2/2′ (Figure 4)
are progressively closer to the site B, reﬂecting the large PCSs
induced by C2 tags at this site (Figure 3B). This provides
strong support for the orientation of the tert-butyl phenyl
group. The apparent discrepancies between experimental
localization spaces and actual proton positions in the model
of Figure 4 may arise from mobility of the tag at site B, which
can increase the PCSs by transiently shortening the distance
between metal and ligand. As PCSs present long-range
restraints, experimental uncertainties translate into relatively
large uncertainties for localization spaces. Therefore, we used
the intermolecular NOEs observed with the tert-butyl group to
verify the correctness of the model of the complex.
Veriﬁcation of the Structural Model by Intermolecular
NOEs. The model of the complex between DENpro and ligand
1 predicts intermolecular NOEs between the tert-butyl group
and the methyl groups of Val154 and Val155. The chemical
shifts of the NOEs observed with the signals of CH3-1 and
CH3-2 (Figure 3) agree with expectations for valine methyl
groups.
To support this assignment, we recorded a NOESY spectrum
of the DENpro-ligand 1 complex in which wild-type DENpro
Figure 4. Model of the complex between DENpro and ligand 1. NS2B
(orange) and NS3pro (gray) are drawn in a cartoon representation,
and ligand 1 is shown in a stick representation, displaying hydrogens
only for amide and guanidinium groups. Green balls indicate the
positions of the lanthanide ions as determined by PCSs for the tags at
sites A−C. Meshes identify the localization spaces of the tert-butyl
group (magenta), protons 1/1′ (purple), and protons 2/2′ (cyan)
identiﬁed by PCSs from C2−Tm3+ and C2−Tb3+ tags at sites A−C.
The meshes capture localization spaces with PCS deviations smaller
than 0.02 ppm from the experimental PCSs.
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was selectively labeled with 13C-valine. In the absence of 13C
decoupling, the NOESY cross-peaks labeled 1 and 2 in Figure 2
split by 1JCH coupling constants and the signal of 3 could no
longer be resolved, showing that all three protons indeed
belong to valine (Figure S8). To distinguish between Val154
and Val155, we measured a NOESY spectrum of the mutant
Val155Ile selectively labeled with 13C-valine. The NOESY
cross-peaks observed were in agreement with an isoleucine
residue and did not split in the absence of 13C-decoupling,
indicating that the NOEs between the tert-butyl group of ligand
1 and wild-type DENpro are with Val155 (Figure S9).
■ DISCUSSION
The surprisingly high signal-to-noise ratio of NOESY cross-
peaks with a tert-butyl group can be attributed to three factors.
Most importantly, its 1H NMR resonance is intrinsically narrow
because of short eﬀective rotational correlation times arising
from fast methyl group rotation and rotation of the tert-butyl
group. Second, the signal stands out because it corresponds to
nine protons. Finally, due to the very strong distance
dependence of NOEs, a small population of a short 1H−1H
distance can lead to a stronger NOE than a larger population of
a slightly longer 1H−1H distance. Therefore, motions of the
tert-butyl group that transiently shorten the 1H−1H distance
can strongly enhance the overall NOE. In this way, NOEs can
be observed for proteins of increased molecular weight, which
usually display broad 1H NMR lines. In fact, the broad widths
of the protein resonances are an advantage in our approach, as
this decreases the background of NOESY cross-peaks between
other protons. The high sensitivity of the NOESY cross-peaks
with the tert-butyl resonance enabled their detection in a few
hours, using about 100 μM solutions of the complex in 3 mm
NMR tubes.
The attempt to use the prominence of the tert-butyl
resonance in 1D 1H NMR spectra for PCS measurements
was compromised by too many spectral changes caused by the
paramagnetic tags, including a much broader tert-butyl
resonance (Figure S5). In contrast, the line-up of NOESY
cross-peaks with the same tert-butyl signal delivered safe
assignments of its PCSs. It is an advantage of the NOESY
spectrum that diﬀerent cross-peaks have diﬀerent intensities, as
this can be used to track the cross-peaks in the paramagnetic
samples, as in the example of the aromatic peaks in Figure 3B.
This makes the assignment of PCSs easier in 2D NOESY
spectra than in 2D 15N-HSQC spectra.
It is an important additional beneﬁt that NOESY cross-peaks
also deliver the PCSs of the interacting proton spins. While the
PCSs of a 15N−1H group tend to be very similar for the 15N
and 1H spins due to their close spatial proximity, the 1H spins
involved in a NOE are further apart and thus more likely to
display PCSs of diﬀerent magnitude. This presents highly useful
information for orienting the internuclear vector relative to the
Δχ tensor. In the case of the tert-butyl phenyl group of ligand 1,
PCSs were available from three diﬀerent tagging sites, which
unambiguously determined its orientation relative to the
protein.
As is common with drug targets of moderate complexity,
resonance assignments of DENpro could be obtained with
reasonable eﬀort for spectrally resolved 15N-HSQC cross-peaks,
whereas near-complete resonance assignments, as required for
conventional NOESY cross-peak assignments, would be
prohibitively laborious to establish for every complex with a
new ligand. In this situation, PCSs present a much more
eﬃcient route to structural information, as Δχ tensors can be
determined from PCSs of a small number of resolved backbone
amide peaks, which can be assigned by, e.g., systematic site-
directed mutagenesis of selectively isotope-labeled samples.50,51
While the accuracy of PCSs may be insuﬃcient to predict close
intermolecular protein−ligand contacts, the localization spaces
deﬁned by PCSs from paramagnetic tags at multiple sites
greatly limit the number of possible assignments for
intermolecular NOEs observed with the tert-butyl resonance.
As shown in the present work, the residue type of the protein
protons involved in the intermolecular NOEs can be
ascertained by chemical shifts as well as selective isotope
labeling.
In many instances, it is easier to synthesize a ligand molecule
with a tert-butyl group than with a stable isotope, in particular
as tert-butyl groups are part of common synthetic building
blocks and protection strategies. Consequently, tert-butyl
groups are also frequently found in fragment libraries and
series of inhibitor candidates during the early phases of the drug
discovery process. The tert-butyl moiety can establish hydro-
phobic protein−ligand interactions and therefore often
increases ligand aﬃnity. It is also present in recently approved
drugs, such as the HCV protease inhibitors boceprevir and
telaprevir.52 If a tert-butyl group is highly solvent exposed and
ﬂexible, it will produce less intense NOEs, but its 1H NMR
signal will be narrower, which facilitates identiﬁcation of its
localization space as a taller signal makes it easier to extract
PCSs from 1D NMR spectra.
Ligands containing ﬂuorine have found widespread applica-
tion as NMR probes for protein−ligand studies.16,53 In
principle, the combined PCS and NOE strategy outlined in
the present work could be extended to 1H−19F HOESY
spectra, except that sensitivity would be compromised by the
much broader line width of 19F combined with typically fewer
19F spins in the ligand molecules.
In conclusion, the combined PCS and NOE approach of the
present work opens a practical and expedient route to elucidate
the binding mode of high-aﬃnity ligands in 1:1 complexes of
protein targets. In contrast to studies with weakly binding
ligands, no excess of ligand is required, which is an important
advantage in the case of poorly soluble compounds. Detailed
structural information about the protein−ligand complex can
be obtained without costly perdeuteration, and dilute solutions
of protein−ligand complexes with highly incomplete NMR
resonance assignments can be investigated. While multiple
samples with diﬀerent paramagnetic tags are required to
measure the PCSs and NOEs, each NMR experiment is quick
and uses protein sparingly, making it practical to study a protein
with a set of diﬀerent ligands. The structural data that can be
obtained with this strategy open a new and unique window of
opportunity for the rational development of high-aﬃnity lead
compounds in drug development projects, when cocrystal
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Table S1. PCSs measured of backbone amide protons of DENpro in complex with ligand 1.a 












(ppm) NS2B         
Ser70* -0.35  0.46  -0.06  0.08  -0.01  0 
Ser71* -0.26  0.33  -0.05  0.06  -0.02  0.02 
Ile73* - -  -0.05  0.07  -0.08  0.09 
Leu74* -0.12  0.18  -0.06  0.09  -0.05  0.08 
Ser75*  -0.09  0.11  -0.06  0.08  -0.06  0.09 
Ile78* -0.07 -  -0.11  0.17  -0.09  0.20 
Ser79* -0.01  0.02  -0.21  0.25  -0.23  0.34 
Asp81* - -  -  0.33  -0.34 -0.54 
Gly82*  - -  -0.26  0.33  -0.37  0.58 
Ser83* - -  -0.34  0.42  -0.31  0.48 
Ser85* -0.03  0.05  -0.16  0.20  -0.14  0.21 
Ile86*  -0.05 -  -0.11  0.12  -0.09  0.14 
Lys87* -0.05  0.08  -0.07  0.08  -0.08  0.11 
NS3pro         
Gly21  0.58 -   0.16 -0.19  - - 
Ala22 - -   0.18 -0.22  - - 
Tyr23 - -   0.32 -0.38  - - 
Lys28 - -  - -   0.31 -0.53 
Ser34 - -  - -   0.21 - 
 S3 
Gly39  0.83 -0.99   0.37 -0.44   0.49 -0.76 
Tyr41  0.59 -0.72   0.20 -0.23   0.56 -0.84 
Lys42  0.20 -0.25   0.15 -0.17  - - 
Glu43  0.04 -0.06   0.10 -0.12  - - 
Gly44  0.14 -0.19   0.12 -0.16  - - 
Phe46  0.26 -0.30   0.20 -0.23  - - 
Trp50  0.10 -0.12  - -  - - 
His51  0.12 -0.14  - -  -0.32  0.05 
Val52  0.19 -0.23  - -  -0.03 - 
Thr53  0.24 -0.29  - -   0.14 -0.26 
Gly55  0.19 -0.23  - -  - - 
Gly62  0.47 -0.58   0.38 -0.44  - -1.26 
Glu66  0.23 -   0.24 -  - - 
Ala70  0.05 -0.05  -0.05  0.05  - - 
Ser78 - -   0.06 -0.07  - - 
Gly81  0.14 -0.15   0.12 -0.16  - - 
Gly82  0.05 -0.06   0.07 -0.08  - - 
Leu85 -  0.10   0.05 -0.04  - - 
Trp89 - -  -0.03  0.03  -0.06  0.08 
Gly92 -0.28  0.37  - -  -0.03  0.04 
Gln96 - -  - -   0.04 -0.07 
Leu98 -1.15 -  - -   0.10 -0.17 
Leu100 - -  - -   0.17 -0.26 
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Gly103 - -  - -   0.16 -0.26 
Gln110 - -  -0.03  0.05   0.03 -0.06 
Thr111 -  1.18  -0.04  0.06  - - 
Gly114 -0.28 -  -0.08  0.08  - - 
Phe116 -0.15  0.21  -0.09  0.10  -0.08  0.11 
Lys117 - -  -0.08  0.09  -0.07  0.11 
Thr120 -0.06  0.08  -0.07  0.09  -0.12  0.19 
Gly121 -0.07  0.10  -0.06  0.08  -0.11  0.15 
Thr122 - -  -0.05  0.07  -0.10  0.14 
Ile123 - -  - -  -0.12  0.11 
Ser127 -0.36 -  -0.09  0.11  - - 
Val140 - -  - -   0.06 -0.10 
Gly148 -0.38  0.49  - -   0.02 -0.06 
Ala160 -0.11  0.15  -0.04  0.05  -0.03  0.05 
Ala164 - -  -0.22  0.28  -0.08  0.12 
Ile165 - -  -0.12  0.14  - - 
Ala166 - -  -0.08 -  -0.08  0.13 
 
a PCSs were generated by C2-Tm3+ and C2-Tb3+ tags at sites A-C. Corresponding samples with 
C2-Y3+ tags were used as the diamagnetic reference. PCSs are reported in ppm as the 1H 
chemical shift measured in the presence of paramagnetic tag minus the 1H chemical shift 





Table S2. PCSs observed in NOESY spectra of the complex between ligand 1 and DENpro with 
C2-Ln3+ tagsa 
 Ligand 1  Protein 
















A-Tm3+ -0.01  0.00  0.00  -0.05 -0.06 -0.05 
A-Tb3+  0.02  0.01  0.01   0.07  0.09  0.08 
B-Tm3+ -0.09 -0.27 -0.56  -0.14 n.d. n.d. 
B-Tb3+ 0.10  0.33  0.67   0.15 n.d. n.d. 
C-Tm3+ -0.10 -0.10 -0.10  -0.06 -0.05 -0.06 
C-Tb3+  0.16  0.16  0.16   0.09  0.07  0.10 
Chemical 
shifta 
 1.30  7.54  7.66   0.67  0.78  1.73 
 
a Measured for the complex of ligand 1 with wild-type DENpro without tag. See Figures 1A and 
2B for the numbering of the proton resonances. n.d., not detected. 
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Table S3. Δχ tensor parameters fitted to the homology model built of DENpro and refined by 
Rosettaa 
Tagging site and 
metal 
Δχax Δχrh x y z α β γ 
A-Tm3+  17.1  6.7 16.415 -18.172 36.099 140.1 139.5 38.5 
A-Tb3+ -21.1 -8.3 16.415 -18.172 36.099 141.4 139.8 42.7 
B-Tm3+    8.7  2.0   8.634 -21.149  7.976 102.9   54.8 43.0 
B-Tb3+ -10.5 -2.7   8.634 -21.149  7.976 102.5   56.8 41.8 
C-Tm3+  17.7  3.5 13.935    4.362  4.462   49.3 147.9 82.2 
C-Tb3+ -27.4 -6.9 13.935    4.362  4.462   49.3 147.9 82.2 
 
a The tensor parameters are reported with respect to the final Rosetta-refined model, which is 
available from http://rsc.anu.edu.au/~go/coordinates/. The axial and rhombic components of the 
Δχ tensors are given in 10-32 m3 and the Euler angles in degrees, using the zyz convention and 






















Figure S1. Chemical structure of the C2-Ln3+ tag.2 
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Figure S2. 15N-HSQC spectra of DENpro without (left spectrum) and with ligand 1 (right 
spectrum). The spectra were recorded of 150 µM solutions of uniformly 15N-labeled DENpro 
tagged at site B with a diamagnetic C2-Y3+ tag. The comparison shows that many of the well-
resolved peaks can be tracked despite some changes in chemical shifts.   
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Figure S3. 15N-HSQC spectrum recorded of a 150 µM solution of uniformly 15N-labeled 
DENpro tagged at site A with a diamagnetic C2-Y3+ tag and in complex with ligand 1. Solution 
conditions: 20 mM MES, pH 6.5, 50 mM NaCl, 25 oC. The spectrum was recorded using a 3 mm 
NMR tube on a Bruker 800 MHz NMR spectrometer equipped with a TCI cryoprobe. The cross-
peaks used as diamagnetic reference for PCS measurements (Table S1) are marked with their 
sequence-specific residue assignments. 
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Figure S4. PCS measurements of backbone amide protons. The figure shows superimpositions 
of 15N-HSQC spectra recorded of uniformly 15N-labeled DENpro in complex with ligand 1 with 
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C2-Ln3+ tags at different sites of DENpro. Panels A-C show the spectra with tags at sites A, B, 
and C, respectively. Spectra of DENpro with diamagnetic tag (C2-Y3+) are shown in black, and 
the corresponding spectra with paramagnetic tags are plotted in red (C2-Tm3+) and blue (C2-
Tb3+). Selected cross-peaks are linked by lines indicating the pseudocontact shifts. The spectra 
were recorded of 150 µM solutions of DENpro-ligand 1 complexes in NMR buffer (pH 6.5) at 
25 oC, using a Bruker 800 MHz NMR spectrometer. Based on the cross-peaks observed in these 





Figure S5. PCSs of the tert-butyl signal observed in 1D 1H NMR spectra measured of ligand 1 in 
complex with DENpro with different C2-Ln3+ tags loaded with different metal ions as indicated. 
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The panels A-C show the data obtained with C2-Ln3+ tags at sites A, B, and C, respectively. The 
spectra were recorded of ca. 150 µM solutions of uniformly 15N labeled DENpro samples in 
NMR buffer containing 10% D2O at 25 oC. Each panel contains three groups of three spectra, 
where each group shows the result of titration of the tagged protein with increasing amounts of 
ligand 1 from bottom to top in stoichiometric ratios as indicated. The dashed line identifies the 
chemical shift of the tert-butyl signal of the bound ligand in the diamagnetic samples. This 
chemical shift is independent of the site of the diamagnetic tag and the same as in wild-type 
protein. Signals from a non-binding impurity in the ligand stock are labeled with a star. Filled 
rhombuses and triangles mark the chemical shifts of the tert-butyl group in samples tagged with 
C2-Tm3+ and C2-Tb3+, respectively. Note the increase of the tert-butyl resonance of bound 
ligand 1 with increasing ligand concentrations, but also that the tert-butyl resonance is difficult 
to assign in panels A and B due to spectral changes induced in the protein NMR spectrum upon 
ligand binding as well as PREs associated with paramagnetic metal ions.  
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Figure S6. PCS energies and RMSDs of the ligand poses after all-atom Rosetta refinement. (A) 
PCS energy of the protein (in Rosetta energy units) vs RMSD of the ligand to the final pose 
(highlighted in red). 1000 structures were produced by the Rosetta refinement protocol, which 
were all very similar and showed very similar PCS energies. The final ligand pose and protein 
structure was chosen as the protein-ligand complex with the lowest PCS energy of the protein. 
The RMSD was calculated for heavy atoms of the ligand only. All ligand poses were within 2.5 
Å from the best pose. (B) Probability density plot of the ligand RMSDs with respect to the final 
docked pose of the ligand. The vertical bar shows that about 92% of the ligand poses are within 




Figure S7. Correlation between experimental and back-calculated PCSs fitted on the model 
structure. The data from C2-Tm3+ and C2-Tb3+ tags are shown as red and black points, 
respectively. (A)-(C) are the correlation plots drawn for the three different mutants A, B, and C, 
respectively. The Δχ tensor parameters are reported in Table S3. 
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Figure S8. Selected spectral region of NOESY spectra of DENpro in complex with ligand 1, 
showing cross-peaks between the methyl groups of Val and the tert-butyl resonance of the 
ligand. The left-most panel shows the spectrum recorded with ligand 2, which is devoid of a tert-
butyl group. The center and right panels show the spectra of complexes of ligand 1 with 
unlabeled DENpro and DENpro prepared with 13C/15N-labeled valine, respectively. The cross-
peaks are clearly split by 1JCH couplings in the spectrum with isotope-labeled valine. The 
chemical shifts of the cross-peaks in the indirect dimensions identify the cross-peaks as NOEs 
with methyl groups of valine. 
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Figure S9. Assignment of NOEs between methyl groups of protein side chains and the tert-butyl 
group of ligand 1. Right panel: zoom into the spectral region from the NOESY spectrum shown 
in Figure 2B of the main text. Cross-peaks with the tert-butyl resonance of ligand 1 are 
numbered as in Figure 2B. Left panel: same as the right panel, except for the complex of ligand 1 
with the mutant Val155Ile of DENpro rather than wild-type DENpro. Note that the cross-peaks 
of the Val155Ile mutant display no splitting by 1JHC couplings, although the protein had been 
prepared with 13C-labeled valine and the spectrum was recorded without 13C-decoupling. This 
result indicates that the cross-peaks 1–3 in wild-type DENpro are with Val155 rather than 
Val154, and that the corresponding cross-peaks observed in the Val155Ile mutant are with 
isoleucine. The localization space of the tert-butyl group shown in Figure 4 of the main text is 
not near any other methyl group of DENpro. Also note that all NOESY cross-peaks with the tert-
butyl group are slightly shifted because of a small change in its chemical shift, providing an 
independent means of identification beyond their narrow line width in the detection dimension. 
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Figure S10.	 Stereo view comparing the crystal structure of serotype 3 with peptide inhibitor 
(PDB code 3U1I),3 and the Rosetta-refined model structure of DENpro in complex with ligand 1 
determined in the present work. The Rosetta all-atom refinement adjusted the conformation of 
the backbone atoms around the ligand binding site both for NS2B and NS3pro. NS2B and 
NS3pro of the crystal structure are shown in blue and red, respectively, with the peptide ligand 
shown in a stick representation with a cyan backbone. NS2B and NS3pro of the model are shown 
in orange and grey, with ligand 1 in a stick representation with green backbone atoms. Nitrogen 
and oxygen atoms are shown in dark blue and red, respectively. Yellow balls mark the sites A-C 
mutated to cysteine for attachment of C2-Ln3+ tags. The backbone of ligand 1 closely aligns with 
the backbone of the peptide ligand in the crystal structure. The Rosetta all-atom refinement 
resulted in a small shift of the C-terminal two-stranded β-sheet of NS3pro (residues 154-164) 
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